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Abstract
In modern intensive care units (ICUs) a vast and varied amount of physiological data is measured and
collected, with the intent of providing clinicians with detailed information about the physiological state of
each patient. The data include measurements from the bedside monitors of heavily instrumented patients,
imaging studies, laboratory test results, and clinical observations. The clinician’s task of integrating and
interpreting the data, however, is complicated by the sheer volume of information and the challenges of
organizing it appropriately. This task is made even more difficult by ICU patients’ frequently-changing
physiological state.
Although the extensive clinical information collected in ICUs presents a challenge, it also opens up several
opportunities. In particular, we believe that physiologically-based computational models and model-based
estimation methods can be harnessed to better understand and track patient state. These methods would
integrate a patient’s hemodynamic data streams by analyzing and interpreting the available information,
and presenting resultant pathophysiological hypotheses to the clinical staff in an efficient manner. In this
thesis, such a possibility is developed in the context of cardiovascular dynamics.
The central results of this thesis concern averaged models of cardiovascular dynamics and a novel estimation
method for continuously tracking cardiac output and total peripheral resistance. This method exploits both
intra-beat and inter-beat dynamics of arterial blood pressure, and incorporates a parametrized model of
arterial compliance. We validated our method with animal data from laboratory experiments and ICU
patient data. The resulting root-mean-square-normalized errors – at most 15% depending on the data set –
are quite low and clinically acceptable. In addition, we describe a novel estimation scheme for continuously
monitoring left ventricular ejection fraction and left ventricular end-diastolic volume. We validated this
method on an animal data set. Again, the resulting root-mean-square-normalized errors were quite low
– at most 13%. By continuously monitoring cardiac output, total peripheral resistance, left ventricular
ejection fraction, left ventricular end-diastolic volume, and arterial blood pressure, one has the basis for
distinguishing between cardiogenic, hypovolemic, and septic shock.
We hope that the results in this thesis will contribute to the development of a next-generation patient
monitoring system.
Thesis Supervisor: Professor George C. Verghese
Title: Professor of Electrical Engineering
Thesis Supervisor: Dr. Thomas Heldt
Title: Postdoctoral Associate
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Chapter 1
Introduction and Contributions
WITH recent improvements in both computer and medical devices technology, modern critical careunits or intensive care units (ICUs) measure and collect a vast and varied amount of data, with the
intent of providing clinicians with detailed information about the pathophysiological state of each patient.
The data include measurements from the bedside monitors of heavily instrumented patients, imaging
studies, laboratory test results, medication records, fluid balance records, and other clinical observations.
Because the data come from several diverse sources, e.g., digital data from bedside monitors, paper copies
of images and laboratory tests, and data entered at the nurses station, and are thus not well-organized,
an information overload results, as illustrated in Fig. 1.1, making the clinician’s task of integrating and
interpreting the data very time-consuming. Quite often, this may lead to human errors in clinical decision-
making as it is difficult to recognize the non-stationary complex relationships among the diverse data.
Clinicians often miss significant physiological trends and early warning signs for diseases. For instance, a
recent study by Donchin et al. [1] showed that at least one error in patient care occurs per patient day in
the ICU.
While patient monitoring systems have come a long way, state-of-the-art bedside patient monitoring sys-
tems do not integrate the information from individual data streams to provide clinicians with reasonable
hypotheses and/or alarms, nor do they correlate information from different data streams. Current ICU
patient monitor alarms, for example, are highly sensitive, with an approximately 80% false positive rate [2].
The clinician’s task of data integration and interpretation is further complicated by the frequently-changing
physiological state of patients in critical care, and the lack of time for clinician-patient interaction. For
instance, while current patient monitoring systems can be used to track the dynamics of a single variable
(e.g., mean arterial blood pressure) over time, monitoring the trajectories of several frequently-changing
variables or variables derived from them usually requires more time than a clinician can devote to a single
ICU patient. In the current ICU environment, important clinical information can be easily overlooked as
it is very difficult for humans to keep track of and make routine sense of multiple data time series [3].
In the near future, the clinician’s task will only become more difficult. The amount of data collected in
the ICU has been growing rapidly in recent years [4, 5], and thus the information overload is expected
to increase dramatically. In addition, there is a projected shortage in nursing staff expected in the next
10 years [6]. These projections, when combined with a U.S. population that has a growing percentage of
elderly citizens with accompanying growing health care costs, make the need to address the information
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Figure 1.1: The data explosion or information overload in modern intensive care units. Clinicians must
make informed decisions based on the interpretation of the data.
overload problem quite urgent.
Fortunately, the vast amount of clinical information, ranging from nurses’ notes and blood chemistry tests
to arterial blood pressure (ABP) and electrocardiogram (ECG) waveforms, allow for the development of
a next-generation patient monitoring system. Ideally, such a monitoring system would assimilate and
interpret the available data to provide clinicians with a list of differential diagnoses and timely and highly-
specific alarms related to a patient’s pathophysiological state.
1.1 The MIT Bioengineering Research Partnership
The goal of the National Institutes of Health-funded Bioengineering Research Partnership (BRP) project
on Integrating Data, Models, and Reasoning in Critical Care at the Massachusetts Institute of Technology
(MIT) is to develop the patient monitoring system of the 21st century. We envision a modern ICU having
a patient monitoring system that provides clinicians in the ICU with a real-time comprehensive assessment
of patient pathophysiological state. Ideally, this system would facilitate the clinician’s task of reasoning
by issuing patient-specific pathophysiological hypotheses and alarms, thereby allowing for more rapid
diagnoses and treatments , i.e., we anticipate that such a system would identify the complex relationships
among data elements and patterns, and suggest feasible differential diagnoses to make sense of the data.
This project is a large collaborative effort between researchers in three MIT laboratories (Computer Science
and Artificial Intelligence Laboratory, Laboratory for Computational Physiology, Laboratory for Electro-
magnetic and Electronic Systems), a hospital in Boston (Beth-Israel Deaconess Medical Center), and a
manufacturer of ICU patient monitoring systems (Philips Medical Systems, Inc.).
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1.2 The MIMIC II ICU Patient Database
One of the specific aims of the MIT BRP project is to create an annotated database of ICU patients.
The development of this Multi-parameter Intelligent Monitoring for the Intensive Care II (MIMIC II)
database is underway, headed by researchers in the Laboratory for Computational Physiology (LCP) [7],
and assisted by their colleagues in the Computer Science and Artificial Intelligence Laboratory (CSAIL).
The LCP group is focused mainly on database development, while the group in CSAIL is heavily involved
in the de-identification of patient data, i.e., the removal of protected health information (PHI) from the
patient records, a task that must be completed before the database can be made public. Both groups are
also involved in research projects that use the MIMIC II database to develop novel tools for an advanced
patient monitoring system.
The MIMIC II database will serve two purposes. First, a publicly available annotated ICU patient database
does not currently exist. Thus, once made public, this database will serve as a resource for medical
researchers worldwide. Second, the annotated database will be used in the development and evaluation of
a next-generation patient monitoring system.
The MIMIC II database will contain thousands of de-identified patient records from several ICUs [7].
Some of these records will be annotated. To annotate a patient record, a clinician is asked to mark critical
events during the patient’s stay and evaluate the patient’s pathophysiological state, based on all of the
available data. These events are then confirmed by other clinicians. The result of the annotation process
is a gold-standard patient record that can be used to evaluate ICU patient monitoring techniques/systems.
By gold-standard patient record, we mean a patient record in which the available measurements and
interventions have been analyzed and interpreted accurately.
The annotation process is quite time-intensive and it is therefore a daunting task to complete the annota-
tions for even a hundred patient records. For this thesis research, we could not rely on annotated patient
data to verify our estimation methods because relatively few patient records have so far been annotated.
The types of data that are currently collected from the various hospital critical care units include:
• High-resolution waveform data recorded with 8-bit resolution at 125 samples/sec. At the moment, up
to four waveforms can be simultaneously recorded. These recordings could include one or two surface
electrocardiogram (ECG) traces, arterial blood pressure (ABP) waveforms, central venous pressure
(CVP) waveforms, and pulmonary artery pressure (PAP) waveforms. Waveform data tend to be quite
noisy and heavily prone to artifacts caused by patient movement and other sources.
• Less frequently obtained data trends. We may obtain up to 30 averaged physiological measurements
that are usually derived from the waveform data streams and recorded at a rate of 1 sample/min.
Examples include heart rate (HR), mean, systolic, and diastolic arterial blood pressure (MAP, SAP,
– 31 –
Introduction and Contributions
2000 2500 3000 3500 4000 4500 5000 5500 6000 6500 7000
50
100
150
H
R
 (b
pm
)
Data Trends
2000 2500 3000 3500 4000 4500 5000 5500 6000 6500 7000
0
50
100
150
200
A
B
P(
mm
 H
g)
2000 2500 3000 3500 4000 4500 5000 5500 6000 6500 7000
0
10
20
30
40
D
PA
P 
(m
m 
Hg
)
2000 2500 3000 3500 4000 4500 5000 5500 6000 6500 7000
0
100
200
300
400
CV
P 
(m
m 
Hg
)
2000 2500 3000 3500 4000 4500 5000 5500 6000 6500 7000
0
10
20
30
Time (min)F
IL
TE
R
ED
 C
VP
  (m
m 
Hg
)
Figure 1.2: Data trends for a MIMIC II ICU patient. The data streams from top to bottom are HR; SAP,
MAP, and DAP; DPAP; CVP; filtered CVP.
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DAP, respectively), and diastolic pulmonary artery pressure (DPAP)1.
• Other intermittent data, which may be recorded only as often as once a day. Examples include results
from blood chemistry tests, results from imaging studies, provider-order-entry (POE) medications or-
dered, changes in medication infusion rates, changes in fluids administered, urine output, nurses notes,
nurse-verified ABP and HR recordings, and hospital discharge summaries. Some of the intermittent
data is machine-generated, e.g., changes in medication infusion rates, but most is human-entered data,
e.g., nurses’ notes. For the human-entered data, the time stamping is not always accurate as human
data recorders are not always meticulous about entering their observations in a timely manner.
There are two issues to point out related to this database. First, although the current size of the database
stands at approximately 17000 patients, of which approximately 2500 have waveform data, the database is
quite sparse in terms of gold-standard (accurately measured and recorded) trend data, i.e., there is little,
if any, data in the MIMIC II database that could potentially be used to validate some of the estimation
methods we propose below. For example, while evaluating our CO estimation method, we discovered in a
set of 1510 MIMIC II patient records that had waveform data, all have at least one ECG lead recorded,
while only 58% have at least one ECG recording and an ABP recording, and only 8% have one ECG
recording and an ABP recording and one or more cardiac output (CO) recordings. Second, there is a
lack of noise-free waveform data, making it critical that we filter and/or use a signal quality assessment
algorithm to pre-process any data we intend to use with our model-based estimation methods.
Figure 1.2 shows typical ICU data trends (at 1 sample/minute) from the MIMIC II database. This patient
is a 74-year old female admitted to the ICU with critical aortic stenosis and congestive heart failure (CHF).
She stayed in the ICU for seven days and in the hospital for a total of twenty-six days. However, we only
have four days worth of waveform data. During her hospital stay, she underwent surgery to replace her
aortic valve. From top to bottom, the data streams available are HR, SAP, MAP, DAP, DPAP, CVP, and
filtered CVP (i.e.,the trend at the bottom of the figure is the CVP waveform where many of the artifacts
have been removed2).
From Fig. 1.2, we can observe many transients in the data trends. Most of these transients occur at
timescales of minutes to hours. There are also some problems with these data streams. At times, there are
artifacts in the data caused by patient movements or by equipment malfunctions. For example, large parts
of the CVP waveform are at values greater than 200 mm Hg – values that are physiologically impossible. In
addition, there may be data streams that are not recorded at certain times because the measurement sensors
are disconnected. For example, the catheter that measures ABP is quite often disconnected, perhaps to
remove blood clots (catheter “flushing”).
Figure 1.3 is a shorter timescale view of the same patient’s ABP waveform data, at a sampling rate of 125
1For blood pressure waveforms, the minimum value over one cardiac cycle is referred to as the diastolic blood pressure,
whereas the maximum is termed the systolic blood pressure.
2Central venous pressure is usually less than 30 mm Hg, so all CVP values above this threshold were removed.
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Figure 1.3: A shorter window of ABP waveform data for a MIMIC II patient. A variety of transients in
mean ABP (white dashed line) can be observed, even in this short period of time.
Hz, where we can see a variety of transients in the mean blood pressure. Transients such as these could
have signified important events during the patient’s ICU stay. Ideally, we envision our models and model-
based estimation methods as being capable of tracking these transients in terms of clinically important
variables. In particular, later we show how averaged models of cardiovascular dynamics can be used to
track transients in MAP as opposed to the ABP waveform itself.
Of the hemodynamic variables measured in modern ICUs, the most important for the purposes of cardio-
vascular system modeling and monitoring [3, 8] are:
• The surface electrocardiogram, which is a very important diagnostic tool for determining heart function,
and a measure of the electrical activity in the heart. It is a noninvasive measurement – three or more leads
are attached to the patient’s skin. Patient heart rate, measured in beats per minute, is derived from ECG
waveforms. The ECG can be used to detect cardiac arrhythmias, as well as heart diseases/conditions
such as myocardial infarctions, ischemia, and ventricular hypertrophy.
• Arterial blood pressure, which is used as a diagnostic tool for cardiovascular function. ABP is tightly
controlled by cardiovascular control mechanisms, making it an important indicator of cardiovascular
system function. ABP is usually measured invasively by inserting a pressure-measuring catheter into
one of the body’s main arteries, e.g., the radial or femoral artery. Intermittent noninvasive blood pressure
measurements are also frequently recorded using an oscillometric system. The systolic, diastolic, and
mean ABP are all derived from these pressure measurements.
• Pulmonary artery pressure, from which a measure of left-heart preload (or filling pressure at the left
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atrium) can be determined3, and an indicator of left ventricular function. PAP is measured invasively
using a Swan-Ganz catheter inserted into the pulmonary artery [9].
• Central venous pressure, which is a measure of preload (or filling pressure at the right atrium) of
the right ventricle, and is important in diagnosing cardiac function. It is measured invasively using
a catheter inserted into one of the large veins near the heart, e.g., the jugular vein. It may also be
measured using a Swan-Ganz catheter.
• Cardiac output, which is the blood volume pumped by the heart per minute. It is measured only
infrequently in the ICU, usually using an indicator-dilution technique known as thermodilution, or with
an echocardiography imaging study [3].
In the ICU setting, the most readily available signals are the ECG and ABP. PAP measurements, and to
a lesser extent, CVP measurements, are generally much less readily available in the ICU. For the purposes
of the model development for this research, we have focused primarily on ECG and ABP, and the trends
derived from these signals.
In addition to these variables, it would be prudent to monitor vasoactive medications, i.e., medications that
alter total peripheral resistance (TPR), also referred to as systemic vascular resistance (SVR). Knowing the
amounts of these medications that were administered is critical for the validation of model-based estimation
methods for CO and TPR. For example, norepinephrine causes smooth muscle contraction (by stimulating
α receptors in the muscle), and thus increases TPR, while isoproterenol and nitroglycerine cause smooth
muscle relaxation (by stimulating β2 receptors in the muscle), and thus lower TPR. Isoproterenol also acts
to increase ventricular contractility (by stimulating β1 receptors in the heart).
1.3 Model-based Intelligent Monitoring for the ICU
The research described in this thesis was pursued as part of the ongoing work in the BRP model-based
intelligent monitoring for the ICU (MIMICU) group in the Laboratory for Electromagnetic and Electronic
Systems (LEES). The overarching goal of the MIMICU group is to investigate the use of models of cardio-
vascular dynamics, model-based estimation methods, and knowledge-based clinical reasoning systems to
identify and track a patient’s cardiovascular state4. Previous work on intelligent patient monitoring, such
as the SIMON project [11, 12], has focused on artificial intelligence (AI) methods, with no emphasis on
lumped-parameter electrical circuit models of cardiovascular dynamics.
The specific questions the MIMICU group is addressing are:
3Diastolic PAP is a surrogate for Pulmonary Capillary Wedge Pressure (PCWP), which is a measure of left atrial transmural
pressure.
4Another goal of the MIMICU group is to investigate better means of displaying data (see [10] for example) in the ICU,
but this work will not be described here.
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Figure 1.4: A schematic showing the MIMICU group’s approach. The tasks range from cardiovascular
modeling to robust model identification and alarm/hypothesis generation.
• Given some set of ICU patient data, how effectively can one use models of cardiovascular dynamics to
infer the patient’s pathophysiological state?
• Furthermore, how can this information be integrated to generate pathophysiological hypotheses and/or
alarms?
We envision the BRP MIMICU group task to be that shown schematically in Fig. 1.4.
Because of the different types of data present in the ICU – both in terms of data format, e.g., textual
or numerical, and in terms of timescale, e.g., continuously monitored ECG waveforms versus once-a-day
laboratory tests – data analysis would potentially require several different types of models. In addition,
the wide variety of pathologies seen in the ICU implies that the cardiovascular models we develop have
to be capable of robustly tracking hemodynamic parameters for varying patient conditions. Finally, the
model-based estimation must be carried out in real-time in the presence of artifacts and noise in the data.
In Fig. 1.4, we see that ICU patient data is fed into a model identification block that will estimate
parameters and states of the cardiovascular dynamics models. The estimated parameters and states, and
other model outputs are then used to give an estimate of the patient’s current hemodynamic state and
to predict the patient’s hemodynamic trajectory. When combined with a clinical reasoning system, the
outputs of the model identification block can be used to generate alarms and pathophysiological hypotheses
that could be used by clinicians to make an informed assessment of patient cardiovascular function.
Due to the varying timescales on which measurements and observations are recorded in the ICU, the models
themselves need to span the gamut of resolutions in time – from intra-beat (or, equivalently, intra-cycle)
timescales typical of waveforms in the ICU, to inter-beat (or, equivalently, inter-cycle) timescales of the
trends of these waveforms, through infrequently acquired measurements, such as radiology reports. To
capture patient dynamics on these timescales, we envision a hierarchy of models with the basic structure
as shown in Fig. 1.5 – a so-called multi-scale model hierarchy – where each level in the hierarchy operates
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Figure 1.5: An example of a model hierarchy where the models share their parameters, states, and outputs.
on a different timescale . For instance, one cardiovascular model is used for waveform data analysis and
another for trend data analysis.
In addition, for more robust model state and parameter identification, we envision that identified parame-
ters, states, and model outputs are passed from one level of the hierarchy to another. Thus, outputs from
one model can then be used to estimate parameters in another model. Clinical reasoning systems can also
be used to determine which model is used to analyze a particular set of data, although we envision their
primary use to be in the “model integration” block in this hierarchy.
Our group has begun work on all these fronts, some of which has already been published [8, 10, 13, 14, 15,
16], and some of which will be reported in documents to be published shortly [17, 18]. In particular, we are
pursuing projects in which we are using models of cardiovascular dynamics at three different timescales:
• Intra-beat timescales: we are investigating parameter identification schemes using pulsatile models of
cardiovascular dynamics;
• Inter-beat timescales: we are investigating model-based estimation methods using averaged models –
both discrete-time beat-to-beat averaged and continuous-time cycle-averaged;
• Steady-state or coarse timescales: we are trying to estimate/predict/infer unobservable states and pa-
rameters on coarse timescales using probabilistic models. In particular, we are exploring both Bayesian
Belief Networks (BBNs) and Hidden Markov Models (HMMs).
This detailed model hierarchy is illustrated in Fig. 1.6, where we show the approach we have taken for
model-based ICU patient monitoring.
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1.4 Specific Aims
For the purposes of this research, we restrict ourselves to the task of tracking patient cardiovascular dynam-
ics, which is particularly useful in the ICU setting [3]. As mentioned above, we believe that computational
models of cardiovascular dynamics can be incorporated into a next-generation monitoring system, and we
are pursuing research avenues in this direction.
In particular, we hope that a next-generation monitoring system that incorporates cardiovascular dynamics
models will also reduce the use of invasive procedures in the ICU. For example, if one could continuously es-
timate cardiac output (CO) from a less invasively obtained measurement, i.e., without inserting a catheter
into the pulmonary artery, this would eliminate the need for expensive and invasive intermittent thermod-
ilution measurements.
The specific aims of this thesis research are:
1. To develop models of cardiovascular dynamics for tracking patient hemodynamics and cardiovascular
function in the ICU.
2. To explore parameter and state estimation methods for these models in order to track important clinical
variables in the ICU.
3. To validate our model-based estimation methods with numerical simulations, data from laboratory
animal experiments, and human ICU data.
The focus of this research, therefore, is the development of models and model-based estimation methods
for better understanding and tracking of patient cardiovascular dynamics in the ICU. While we intend our
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Figure 1.7: Block diagram showing how one could use measurements of CO, EF, LVEDV and HR to
distinguish between septic, cardiogenic, and hypovolemic shock.
models and estimation methods to be used as aids in the clinical decision-making process in the ICU, the
validation of our work in the clinical setting is beyond the scope of the research.
Of particular relevance is the problem of distinguishing between three types of shock, i.e., severe hypoten-
sion (or dangerously low MAP): septic shock (due to infections in the systemic vasculature), cardiogenic
shock (relating to heart (pump) failure associated with myocardial infarction, cardiomyopathy, cardiac
tamponade, etc.), and hypovolemic shock (relating to low blood volume, e.g., as a consequence of hem-
orrhage). Figure 1.7 is a block diagram showing how one can distinguish between septic, cardiogenic
and hypovolemic shock using trends of HR, CO, TPR, left ventricular ejection fraction (EF)5, and left
ventricular end-diastolic volume (LVEDV).
CO and LVEDV (or left-ventricular end-diastolic pressure, LVEDP) by themselves are two of the most
important quantities for monitoring critically ill patients [19]. For instance, low CO and high LVEDV
would indicate left ventricular failure, while low CO and low LVEDV would be indicative of hypovolemia.
Ejection fraction allows for the additional distinction between sepsis, cardiac failure and hypovolemia, since
sepsis and hypovolemia are usually not associated with low EF.
Of the patient data collected so far, we have observed that many MIMIC II ICU patients suffer from at
least one (if not many) acute hypotensive episodes during their ICU stay. In the ICU, clinical interventions
for each of these types of hypotension are different. In the case of hypovolemic shock, for example, one
would try to increase the patient’s blood volume, perhaps with a saline infusion. With cardiogenic shock,
on the other hand, one would try to reduce the load, i.e., either the inlet (preload) or outlet (afterload)
pressures acting on the patient’s heart, perhaps by administering drugs that would reduce the patient’s
vascular resistance or increase cardiac contractility. For patients with sepsis, intravenous saline infusions
and/or medications that increase MAP by increasing TPR are given.
5Left ventricular ejection fraction is the ratio of blood volume ejected by the left ventricle in a single cardiac cycle to the
ventricular blood volume at the instant prior to ejection – the left ventricular end-diastolic volume.
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The therapeutic interventions given to patients for low MAP can often be incorrect if the relevant clinical
information is not available. For instance, for patients with CHF, one would attempt diuresis (say, by
giving a drug such as furosemide (‘Lasix’) to reduce the preload on the heart and remove any water that
may have accumulated in the lungs (a condition known as pulmonary edema). On the other hand, for
patients with hypovolemia, one would give the patient a bolus of fluid, e.g., saline infusion, in an attempt
to increase distending blood volume, and in turn, MAP. If one were to give a patient with CHF a fluid
bolus, this would worsen the preload on the heart and probably worsen the patient’s pulmonary edema
symptoms [20].
Currently, it is quite difficult to determine the root cause of a patient’s shock, mainly for two reasons.
First, CO, EF, and LVEDV are not frequently measured in the ICU. Of these, CO can be measured with
relative ease once a pulmonary artery catheter is in place, but this is an invasive procedure that is reserved
for the sickest of patients [3]. Second, for many ICU patients, there is always the possibility that the shock
is a result of multiple organs failing, i.e., they may be suffering from heart failure and a systemic infection.
Our hope is that with estimates of CO, TPR, EF, and LVEDV, we will be able to distinguish between
these three types of shock. Furthermore, by providing robust and continuous estimates of these variables,
clinicians can track a patient’s response to therapeutic interventions. Therefore, the central parts of this
thesis are devoted to estimating these three critically important clinical variables.
1.5 Thesis Contributions
We see the contributions of this thesis as being threefold:
• We have developed and applied novel averaging methodology to existing lumped-parameter continuous-
time (pulsatile) electrical circuit models of cardiovascular dynamics. The resulting averaged models –
discrete-time beat-to-beat averaged and continuous-time cycle-averaged models – are capable of tracking
cardiovascular dynamics on timescales larger than a single cardiac beat (inter-beat rather than intra-beat
timescales), are computationally efficient, and allow for model-based estimation methods that would be
difficult to develop with existing models of intra-beat cardiovascular dynamics.
• We have developed and used a discrete-time beat-to-beat averaged model-based estimation method to
estimate cardiac output and total peripheral resistance from central or peripheral arterial blood pressure
waveforms. We have validated this estimation method on two animal data sets: a porcine data set
comprising six swine with 82,734 ultrasound flow-probe based CO measurements, and a canine data set
comprising three dogs with 10,743 reference ultrasound flow-probe and/or echocardiography-based CO
measurements, and on two human ICU data sets: one with 12 patients and 124 reference thermodilution-
based CO measurements, and another with 120 patients and 1378 reference thermodilution-based CO
measurements. The errors obtained on application of our CO estimation method are well within the
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margin of clinically-acceptable error.
• We also used the steady-state ventricular pressure-volume relationship to develop a novel method for
estimating left ventricular ejection fraction and left ventricular end-diastolic volume from a central or
peripheral arterial blood pressure waveform. We applied these estimation methods to a canine data
set with three dogs and 64 reference echocardiography-based EF and LVEDV measurements. The
errors obtained on application of our EF and LVEDV estimation methods are close to the margin of
clinically-acceptable error.
Thus, the central results of this thesis concern averaged models and novel, simple, minimally-invasive,
model-based estimation methods for tracking CO, TPR, left ventricular EF, and LVEDV. By tracking
these variables over time, one can distinguish between cardiogenic, hypovolemic, and septic shock.
1.6 Intended Audience
This thesis is intended for engineers with a strong interest in systems level physiology and cardiovascular
pathophysiology in particular. Wherever possible, we have included tutorials on the main physiological
concepts – mainly from cardiovascular physiology – that were used to obtain the central results in this
thesis. A beginner would do well to start by browsing some of the chapters in Costanzo’s physiology text
[21] or the Berne et al. Physiology text [22], before moving on to a more detailed exposition, by Berne and
Levy [23], for example.
This thesis could also be read by practicing clinicians or clinical researchers with a strong interest in
physiological modeling and model-based parameter estimation. The engineering concepts – primarily
electrical circuit analysis tools, least squares estimation, and systems of differential equations – described
herein can be mastered with some effort, and appropriate references are provided throughout the document.
1.7 Document Outline
This document is made up of four parts, with a total of nine chapters and several appendices. The document
outline is as follows:
• Part I: Introduction and Background
In this part, we give an introduction to and the background for the thesis research described later in
the document. The focus in this part is on the specific aims of the thesis, the thesis contributions, and
the necessary background in cardiovascular physiology.
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– In Chapter 1, we placed the thesis research in context, and provided a description of the thesis
aims and contributions. We gave an overview of the MIT Bioengineering Research Partnership
and the modeling group within that partnership. We also included details on the MIMIC II ICU
patient database, explaining which signals are routinely collected and what types of gold-standard
data are available to researchers who would use the database. We end this chapter with the specific
aims and contributions of this thesis research, and an outline of the thesis document.
– Chapter 2 gives a brief overview of cardiovascular physiology. We begin with a historical overview
of studies of human circulation and experimental work on cardiovascular physiology. We then give a
detailed description of the circulatory system and the heart, including ventricular pressure-volume
loops, arterial blood pressure and mechanisms for its control, and cardiac output and its control.
Readers familiar with this material should skip this chapter and move to Chapter 3.
• Part II: Lumped-Parameter Electrical Circuit Models of Cardiovascular Dynamics
We present lumped-parameter continuous-time electrical circuit models of cardiovascular dynamics in
this part, where we describe pulsatile and averaged – both discrete-time beat-to-beat averaged and
continuous-time cycle-averaged – models, many of which we developed.
– In Chapter 3 we describe pulsatile models of cardiovascular dynamics. These models are used to
simulate cardiovascular dynamics on an intrabeat timescale. The well-known Windkessel model is
introduced in this chapter, and we show how electrical circuit analogs for the cardiovascular system
can be used to create models such as the modified Windkessel model, the cardiovascular simulator
(CVSIM) model, and its derivatives – the simple cardiovascular simulator (CVSIMple) model and
the simple pulsatile cardiovascular model (SPCVM).
– We show how we can average pulsatile models of cardiovascular dynamics to obtain averaged models
of cardiovascular dynamics in Chapter 4. We illustrate these averaging techniques on the linear,
time-invariant Windkessel model, and also show how one could cycle-average a time-varying model
such as the SPCVM.
• Part III: Estimation and Monitoring of Cardiovascular Dynamics
In this part, we describe our model-based estimation methods for cardiac output, total peripheral
resistance, left-ventricular ejection fraction, and left-ventricular end-diastolic volume. This part contains
the main, clinically important research results.
– Chapter 5 presents the main results of this thesis. We show how the beat-to-beat averaged
Windkessel model from Chapter 4 can be used to estimate cardiac output and total peripheral
resistance, using both intra-beat and inter-beat variations in arterial blood pressure. We show that
this estimation is possible using either a central or a peripheral arterial blood pressure waveform. A
key feature of our method is its use of an arterial compliance model that is a parametrized function
of MAP. In this chapter, we describe the validation of our estimation method on two animal data
sets and two human ICU patient data sets.
– Chapter 6 presents a novel method for estimating left ventricular ejection fraction based on the
steady-state left ventricular pressure-volume relationship. This method requires either a central or
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a peripheral arterial blood pressure waveform, and at least one reference EF measurement. As an
extension of our EF estimation method, we also estimated left ventricular end-diastolic volume.
This extension is also described in this chapter. We end the chapter with results on the performance
of these methods on a canine data set.
• Part IV: Conclusions, Future Work, and Appendices
We conclude the thesis with a chapter describing the thesis research and potential avenues for further
research, and several supporting appendices.
– Chapter 7 concludes this document with a recapitulation of the thesis goals and contributions,
and a brief description of potential directions for further research.
– In the Appendices, we give a description of the notation used in this thesis (Appendix A), and
have placed ancillary material, such as derivations (Appendices B, C, D), and programming scripts
(Appendices E and F).
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Chapter 2
Overview of Cardiovascular Physiology
WE have learned much about cardiovascular physiology in the 400 years since the English physicianWilliam Harvey published his treatise on the human circulation – Exercitatio Anatomica de Motu
Cordis et Sanguinis in Animalibus (An Anatomical Exercise Concerning the Motion of the Heart and
Blood in Animals), and our knowledge of the cardiovascular system is still growing1.
William Harvey made his observations using vivisections of humans and other animals, and was thus a
pioneer in experimental systems-level physiology. In De Motu Cordis, Harvey proposed that the circulation
was comprised of two closed circuits – a pulmonary circulation from the heart to the lungs, and a main
circulation from the heart to the other organs. In proposing these circuits, he also showed, with a simple
calculation involving a crude estimate of cardiac output, that blood is constantly recycled through the
system. At the time, the common belief was that blood was constantly produced by the liver.
The pioneering work of William Harvey and others, such as the Italian histologist Marcello Malphigi, lay
the foundation for the physiological experiments performed by Stephen Hales in the 18th century. Stephen
Hales studied both animal and plant physiology, and published the two-volume collection Statical Essays in
1733 detailing his work, with Vegetable Staticks, the first volume, on plant physiology, and Haemastaticks,
the second volume, on animal physiology. Hales is also credited with the first blood pressure measurement
taken – in 1718 – by inserting a brass tube into a horse’s carotid artery and measuring the height of the
resulting pressure column [24].
Our knowledge of cardiovascular (CV) physiology has steadily grown since the pioneering work by Harvey,
Malphigi, and Hales. It has literally exploded in the latter part of the last century when cardiovascular
diseases became the leading cause of death in the United States – accounting for approximately 1 million
deaths/year2 – and in many other industrialized countries. A significant portion of national resources are
therefore consumed by the cost of patient care and basic research of CV physiology, and its aberrations
under pathological conditions.
In this chapter, we give a brief overview of the fundamentals of CV systems physiology, including an
overview of the human circulation, the cardiac cycle, and a description of the control mechanisms that
1Much of this historical perspective is based on Harvey, William. Encyclopedia Britannica Online
at http://search.eb.com/eb/article-9106277, and Hales, Stephen. Encyclopedia Britannica Online at
http://search.eb.com/eb/article-9038874, site accessed on April 22, 2007.
2American Heart Association. 2002 Heart and Stroke Statistical Update. 2002.
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tend to maintain cardiac output and mean arterial blood pressure constant. For those interested in getting
into more detail than provided here, a good start would be either Costanzo’s Physiology [21] or the Berne
et al. physiology text [22], before moving on to the more detailed cardiovascular physiology text by Berne
and Levy [23]. Readers familiar with this material should move on to Chapter 3.
2.1 Introduction to the Cardiovascular System
The human cardiovascular system (CVS) performs several key functions, the most important being to carry
oxygenated blood and other nutrients to the body’s organs, particularly the brain and central nervous
system, and to remove carbon dioxide and other waste products from them.
The CVS is comprised of the heart, which is responsible for pumping blood, and the various blood vessels,
which serve as the distribution system – the “plumbing” – for blood to go from the heart to the main
organs in the body, as illustrated in the schematic in Fig. 2.1. As we see in Fig. 2.1, the heart is comprised
of two distinct pumps: the left heart and the right heart. Each of these pumps can be further divided
into two chambers: an atrium and a ventricle. There are unidirectional valves (the tricuspid and mitral
valves) between the atria and ventricles in both the left and right heart, and between the right ventricle
and the pulmonary artery (pulmonic valve), and the left ventricle and the aorta (aortic valve). The right
heart pumps deoxygenated blood from the systemic circulation to the lungs, while the left heart pumps
oxygenated blood from the lungs to the various parts of the systemic circulation.
As William Harvey observed in his experimental work, the circulation can be divided into two parts:
the pulmonary circulation referring to blood flow through the lungs where gas exchange occurs, and the
systemic circulation referring to blood flow through rest of the body. These two parts are connected in
series i.e., the flow through each part is equal. The various vascular beds in the circulation are connected to
the heart in parallel i.e., approximately the same arterial blood pressure drives flow through each vascular
bed.
There are three main types of blood vessels: arteries, capillaries, and veins. The arteries are thick-walled
vessels that carry blood away from the heart, usually at high pressures. The largest of the arteries, the
aorta, branches out successively into smaller arteries which carry blood to the various organs in the body
(see Fig. 2.1). Within these organs the arterioles feed the capillaries across whose walls the exchange of
oxygen/carbon dioxide and nutrients takes place. The veins are thin-walled vessels that carry blood from
the capillary networks to the heart at low pressures. Many of the body’s veins have unidirectional valves
that only allow blood to flow back to the heart. Approximately two-thirds of the blood in the body resides
in the veins [22].
Blood vessels offer resistance to the flow of blood from the heart, with most of this resistance concentrated
at the level of the smaller arterioles (shown in Fig. 2.1), which are often modeled as resistance elements. As
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Figure 2.1: A schematic representation of the human cardiovascular system showing the heart and the
blood vessels, including major vascular beds. The venous system, comprised of veins that may have
unidirectional valves, appear on the left of the figure, while the arterial tree, with no valves, appears on
the right. The majority of the resistance to blood flow is concentrated in the arterioles (dark ovals before
the capillaries). This figure appears as Fig 1.4 in [23] and was reproduced with permission from Elsevier
Health Sciences Division.
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Figure 2.2: Schematic of the electrical conduction system of the heart. Normally, impulses originate from
the SA node, and spread through the atria and AV node to the ventricles. This figure appears as Fig 2.28
in [23] and was reproduced with permission from Elsevier Health Sciences Division.
the body’s blood vessels, especially the larger arteries, have elastic tissue, they have an inherent capacitive
property i.e., the ability to store blood. This is commonly referred to as compliance (the change in volume
per unit of change in pressure). (Note that compliance is the inverse of elastance, which is an indicator of
the blood vessel elasticity.) The resistance to blood flow of the arterioles is much higher than the resistance
of the main arteries or veins. The compliance of the veins is generally much higher than that of the arteries
[25]. In Chapter 3, we show how electrical circuit analogs of the cardiovascular system can be constructed
by appropriately combining resistance and capacitance (or compliance) elements. In the circuit models
we present later, the large arteries and veins are modeled as compliance elements, while the arterioles are
modeled as resistance elements. In some of the circuits, inductance elements are used to model the blood’s
inertia as it propagates through the arterial tree.
2.2 Electrical Activity of the Heart
The pumping action of the heart is a culmination of an electromechanical coupling that begins with
electrical pulses that are initiated by the sinoatrial (SA) node. These pulses spread through the atria and
the atrioventricular (AV) node and eventually reach the ventricular walls (via the bundle of His and the
Purkinje fibers), as shown in Fig. 2.2. At the level of the individual myocyte, the electrical pulses initiate
a sequence of events that ultimately lead to the shortening of the contractile cellular elements. It is the
coordinated contraction of all myocardial cells that gives rise to the heart’s macroscopic pumping action.
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The surface electrocardiogram (ECG) (see bottom of Fig. 2.3) is based on the detection of the cardiac
electrical activity – de- and re-polarization of the atria and ventricles, leading to contraction and relax-
ation, respectively – at the body’s surface, making it an essential tool in diagnosing cardiac abnormalities,
including cardiac arrhythmias, some of which are exacerbated by underlying cardiovascular disease. For
example, the ECG can be used to diagnose acute cardiovascular conditions such as an acute myocardial
infarction (MI) quite often results in an elevated ST-segment in the ECG. Other salient features of the
ECG are also used to detect heart rhythm abnormalities. For instance, a normal QRS complex, as seen in
Fig. 2.3, is indicative of normal ventricular depolarization. Thus, abnormalities in the QRS complex can
be indicative of abnormalities in the electrical conduction system in the heart or in the ventricle itself. For
more on the ECG and heart arrhythmias, see [21] or [23].
2.3 The Cardiac Cycle
The cardiac cycle refers to the sequence of events ensuing from the cyclical quasi-periodic pumping action
of the heart. Two descriptions, both from the perspective of the left ventricle, have gained particular
popularity: the description of the temporal evolution of pressures, flows, and volumes as encompassed in
the Wiggers diagram, and the description in terms of the pressure-volume loops of the left ventricle. We
turn to the latter in Section 2.4.
The cardiac cycle can be divided into two distinct phases: diastole and systole. During diastole, the
ventricles relax (isovolumic relaxation) and fill with blood (filling), while during systole, the ventricles
contract (isovolumic contraction) and eject blood into the circulation (ejection). Diastole is typically two
thirds of each cardiac cycle [23]. When the ventricles start to contract, the tricuspid and mitral valves
close. While the pulmonic and aortic valves are still closed, the ventricles go through a brief period of
isovolumic (or isovolumetric) contraction. The opening and closing of the aortic valve correlates with the
first and second heart sounds in the thoracic cavity.
The cardiac cycle for the left ventricle is shown in Fig. 2.3, where the regions labeled isovolumic contraction,
rapid ejection, and reduced ejection correspond to systole, and the regions labeled isovolumic relaxation,
rapid ventricular filling, diastasis, and atrial systole correspond to diastole. From Fig. 2.3, we can also
easily pick out the the systolic and diastolic ABP (SAP and DAP). SAP roughly corresponds to the
peak-systolic3 left ventricular pressure.
3By peak we mean the local maximum of the ventricular pressure waveform.
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Figure 2.3: Wiggers diagram depicting the cardiac cycle in the left ventricle showing the various stages
of diastole and systole. This figure appears as Fig 3.11 in [23] and was reproduced with permission from
Elsevier Health Sciences Division.
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2.4 Ventricular Pressure-Volume Relationships
In this section, we focus on the ventricle in the heart, and on the ventricular pressure-volume relationship
in particular.
2.4.1 Ventricular Volumes, Stroke Volume, and Ejection Fraction
The electrical activity in the heart is translated to mechanical activity by myocardial cells in the heart.
These cells have a pressure-dependent initial length as explained below, with larger forces, and thus larger
pressures for cardiac contraction occurring when the initial length of the myocardial fibers is large. Fig-
ure 2.4 shows how changes in ventricular contraction during the cardiac cycle relate to changes in ventricular
volume.
The ventricular end-diastolic volume (EDV) is the amount of blood in the ventricle at the end of filling.
Ventricular end-systolic volume (ESV) is the amount of blood in the ventricle at the end of ejection.
Similarly, ventricular end-diastolic pressure (EDP) is the transmural pressure across the ventricular walls
at the end of filling, and ventricular end-systolic pressure (ESP) is the transmural pressure across the
ventricular walls at the end of ejection. When describing these pressures or volumes, we quite often specify
whether we are referring to left ventricular (LV) or right ventricular (RV) quantities. LVEDV refers to left
ventricular end-diastolic volume, for example.
Stroke volume (SV) is defined as the difference between EDV and ESV, i.e., the amount of blood ejected
by the right or left ventricle during a single cardiac cycle:
SV = EDV− ESV (2.1)
These three volumes – EDV, ESV, and SV – are labeled in Fig. 2.4.
Left ventricular ejection fraction (EF) is the ratio of SV to EDV, i.e., the fraction of blood ejected from
the heart during systole:
EF =
SV
EDV
(2.2)
Ejection fraction is expressed as a percentage, with typical values for normal, healthy individuals ranging
from 40–60%. Left ventricular ejection fraction is a strong indicator of heart function, perhaps the most
significant index that is currently in clinical use [27]. Low ejection fraction is usually indicative of heart
failure. Monitoring EF, even for outpatients, can be quite useful. For instance, Curtis and co-workers (see
[28]) describe a powerful relationship between EF and mortality in heart failure outpatients – the lower
the EF, the worse the patient outcome.
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Figure 2.4: The human cardiac cycle (adapted from Fig. 2.3 in [26]) showing how changes in ventricular
contractile state relate to ventricular volume. This figure appears as Fig 2.3 in [26] and was reproduced
with permission from the Lippincott, Williams, and Wilkins Company.
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Figure 2.5: Typical ventricular systolic and diastolic elastance curves. This figure appears as Fig 3.4 in
[23] and was reproduced with permission from Elsevier Health Sciences Division.
2.4.2 Ventricular Compliance
Figure 2.5 shows typical ventricular systolic and diastolic elastance curves, but in terms of developed
force (or, equivalently, ventricular pressure) and initial fiber length in the myocardium (or, equivalently,
ventricular EDV). The diastolic curve is quite flat, i.e., the incremental diastolic compliance is large, such
that small increases in pressure lead to large increases in volume. On the other hand, the systolic curve has
a large positive slope, i.e., the incremental systolic compliance is small. The positive slope on the systolic
curve is quite often called the Frank-Starling curve or relationship. For normally functioning hearts, we
can assume the incremental compliance to be constant during diastole and systole. However, for many
disease conditions, this may not be true at the extreme of very large end-diastolic volumes.
2.4.3 Pressure-Volume Loops/Diagrams
Ventricular pressure-volume diagrams are frequently used to explain the pumping action of the heart and
to study the effects of preload (pressure at the inlet of a particular atrium or EDP), afterload (pressure at
the outlet of a particular ventricle or ESP), and ventricular compliance or capacitance (change in volume
per unit of change in transmural pressure across wall of the ventricle) on the heart’s ability to pump blood
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(a) Typical human left ventricular pressure-volume loop.
Stroke volume is defined as the width of the loop, while stroke
work is the area of the loop. This figure appears as Fig. 2.5 in
[26] and was reproduced with permission from the Lippincott,
Williams, and Wilkins Company.
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Figure 2.6: Human left ventricular pressure-volume loops showing how pressure and volume in the ventricle
change during the cardiac cycle.
[23]. The diastolic and systolic compliances of the ventricle define several points on the pressure-volume
diagram [29]. A typical pressure-volume diagram for the left ventricle during the cardiac cycle is shown in
the left panel of Fig. 2.6. An annotated schematic of the same pressure-volume loop is shown in the right
panel of Fig. 2.6 with lines defining the end-diastolic and end-systolic compliances, as well as the EDP and
ESP. In this panel, the slopes of the two lines define the fixed compliances Cd (end-diastolic compliance)
and Ces (end-systolic compliance), and their intersection with the volume axis defines the ventricular dead
volume, or Qd. (Note that we assume in this thesis that the ventricular systolic and diastolic dead volumes
are equal to Qd.) Qd is the blood volume in the ventricle when there is no transmural pressure applied to
it. Note that the pressures in pressure-volume diagrams are transmural pressures and since the ventricles
are inside the thorax, any pressures measured in that cavity are referenced to the intrathoracic pressure,
Vth.
2.5 Stroke Volume and Ejection Fraction
Stroke volume in the right panel of Fig. 2.6 is defined by
SV = Cd(LVEDP− Vth)− Ces(LVESP− Vth) . (2.3)
Although the incremental compliances Cs and Cd are fixed, this assumes a linear volume-pressure relation-
ship in the ventricles in Fig. 2.6, an assumption that is valid only when the heart is pumping normally,
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that is, when preload and afterload in steady-state are within a certain range of the typical LV elastance
curve shown in Fig. 2.5 [23]. For other conditions, e.g., at higher preload, end-systolic compliance becomes
very large, and SV can be severely impaired.
Assuming the same fixed incremental end-diastolic and end-systolic compliances as above, ejection fraction
can be defined as
EF =
SV
EDV
=
Cd(LVEDP− Vth)− Ces(LVESP− Vth)
Cd(LVEDP− Vth) +Qd . (2.4)
Note the prominence of both Qd and Vth in Equation (2.4), something we discuss when we use a variant
of (2.4) in Chapter 6 to estimate EF.
EF can be estimated in two ways in the ICU. The first, an imaging technique, involves obtaining a 2-
or 3-dimensional image of the ventricle during the cardiac cycle, and estimating EDV and ESV from
the images. The second is based on the thermodilution technique (described in Section 2.6), in which a
thermistor-bearing Swan-Ganz catheter is inserted into the pulmonary artery. A cold solution of dextrose
or saline is then injected into the right atrium and the resultant temperature-time waveform recorded in
the pulmonary artery is used to estimate ejection fraction. In particular, the difference between the two
temperature peaks in the waveform is proportional to ejection fraction [3].
2.6 Cardiac Output and Venous Return
Cardiac output (CO), the amount of blood pumped by the heart per minute, is given by
CO = HR · SV (2.5)
where HR is heart rate.
In the ICU, CO is estimated using the thermodilution technique, in which a balloon-tipped catheter with
a temperature-sensing thermistor (a Swan-Ganz catheter) is placed in the pulmonary artery via the right
atrium. A cold solution of dextrose or saline is then injected into the right atrium. CO is inversely
proportional to the area under the resultant pulmonary artery temperature-time curve waveform recorded
by the thermistor [3].
In the clinical setting, CO can be used with MAP to obtain total peripheral resistance (TPR) defined as
TPR =
MAP
CO
(2.6)
This relationship links CO to MAP through TPR, a fact that is exploited when using certain drugs in the
ICU, e.g., vasodilators which decrease TPR. We shall see later that this relationship can be derived from
the Windkessel model under steady-state assumptions.
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Figure 2.7: Cardiac output curves showing the effect of right heart failure on the Frank-Starling relation-
ship.
Under normal operating conditions of the heart, i.e., with both the right and left ventricles functioning
well, stroke volume (and hence cardiac output) is a strong function of right ventricular filling pressure or
RVEDP. All other things being equal, increases in RVEDP result in increases in CO, except at very high
RVEDP. When one or both of the ventricles fail, stroke volume is severely limited, and as a consequence,
so is cardiac output. Figure 2.7 is a schematic showing CO-RVEDP curves (also called Frank-Starling
curves) under normal conditions and during right heart failure. Both curves have been drawn assuming
open-chest conditions i.e., neglecting Vth.
In general, CO is a complex function of many variables – heart rate, total blood volume, venous compliance,
venous resistance, intrathoracic pressure, and the end-diastolic compliance of the right ventricle [25]. All
other things being unperturbed, as heart rate or total blood volume or right ventricular end-diastolic
compliance increase, CO increases. On the other hand, as arteriolar resistance or venous resistance or
intrathoracic pressure increase, CO decreases. A typical value of cardiac output for a 70 kg human male
is 5 l/min [23].
One way to envision what determines CO is shown in Fig. 2.8, in which the heart-lung pumping unit – the
combination of the heart and lungs in the cardiovascular system – appears on the left, and the peripheral
circulation appears on the right. The output of the heart-lung pumping unit is cardiac output, while
that of the peripheral circulation is venous return (VR). Each of these units may be, in general, nonlinear
and time-varying. Under normal conditions, we can plot CO and VR curves as a function of RVEDP [30].
Cardiac output itself is determined by the intersection of the CO and VR curves, analogous to the load-line
analysis of the combination of two nonlinear circuits.
Figure 2.9 shows CO and VR curves for a variety of conditions – normal, right heart failure, hypovolemia,
and right heart failure (left heart failure would result in a similar curve) and hypovolemia. (The VR
curve has a negative slope, while the CO curve has a positive slope.) Each of these conditions results in
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Figure 2.8: Cardiac output and venous return determination posed as a load-line problem.
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Figure 2.9: Cardiac output and venous return curves for a variety of conditions. The intersection of the
cardiac output curve and venous return curve determines cardiac output.
a different intersection or operating point – A, B, C, or D – and thus a different cardiac output. Cardiac
output decreases during hypovolemia or right heart failure, however, the values of RVEDP in each of these
conditions is quite different.
2.7 Arterial Blood Pressure
Arterial blood pressure is probably the most important vital sign in any clinical setting, and is especially
so in the ICU. While the arterial blood pressure wavelet morphology may change as blood travels from the
aorta to the peripheral arteries (due to the reflections of the arterial pulse wave and changes in arterial
impedance), mean arterial blood pressure (MAP) is essentially constant in the large arteries, and is normally
around 100 mmHg at the level of the heart. This value is surprisingly common to all mammals except
giraffes, which, given their unique anatomy, need a much higher mean ABP at the level of the heart in
order to perfuse their neck and brain [31, 32].
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Figure 2.10: ABP waveform from a MIMIC II patient. The systolic and diastolic pressures for one ABP
wavelet are shown in the figure. Mean ABP is proportional to the area under this wavelet. This figure was
adapted with permission from Elsevier Health Sciences Division, i.e., the superimposition and integral are
adapted from Fig. 6.7 in [23]).
Figure 2.10 shows a radial ABP waveform from an ICU patient record where we have annotated the ABP
wavelet in the center with the systolic and diastolic arterial blood pressures. Mean arterial blood pressure
over one cardiac beat is calculated using the area under that wavelet (shaded in the figure) as shown by
the formula in Fig. 2.10, where we use Va(t) to denote ABP. Note that we have not drawn in the value of
MAP for the center ABP wavelet.
2.8 Cardiovascular Control Loops
In this section we discuss the main control loops of the cardiovascular system. The principal control system
we discuss is the arterial baroreflex control loop, which, on a beat-to-beat basis (short timescale i.e., seconds
to minutes), tightly controls mean ABP. We also discuss the cardiopulmonary reflex, the chemoreflex, and
the direct neural coupling between heart rate and respiration. The Ph.D. theses of both Mukkamala [33]
and Heldt [34] can serve as good references on how to model and implement these control loops. For many
ICU patients, a common problem is that certain disease conditions result in the saturation of the baroreflex
control system, and an appropriate MAP can no longer be maintained [3]. For such patients, therapeutic
interventions must be performed to regulate MAP.
Figure 2.11 is a block diagram of the cardiovascular control system we discuss here. The sensors for arterial
blood pressure are the baroreceptors (located in the aortic arch and carotid sinus). The sensors for right
atrial pressure are the cardiopulmonary receptors (located in the walls of the right atrium). The effectors
for the control system are the heart (modulating heart rate and contractility), the arterioles (modulating
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Figure 2.11: Block diagram of the cardiovascular control system, including both the baroreflex and the
cardiopulmonary reflex mechanisms, but neglecting the direct neural coupling between heart rate and
respiration. The baroreceptors sense arterial blood pressure in the aortic arch and carotid sinus, while the
cardiopulmonary receptors sense right atrial transmural pressure.
TPR), and the veins (modulating zero-pressure filling volume or venous tone). The control inputs to the
system are synthesized in the nucleus tractus solitarius (NTS), a part of the medulla oblongata in the
autonomic nervous system (ANS) [34]. We very briefly discuss this system below.
2.8.1 The Baroreflex Control Loop
The arterial baroreflex control loop tightly controls mean arterial blood pressure on a short-term beat-to-
beat basis. It is a global, hard-wired feedback loop that attempts to maintain mean arterial blood pressure
close to constant. By regulating MAP in this manner, the baroreflex also indirectly changes (but does not
regulate) cardiac output through the interaction summarized by (2.6).
The ANS attempts to alter heart rate, arterial resistance, ventricular contractility, and the body’s venous
unstressed blood volume (the zero-pressure filling volume) to regulate blood pressure. The sensor mecha-
nisms for the baroreflex are the stretch receptors in the carotid sinus and aortic arch, which link to the NTS
in the medulla oblongata in the ANS. An increase in arterial blood pressure corresponds to an increase in
the firing rate of these receptors.
There are two parts of the autonomic nervous system that react to changes in arterial blood pressure: the
sympathetic and the parasympathetic systems. When the sympathetic nervous system, which is responsible
for the so-called fight and flight response, is stimulated, the primary effects are increased arterial resistance
(primarily by stimulating the secretion of the vasoactive neurotransmitter norepinephrine which binds to
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α receptors in the smooth muscle causing vasoconstriction in both the arteries and the veins), increased
heart contractility (by stimulating the secretion of epinephrine with stimulates β1 and β2 receptors in
the myocardium to decrease ventricular end-systolic compliance), increased heart rate (by speeding up
SA node firing by increasing calcium uptake in the SA node), and increased distending blood volume
(by decreasing the zero-pressure filling volume with α receptor stimulation). The overall effect of these
changes is to increase the arterial blood pressure. These changes allow for the potentially dramatic increase
in metabolic activity that would accompany the actions taken to combat the perceived threats, e.g., running
away from a threatening person or situation. The primary effect of the parasympathetic nervous system
is to slow down the heart, i.e., reduce the SA node firing rate – via acetylcholine release mediated by the
vagus nerve [34].
2.8.2 The Cardiopulmonary Reflex
The cardiopulmonary reflex loop can be thought of as an additional part of the blood pressure control
mechanism. The cardiopulmonary receptors are located in the right atrial walls and sense right atrial
transmural pressure. An increase in right atrial transmural pressure (RAP), however, primarily affects
the arteries and veins, with little to no effect on the heart [33]. When right atrial transmural pressure
increases, for example, the ANS acts to decrease TPR and decrease distending blood volume.
2.8.3 Neural Coupling to Heart Rate
A neurally-mediated interaction exists between respiration and heart rate. This interaction is partly
responsible for sinus arrhythmia i.e., the cyclical respiratory modulation of the ECG seen in human ECGs
[33]. During inspiration, as lung volume increases, parasympathetic outflow from the ANS decreases. The
converse occurs during expiration. In addition, there are perturbations induced in heart rate that can be
modeled [33], but we ignore them here.
2.8.4 Local Metabolic Control of Cardiac Output
Blood flow to tissue in the body is regulated locally based on the oxygen demand in the tissue [30].
Although the exact mechanism for this autoregulation is not known, we know that the blood flow to tissue
increases as oxygen demand in the tissue increases.
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2.8.5 The Chemoreflex Loop
In addition to the baroreceptors, there are chemoreceptors in the carotid sinus and aorta which sense the
oxygen content, carbon dioxide content, and blood pH, as blood flows through the vessels. If the oxygen
content in these vessels is low, for example, the firing of these fast-acting receptors results in outflow from
the ANS that increases mean ABP, and thus CO, via Equation (2.6). The mechanisms for this loop are
discussed in [21].
2.8.6 The Renin–Angiontensin II–Aldosterone System
Another mechanism that responds, albeit slower, i.e., on the other of days and weeks, than the baroreflex,
to changes in arterial blood pressure is the renin–angiontensin II–aldosterone system [21]. When aortic
arterial blood pressure decreases, for example, renal arterial blood pressure decreases, which causes the
hormone renin to be secreted. Renin causes the production of the hormone angiotensin I, which is converted
to the hormone angiotensin II, which in turn directly increases arterial resistance and stimulates the
secretion of the hormone aldosterone. Aldosterone causes the blood volume in the body to increase (through
actions on the kidneys), which in turn increases RVEDP and LVEDP. The increased preload of the heart
increases stroke volume and tends to return mean ABP to normal values.
2.9 Medications used in the ICU
In this section we give an overview of medications commonly used in the intensive care unit. Most of
these medications can be classified by their chemical composition or their effect, e.g., a β2-agonist causes
vasodilation by stimulating β2 receptors in the smooth muscle, while nitrates such as nitroprusside cause
vasodilation via nitric oxide (NO) to stimulate the production of guanosine triphosphate (GTP).
Here, we list the most common hemodynamic drugs in the ICU and describe their effect in terms of
stimulating α (vasoconstriction), β1 (increased contractility and/or heart rate), and β2 (vasodilation)
receptors. Both [3] and [20] are excellent references for this material.
Hemodynamic drugs
Amrinone is a calcium (Ca2+) channel blocker and β2 agonist that increases contractility in the heart
and causes vasodilation in the vascular smooth muscle, respectively.
Diltiazem is a β1 and β2 agonist that results in reduced heart rate and increased vasodilation.
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Dobutamine is primarily a β1 agonist, increasing contractility in the heart, but also has mild β2 vasodi-
lation effects.
Dopamine has different effects depending on its dosage. In small doses, it causes increased salt-water
excretion by the kidneys. In intermediate doses, it has both β1 and β2 effects i.e., increased contractility
and vasodilation, while at high doses, it is primarily an α agonist (with mild β1 effects), causing a dose-
dependent vasoconstriction – higher doses causing progressively larger vasoconstriction.
In low doses, Epinephrine is a β1 and β2 agonist, while in high doses, it is primarily an α agonist (with
mild β1 effects).
Esmolol is very fast-acting β antagonist i.e., a β blocker which induces a reduction in heart rate and an
increase in arterial resistance by reducing β2 receptor stimulation.
Isoproterenol (commonly known as“Isuprel”) is a β agonist, with both β1 and β2 effects.
Labetalol causes vasodilation by reducing the amount of α-mediated vasoconstriction.
Levophed is an α agonist that causes increased arteriolar resistance.
Milrinone and Natrecor are β agonists, with both β1 and β2 effects.
Neosynephrine (also called Phenylephrine because of its chemical name Phenylephrine Hydrochloride)
is primarily an α agonist that causes increased arteriolar resistance, but also has mild β1 effects.
Nitroprusside and Nitroglycerin are both potent vasodilators. Their vasodilation effects are mediated
by nitric oxide. Nitroprusside, however, has many more adverse side effects, and is thus not as commonly
used as Nitroglycerin.
Norepinephrine is an α agonist that causes widespread vasoconstriction.
Propofol is a sedative used for mechanically-ventilated patients. It also has β2 effects i.e., it causes
vasodilation.
Drugs that affect body fluids
Furosemide (commonly known as “Lasix”) is a very strong diuretic which acts on the loop of Henle in
the kidney to quickly remove fluid from the body. The result is a temporary reduction in distending blood
volume. Furosemide also binds to β2 receptors and thus has a slight vasodilation effect.
Vasopressin or anti-diuretic hormone (ADH) makes the body conserve water by reducing water reabsorp-
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tion in the kidneys, which may cause a temporary increase in distending blood volume. It also has mild
vasoconstrictor effects i.e., it binds to α receptors.
Other drugs
In addition to these drugs, many ICU patients are on pain-relieving medications (analgesics) such as
Ativan and Morphine, while others are on drugs that are anticoagulants and/or anti-platelet forming
agents, e.g., Aggrastat and Integrelin.
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Part II
Lumped-Parameter Electrical Circuit
Models of Cardiovascular Dynamics
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Chapter 3
Pulsatile Models of Cardiovascular Dynamics
MEDICAL teaching and research have a rich tradition of using simple mechanical or electrical modelsto describe and elucidate cardiovascular phenomena1. This tradition dates back over a century to
the work of Moens and Korteweg, who modeled arterial pulse propagation in 1878, and the work of Otto
Frank and his associates in 1899, who used a lumped-parameter mechanical model of the arterial system
– the Windkessel (meaning air chamber in German) – to analyze the arterial pressure pulse [35, 36] and
estimate cardiac stroke volume [37].
Some of these cardiovascular models were later implemented on analog computers [38], and subsequently
in software on digital computing platforms. Such computational models of cardiovascular dynamics vary
in complexity, ranging from simple models (see [39, 40, 41, 41, 42]), to more complicated models such as
those developed from experiments by Dr. A. Guyton and his associates [30, 43, 44, 45]. These models,
particularly in the form of electrical circuit analogs (see [46, 47, 48] for some early work in this area), have
been used in teaching physiology [49, 50, 51, 52], as well as in the research setting.
In the past, these models have generally been used to interpret experimental observations, serving as a
rational framework that links an intervention to the observed system-level response (the forward problem,
see [53, 54, 55] for examples). The forward problem involves tweaking model parameters so that the model
output matches observed data. Thus, the modeler is required to have a deep physiological understanding,
as one is building a model that is capable of simulating realistic hemodynamic responses. The focus in
medical school classes, for example, is mostly on the forward problem, i.e., simulating CV disease conditions
by changing model parameters [49].
More recently, however, these models have been used to link a system-level observation to the underlying
changes in the cardiovascular system (the inverse problem), which involves estimating the states, or the
parameters, or both, of a given computational model using the available hemodynamic data. There are
a plethora of inverse problems to which we can apply our cardiovascular models (see the work of Heldt
[34, 56], Mukkamala [57, 58], Clark [59], and Guarini [60] for examples), ranging from investigating the
effect of micro-gravity on an astronaut’s cardiovascular system [56] to estimating cardiac output in a
hospital ICU, one of the goals of this thesis research.
In the ICU setting, we believe that computational cardiovascular models can be used to provide clinicians
1This chapter is partially based on two IEEE papers [15, 16]. The material has been reproduced with permission.
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with a more comprehensive assessment of patient hemodynamic state. These cardiovascular models would
be used to estimate a patient’s cardiovascular parameters such that the model’s response matches, in some
sense, the available patient data, i.e., a subset of these parameters would be measured and the rest would
be estimated using a model-based estimation method.
It is particularly convenient to model the cardiovascular system using lumped-parameter electrical circuit
models representations for the different cardiac and vascular segments. Such electrical circuit analogs can be
analyzed using Kirchhoff’s current and voltage laws, making them a particularly convenient representation.
In this chapter, we describe a particular class of such models, namely pulsatile electrical circuit models
of cardiovascular dynamics. (Models of cardiovascular dynamics are called pulsatile if they capture the
intra-beat (or intra-cycle) features of individual pressure, flow, and volume waveforms.) We begin with an
overview of prior work in this area, and then describe several pulsatile cardiovascular models including the
well-known Windkessel model, the cardiovascular simulator (CVSIM) model [49], and simplifications of
the CVSIM model – the simple CVSIM model (CVSIMple) and the simple pulsatile cardiovascular model
(SPCVM). Of particular relevance to our work are the Windkessel and SPCVM models, as we use these
models to develop the averaging methodology described in Chapter 4, and employ them in the estimation
problem detailed in Chapter 5.
3.1 Lumped-Parameter Electrical Circuit Analogs for the Cardiovas-
cular System
Under lumped-parameter approximations for the distributed cardiovascular system, the computational
cardiovascular dynamics models that result allow for the simulation of hemodynamic waveforms that are
reasonable approximations of those measured in the human cardiovascular system.
Figure 3.1 shows lumped-parameter electrical circuit analogs for a single ventricular compartment (Fig. 3.1(a))
and a systemic circulation compartment (Fig. 3.1(b)). The electric circuit analogs for cardiovascular vari-
ables and parameters are (not all shown in Fig. 3.1): current I for blood flow, voltage V for blood pressure,
charge Q for blood volume, ideal diodes D for heart valves, resistance R for valvular or vascular resistance
to blood flow, inductance L for blood inertia, and capacitance C for vascular or compartmental compliance.
Elastance, E, is defined as the inverse of capacitance or compliance.
The pressures Vin(t), Vs(t), and Vout(t) can be related using Kirchhoff’s current law. Thus, for the circuit
in Fig. 3.1(b), we obtain:
Cs
dVs(t)
dt
=
Vin(t)− Vs(t)
Rin
+
Vout(t)− Vin(t)
Rout
(3.1)
In the circuit analogs presented in this thesis, pulsatile behavior is simulated with lumped-parameter circuit
models in which the ventricular compartment is comprised of a time-varying capacitor that cycles between
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Figure 3.1: (a) A ventricular compartment showing a time-varying compliance, C(t), two heart valves Di
andDo, valvular resistances Ri and Ro, and an intrathoracic pressure source, Vth; (b) A systemic circulation
compartment with fixed compliance, Cs, and inflow and outflow resistances Rin and Rout, respectively.
a low (systolic or ejection) state and a high (diastolic or filling) state. We describe such time-varying
capacitance functions, e.g., Equation (3.18), in Section 3.6.
There are several simplifying assumptions we make in some of the circuit analogs presented here. We
neglect ventricular interactions in all our models, for example. Except for the modified Windkessel model,
we ignore the effects of inertia in the blood flow (as captured by inductors in the circuit analogs). This is
a reasonable assumption as we are not interested in the finer structure of the blood pressure waveforms,
such as the presence of the dichrotic notch in the central ABP waveform. In addition, since we assume
our models capture only the steady-state values of the hemodynamics – the slow inter-cycle dynamics we
are interested in modeling in the ICU setting – we neglect the baroreflex and cardiopulmonary control
mechanisms which, on an inter-cycle timescale, tightly control the arterial blood pressure by varying heart
rate, ventricular elastance, peripheral resistance, and venous tone. The inclusion of the baroreflex is easily
done (see the theses of Samar [8], Mukkamala [33], Heldt [34], or the work of deBoer [61]). Finally,
we neglect the time-varying nature of intrathoracic pressure, i.e., whenever we include the intrathoracic
pressure source Vth, we keep it fixed. In fact, we neglect all other cardiopulmonary interactions in our
models as well.
3.2 The Windkessel Model
The Windkessel model describes the basic morphology of an arterial pressure pulse [62]. It lumps the
distributed resistive and capacitive properties of the entire arterial tree into two elements, as seen in
electrical circuit analog in Fig. 3.2: a single resistor, Ra, representing total peripheral resistance (TPR),
and a single capacitor, Ca, representing the aggregate elastic properties of all arteries (see [25, 36, 63] for
examples of Windkessel-type models).
The pumping action of the heart is represented by an impulsive current source, I(t), that deposits a stroke
volume, SVn, into the arterial system during the nth cardiac beat (or cycle):
I(t) =
∑
n
SVn · δ(t− tn) (3.2)
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Figure 3.2: Circuit representation for the Windkessel model with a representative pulsatile ABP waveform.
where tn is the onset time of the nth cardiac cycle and δ(t) is a unit Dirac impulse at time t=0. The
differential equation representing the Windkessel circuit at time t is given by
Ca
dV (t)
dt
+
V (t)
Ra
= I(t) (3.3)
where V (t) represents arterial blood pressure at the aortic root at time t. This equation shows that the
time constant τ=RaCa governs the intra-cycle dynamics of the Windkessel model. The same time constant
also governs the inter-cycle dynamics, as noted in [57, 16] and shown in Chapter 4. For now, we assume
both Ra and Ca are fixed, though we will relax this assumption in Chapter 4.
If we assume that Va(0)=0, we can iteratively solve the Windkessel model equation such that we have the
following expression for Va(t) within each cycle:
Va(t) =
SV
Ca
exp(− t−tnRaCa )[
1− exp
(
− tn+1−tnRaCa
)] for tn < t < tn+1 . (3.4)
Pulse pressure in the nth cardiac cycle, PPn, is defined as the difference between the systolic and the
diastolic arterial blood pressures in the cycle, SAPn and DAPn, respectively. Due to the impulsive nature
of the modeled cardiac ejection in the Windkessel model, pulse pressure is directly related to stroke volume
through the arterial compliance:
PPn = SAPn −DAPn = SVn
Ca
. (3.5)
The pulsatile ABP waveform that results from simulating the model (3.3) with V (0)=0 mmHg, Tn=1 s
(such that heart rate in the nth cycle HRn=60 beats/min), SVn=100 ml, Ra=1 mmHg/(ml/s), and Ca=2
ml/mmHg, is shown in Fig. 3.2. The resulting steady-state PP equals 50 mmHg.
The Windkessel model has been the basis of several methods for estimating cardiac output ([37, 54, 64, 65]),
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Figure 3.3: The modified Windkessel model in which the arterial tree is divided into a distal and a proximal
compartment.
and is also the basis for our model-based CO estimation method described in Chapter 5. For instance,
using Equation (2.5), we can write an expression for cardiac output:
CO =
SVn
Tn
= Ca
PPn
Tn
= fnCaPPn . (3.6)
where
Tn = tn+1 − tn (3.7)
is the duration of the nth cardiac cycle. Equation (3.6) states that cardiac output in the Windkessel
model is directly proportional to pulse pressure times heart rate, fn. The proportionality constant is the
lumped arterial compliance. The last expression in Equation (3.6) is the basis for the Windkessel method
of estimating proportional cardiac output.
3.3 The Modified Windkessel Model
The modified Windkessel model2 shown in Fig. 3.3 is a slightly more elaborate version of the Windkessel
model.
In this model, the arterial tree compliance is split into a distal compliance, Ca,d, representing the less
elastic arteries distal from the heart, and a proximal compliance, Ca,p, representing the highly elastic
arteries proximal to the heart. These two compliances are separated by an inductor, La, which captures
the effects of ABP pulse propagation on the distal and proximal ABP waveforms.
The main difference between the modified and the usual Windkessel models is the additional La-Ca,d
branch in the modified Windkessel model. If we assume that La=0, and define Ca=Ca,p + Ca,d, the
modified Windkessel model reduces to the Windkessel model.
Due to these additional two energy-storage elements in the modified Windkessel model, the state space
2This model is the subject of further work in our group [17], which will not be described here.
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Figure 3.4: Proximal (top) and distal (bottom) ABP waveforms for a simulation of the modified Windkessel
model with Va,d(0) = 0 mmHg, Va,p(0) = 0 mmHg, SVn = 100 ml, T=Tn=1 s, Ra= 1 mmHg/(ml/s), La=
0.025 mmHg/ml/s, Ca,p= 1.45 ml/mmHg, and Ca,d= 0.15 ml/mmHg.
representation for this model is given by three equations:
Ca,p
dVa,p
dt
= −IL + I (3.8)
La
dIL
dt
= Va,p − Va,d (3.9)
Ca,d
dVa,d
dt
= −Va,d
Ra
+ IL (3.10)
where the time argument t has been dropped for notational simplicity. As with the Windkessel model, we
assume that the heart is modeled as an impulsive current source I(t), given by Equation (3.2). Note that
when La=0 we recover the usual Windkessel model, with Ca=Ca,p + Ca,d.
The modified Windkessel model can be summarized more compactly using vector-matrix notation:
d
dt
x =

0 − 1Ca,p 0
1
La
0 − 1La
0 1Ca,d − 1RaCa,d
x +

I
Ca,p
0
0
 (3.11)
where x=[Va,p IL Va,d]
′ is the vector of state variables.
Figure 3.4 shows the pulsatile ABP waveforms that result from simulating the modified Windkessel model
(3.11) with Va,d(0) = 0 mmHg, Va,p(0) = 0 mmHg,SVn = 100 ml, T=Tn=1 s, Ra= 1 mmHg/(ml/s), La=
0.025 mmHg/ml/s, Ca,p= 1.45 ml/mmHg, and Ca,d= 0.15 ml/mmHg.
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Figure 3.5: A schematic of a canine arterial tree showing the distributed nature of the arterial tree. This
figure appears as Fig. 2.10 in [66] and was reproduced with permission from Hodder Education.
3.4 Limitations of the Windkessel Model
In this section we describe some limitations of the Windkessel and modified Windkessel models. The main
limitations can be summarized as those pertaining to lumped-parameter modeling – in particular to the
lumped arterial compliance – which ignores the distributed effects of blood flow in the arterial tree.
3.4.1 Distributed Effects
One of the main drawbacks of the Windkessel model is that the distributed arterial tree impedance (see
Fig. 3.5) is described by just two lumped components. Thus, the transmission line-type effects, e.g., wave
propagation, wave speed, etc., in the arterial system are not captured by the usual Windkessel model. For
example, the Windkessel model assumes that ABP rises instantaneously in the entire arterial tree instead
of becoming successively larger as the ABP wavelet propagates through the lower levels of the arterial tree.
In particular, as this wave propagation occurs, arterial blood pressure wavelets become narrower, and have
a higher systolic and pulse pressure [33].
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Nonetheless, the simple Windkessel model captures the low-frequency dynamics of the central and periph-
eral arterial blood pressure waveforms quite well [67]. In fact, it captures the morphology of the aortic
blood pressure wavelet quite well, aside from the high-frequency dichrotic notch [33]. To capture high-
frequency dynamics in the central and/or peripheral arterial blood pressure waveforms (e.g., the dichrotic
notch and/or pulse wave reflections which originate at bifurcation or termination points along the periph-
eral arteries and propagate back to the aorta) along the arterial tree branches, the arterial tree is perhaps
better modeled with two or more arterial compartments – one representing the larger, more elastic arteries,
and one or more representing the smaller, more muscular arteries [67].
The modified Windkessel model, for example, attempts to improve on the simple Windkessel model by
adding on the La-Ca,d branch. This addition, however, is still only an approximation that is not capable of
capturing all the distributed effects. To do so, one would have to add a large number of R-L-C branches
in parallel with the usual arterial tree compliance in the Windkessel model, or go to a distributed model
based on solving the Navier-Stokes equation [68].
In addition to being unable to capture the distributed nature of the arterial tree, the Windkessel model
compliance and resistance are elements with fixed values. While this assumption may be valid for the
lumped arterial tree resistance, it is not necessarily true for the lumped arterial tree compliance, as we
discuss below.
3.4.2 Arterial Tree Compliance
The lumped arterial tree compliance is a function of arterial blood pressure, and is perhaps better modeled
as such rather than as a constant. Furthermore, it is well-known that arterial tree compliance depends
on age (as we grow older, our arteries get less elastic and arterial compliance increases [69, 70]), gender,
and disease state, e.g., acute arteriosclerosis results in lower compliance [71]. However, this compliance
also depends on arterial blood pressure. Figure 3.6 shows mean compliance-pressure curves for thoracic
aortas of various age groups presented. Each curve is an average for a particular age group. This figure
was constructed using ex vivo measurements from eighteen human thoracic aortas, as presented in [69].
If we assume that pulse pressure variations around MAP are small, then we can model the arterial tree
compliance to be a function of mean arterial blood pressure. Some previous work on CO estimation
suggests that the arterial tree compliance is constant over a wide range of mean arterial blood pressures
[72, 73, 74]. However, there is no consensus on this observation. While it may hold true for the largest
arteries in the body, it does not necessarily hold true for the smaller arteries, as shown by Liu et al. [75].
(Since our modeling work is intended for the less invasive peripheral arterial blood pressure waveforms,
we need to understand any nonlinearities in the arterial tree compliance.) In addition, researchers such as
Burattini et al. [76], who conducted canine experiments, have shown that arterial compliance can change
drastically in response to vasoactive drugs – partly due to the effect of these drugs on the mean arterial
blood pressure and partly due to drug-induced changes in the mechanical properties of the arterial wall.
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Figure 3.6: Thoracic aorta compliance-pressure curves for various age groups. Each curve is an average
for a particular age group. This figure was constructed using ex vivo measurements from eighteen human
thoracic aortas, as presented in [69].
Several researchers have investigated total arterial compliance and its dependence on mean arterial blood
pressure. Westerhof and co-workers [63, 77, 78, 79], for example, have argued that the arterial tree volume
depends strongly on pressure – falling sharply at lower pressures and asymptotically converging to a
maximum at high pressures. The (incremental) compliance, therefore, is large at low mean pressures and
steadily decreases with increasing pressure. In their work, they explored the use of such a nonlinear arterial
tree volume-pressure function in various incarnations of the Windkessel model. Liu et al. [75] compared
several nonlinear arterial volume-pressure relationships, including logarithmic, piecewise-parabolic, and
exponential relationships, and a specific linear volume-pressure relationship – with corresponding constant
compliance. They argue that for the larger arteries, e.g., the aortic arch and thoracic aorta, a linear fit
to the volume-pressure data was sufficient, but for the carotid, femoral, and brachial arteries, a nonlinear
relationship fit the volume-pressure data better. In [80, 81], the authors proposed several nonlinear arterial
volume-pressure functions and evaluated them using simulated and human data.
In this chapter, we assume that Ca is fixed; however, we relax this assumption later in this thesis, when
the compliance Ca plays a critical role in our model-based CO estimation method.
3.5 The CVSIM Model
Circuit analogs for the cardiac chambers and peripheral circulation compartments can easily be combined
to create larger, more complex lumped-parameter cardiovascular circuit models, such as the cardiovascular
simulator [49], which has been used extensively as a teaching tool for undergraduates, graduates, and
medical school students.
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Figure 3.7: Cardiovascular model comprised of two heart compartments (the left and right ventricle) and
four systemic circulation compartments for the lungs, arterial system, and venous system.
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A block diagram of the CVSIM model is shown in Fig. 3.7, where the ABP, left ventricular pressure
(LVP), and CVP3 are labeled. This model is comprised of six compartments including the left and right
ventricles, the systemic arteries and veins, and the pulmonary arteries and veins. CVSIM is capable of
representing the hemodynamic manifestations of a variety of cardiovascular diseases such as myocardial
infarction, hemorrhage, valvular disease, and pulmonary edema.
CVSIM can be fully described by six coupled first order differential equations. These equations are nonlin-
ear, as the circuit contains ideal diodes, and are time-varying because of the ventricular compliances. The
equations for the CVSIM model, and the nominal parameters are listed in [49], as well as in the theses of
Mukkamala [82, 83] and Samar [8], that describe the more recent incarnations of the CVSIM model. We
have included the model equations and nominal parameters in Appendix B.
As with the Windkessel-type models above, we again do not describe the baroreflex and cardiopulmonary
control mechanisms that, on a beat-to-beat timescale, tightly control mean arterial blood pressure. These
reflex mechanisms have been incorporated into other implementations of the CVSIM model [8, 49, 56, 82,
83]. If we were to simulate short-term responses to parameters in the CVSIM model, we would need to,
at least, wrap the baroreflex control loop around the model shown in Fig. 3.7, as is done in the work of
Samar [8] and Heldt [34].
3.6 The CVSIMple Model
It is possible to use simpler lumped-parameter models of the cardiovascular dynamics to simulate reasonable
approximations of hemodynamic waveforms. A simpler version of the CVSIM model that was recently
proposed ([41, 42]) provides an abstracted view of the body’s circulation (similar models were proposed by
Guyton and co-workers in 1963 [25], and by a group at Penn. State University in 1982 [84]). This model,
which we will refer to as the CVSIMple model, combines the pulmonary and cardiac compartments from
CVSIM into a single ventricular compartment, which we can usually think of as the left ventricle. In doing
so, it is assumed that the right-heart, pulmonary, and left-heart compartments act as a single functional
unit. This assumption is justified if the model is intended for use mainly in simulating systemic vascular
disease conditions, e.g., hemorrhaging in the systemic circulation.
Figure 3.8 shows the circuit for the CVSIMple model where Ca is the arterial compliance, Cv is the venous
compliance, Ch(t) is the time-varying ventricular compliance, R1 is the inflow resistance to the ventricle,
R2 is the outflow resistance from the ventricle, and Ra is the total peripheral resistance.
3The pressure across Cv is more analogous to peripheral venous pressure, but we nevertheless refer to it as CVP here.
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Figure 3.9: Compliance and piecewise linear elastance functions for the CVSIMple model for T = 1 s.
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The state space equations for the CVSIMple model are as follows4:
dQh
dt
= I1 − I2 (3.12)
dVa
dt
=
I2 − Ia
Ca
(3.13)
dVv
dt
=
Ia − I1
Cv
(3.14)
where the time argument t has been dropped for notational convenience, and where the various flow rates
are given by:
I1 =

Vv−Vh
R1
if Vv > Vh
0 otherwise
(3.15)
I2 =

Vh−Va
R2
if Vh > Va
0 otherwise
(3.16)
Ia =
Va − Vv
Ra
(3.17)
where, again, the time argument t has been dropped for notational simplicity.
The compliance and elastance for the ventricular compartment in the CVSIMple model are illustrated in
Fig. 3.9. The elastance function Eh(t)=1/Ch(t) for the ventricle is represented as a piecewise linear (PWL)
function given by:
Eh(t) =

3(Es−Ed)
T t+Ed for 0 ≤ t ≤ T3
6(Es−Ed)
T (
T
3 − t) + Es for T3 ≤ t ≤ T2
Ed for T2 ≤ t ≤ T
(3.18)
where T is the duration of the cardiac cycle, Es is the end-systolic elastance, and Ed (¿ Es) is the end-
diastolic elastance. For now, we assume that T is fixed, but in general, for implementation purposes, one
only needs to assume that T is fixed within each cardiac cycle. Such a time-varying elastance function
approximates human data quite well [85, 86, 87, 88]. In the CVSIM model and in the models used in
4Qh(t) is used as a state variable instead of Vh(t) because it ensures smaller numerical errors, as the term
dCh(t)
dt
does not
appear in the state-space model.
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Figure 3.10: Comparison of two elastance functions (piecewise linear and sinusoidal) in the CVSIMple for
T=1 s. This simulation was performed in MATLAB R14 (The Mathworks Inc., Natick, MA).
[56, 82, 83], a sinusoidal ventricular elastance function of the following form5:
Eh(t) =

1
2(Es − Ed)
(
1− cos
(
pit
0.3
√
T
))
+Ed,l for 0 ≤ t ≤ 0.3
√
T
1
2(Es − Ed)
(
1− cos
(
2pi(t−0.3√T )
0.3
√
T
))
+ Ed for 0.3
√
T ≤ t ≤ 0.9
√
T
2
Ed for 0.9
√
T
2 ≤ t ≤ T
(3.19)
was used instead of the PWL elastance function. We have confirmed that using a PWL elastance instead
of a sinusoidal elastance function does not result in waveforms with significantly different morphologies.
Figure 3.10 shows ABP waveforms that we obtained using the PWL elastance (3.18) and the sinusoidal
elastance (3.19) in the CVSIMple model. The main difference between the two waveforms is the larger
initial slope of the ABP waveform from the CVSIMple model at the onset of systole. This larger initial
slope results in a slightly larger steady-state pulse pressure.
The parameters used in the CVSIMple model, including the initial conditions (assuming the simulation
begins at t=0) for our simulations, are shown in Table 3.1. These parameters represent typical values for
a 70 kg male human [34], and, when used with Equation (3.18), result in reasonable approximations of the
pressure waveforms during the cardiac cycle.
In the CVSIMple model, the PWL elastance function and the ideal diodes in the heart compartment
result in a cardiac cycle with seven distinct regions as shown in Fig. 3.11. These regions of operation are
5The function (3.19) is used, with Ed and Es from Table 3.1, for the left ventricle in the CVSIM model.
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Parameter Value
R1 0.01 mmHg/(ml/s)
R2 0.03 mmHg/(ml/s)
Ra 1 mmHg/(ml/s)
Ca 2 ml/mmHg
Cv 100 ml/mmHg
Ed 0.1 mmHg/ml
Es 2.5 mmHg/ml
Va(0) 91.2 mmHg
Vv(0) 15.0 mmHg
Qh(0) 127.4 ml
T 1 s
Table 3.1: Summary of parameters for the SPCVM and the CVSIMple models [15].
Region Slope of PWL Function Diode D1 State Diode D2 State
I (contraction) Positive On Off
II (isovolumic contraction) Positive Off Off
III (ejection) Positive Off On
IV (ejection) Positive Off On
V (isovolumic relaxation) Negative Off Off
VI (relaxation) Negative On Off
VII (filling) Zero On Off
Table 3.2: The seven regions of the CVSIMple model. Each region is uniquely determined by the diode
states and the slope of the piecewise linear elastance function.
determined by the states of the two diodes and the behavior of the PWL elastance function as displayed
in Table 3.2.
3.7 The Simple Pulsatile Cardiovascular Model
Another pulsatile model that we recently proposed [15, 16], the simple pulsatile cardiovascular model, or
SPCVM, is a simplification of the CVSIMple model, and is thus, again, justified for use mainly in simulating
systemic vascular disease conditions. We modified the CVSIMple model to create the SPCVM so as to
have a simpler model for applying the cycle-averaging methodology discussed in Chapter 4. Had we used
the CVSIMple model as is, it would have been more difficult to derive the cycle-averaged model, explained
in detail in Chapter 4.
Figure 3.12 illustrates the circuit for the pulsatile model, where Ca is the arterial compliance, Cv is the
venous compliance, Ch(t) is the time-varying ventricular compliance, R1 is the inflow resistance to the
ventricle, R2 is the outflow resistance from the ventricle, and Ra is the total peripheral resistance. The
voltage Vh(t) is the ventricular pressure (VP), Vv(t) is CVP, and Va(t) is ABP. The ventricular volume is
Qh(t). The elastance Eh(t) and the parameters for the SPCVM are the same as those in the CVSIMple
– 81 –
Pulsatile Models of Cardiovascular Dynamics
0 0.2 0.4 0.6 0.8 1
0
50
100
150
Pr
es
su
re
 (m
m 
Hg
) o
r E
las
tan
ce
 (m
m 
Hg
/m
l)
Time (s)
Vh
V
v
V
a
Eh*20
II III V VII
Figure 3.11: Waveforms generated during a single cycle of the CVSIMple for T=1 s. This circuit has seven
regions of operation (four of which are labeled in the figure).
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Figure 3.12: The simple pulsatile cardiovascular model (SPCVM) uses a 3-way switch which allows for
simpler analysis of the circuit.
model, and are given in Table 3.1.
We can define switching functions for the switch and diode in the SPCVM. Figure 3.13 shows these switching
functions for T=1 s where s1(t) equals 1 when the switch is in position 1, and 0 otherwise; s2(t) equals 1
when the switch is in position 2, and 0 otherwise; s3(t) equals 1 when the switch is in position 3, and 0
otherwise; and sD(t) equals 1 when the diode D is conducting (between t=tD and t=T3 ), and 0 otherwise.
The switching function s2(t) is redundant since sD(t) is sufficient for describing the flow through the diode
D. The main reason for using a switch in the SPCVM instead of the two diodes in the CVSIMple model
is to eliminate regions I, IV, and VI of the CVSIMple model. As we can observe in Fig. 3.11, these three
regions have durations that are small compared to regions II, III, V, and VII. Furthermore, by eliminating
regions I, IV and VI, we have a cardiovascular model whose regions of operation correspond directly to the
four periods of the cardiac cycle: isovolumic contraction, ejection and isovolumic relaxation, and filling.
– 82 –
3.7 The Simple Pulsatile Cardiovascular Model
0 0.2 0.4 0.6 0.8 1
0
0.5
1
s 1
(t)
0 0.2 0.4 0.6 0.8 1
0
0.5
1
s 2
(t)
0 0.2 0.4 0.6 0.8 1
0
0.5
1
s 3
(t)
0 0.2 0.4 0.6 0.8 1
0
0.5
1
s D
(t)
Time (s)tD
Figure 3.13: Switching functions for the 3-way switch and diode in the pulsatile model for T=1 s. The
diode turn-on time tD is marked on the bottom panel.
Region Switch Position Diode State
I (isovolumic contraction) 2 Off
II (ejection) 2 On
III (isovolumic relaxation) 3 Off
IV (filling) 1 Off
Table 3.3: Definition of the four regions in the SPCVM.
Therefore, the SPCVM has four regions of operation, corresponding directly to the four periods of the
cardiac cycle: isovolumic contraction (I), ejection (II), isovolumic relaxation (III), and filling (IV), as
shown in Fig. 3.14. The four regions are determined by the position of the switch and the state of the
diode, as indicated in Table 3.3.
With the switching functions described above, and with Qh(t), Va(t) and Vv(t) as state variables, we have
a state-space description for the SPCVM given by
dQh
dt
=
s1(Vv −EhQh)
R1
+
sD(Va − EhQh)
R2
(3.20)
Ca
dVa
dt
=
sD(EhQh − Va)
R2
+
(Vv − Va)
Ra
(3.21)
Cv
dVv
dt
=
s1(EhQh − Vv)
R1
+
(Va − Vv)
Ra
(3.22)
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Figure 3.14: Waveforms generated over a single cycle of the pulsatile model for T=1 s. This circuit has four
regions of operation. Each region is uniquely defined by the switch position, the state of the time-varying
compliance Ch(t), and the diode state.
More compactly, we can write
d
dt
x = A(s1, sD, p)x =
−
(s1R2+sDR1)Eh
R1R2
sD
R2
s1
R1
sDEh
CaR2
− (sDRa+R2)CaR2Ra 1CaRa
s1Eh
CvR1
1
CvRa
− (s1Ra+R1)CvR1Ra
x (3.23)
where x=[QhVaVv]
′ is the vector of state variables.
By making certain assumptions about Vv(t), it is possible to find an analytical solution for the SPCVM
similar to that previously published for the CVSIMple model [42]. For circuit analysis of the different
regions of the SPCVM, see Appendix C. For an example of an implementation of the SPCVM in MATLAB
R14 (The Mathworks Inc., Natick, MA), see Appendix E.
To confirm that using the SPCVM instead of the CVSIM model or CVSIMple models does not result
in intolerable information loss, especially in terms of pressure waveform morphology, we simulated the
CVSIM, CVSIMple, and the SPCVM using the parameter values from [49] (also in Appendix B) for the
CVSIM model, and the values given in Table 3.1 for the CVSIMple model and the SPCVM. The piecewise
linear elastance function (3.18) was used in all three models. The result of this simulation is shown in
Fig. 3.15. It shows that there is little information loss as the waveforms from these three models are quite
comparable.
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Figure 3.15: Comparison of the SPCVM to the CVSIMple and CVSIM models for T=1 s. These models
were simulated in HSPICE circuit simulation software.
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3.8 Conclusion
In this chapter we discussed several pulsatile electrical circuit models of cardiovascular dynamics, with
emphasis on the Windkessel, the modified Windkessel, and the simple pulsatile cardiovascular models.
Pulsatile models are frequently-used to understand and simulate inter-beat (or inter-cycle) dynamics, these
models tend to be too detailed and computationally burdensome as the simulation time step generally has
to be chosen much shorter than the cardiac cycle length.
Averaged models, on the other hand, are much less detailed and computationally burdensome and are
more appropriate for settings such as the ICU in which dynamics occur over timescales of a few seconds
to minutes. In these settings, blood pressure waveform morphology may be less important to track than
average blood pressure. The Windkessel model, being the simplest model presented thus far, is the starting
point for the application of the averaging methodology discussed in Chapter 4.
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Averaged Models of Cardiovascular Dynamics
LUMPED-PARAMETER time-varying electrical circuit analogs for the cardiovascular system are fre-quently used in medical research and teaching for simulating and analyzing hemodynamic data1. In
Chapter 3, we studied pulsatile models of cardiovascular dynamics, which provide details of the intra-
cycle dynamics of each heart beat. In some settings, however, e.g., in the ICU, it may be more useful
to dynamically – either in discrete-time or in continuous-time – track the beat-to-beat or inter -cycle dy-
namics. Figure 4.1, for example, shows the pulsatile arterial blood pressure (ABP) and left ventricular
pressure (LVP) waveforms, along with their calculated continuous-time cycle-averages from a simulation
of the SPCVM of Chapter 3. In order to capture the transient changes in ABP or LVP, it would for many
purposes suffice to capture their discrete-time or continuous time averages. In order to represent these
averages dynamically we need to develop a averaged models of cardiovascular dynamics.
In this chapter, we study two types of averaged models of cardiovascular dynamics – discrete-time beat-to-
beat averaged models and continuous-time cycle-averaged models. We begin by showing how to integrate
the model equations for a pulsatile model of cardiovascular dynamics to obtain a beat-to-beat averaged
model. This type of sampled-data model has wide-ranging applications as we shall see in Chapter 5.
We then compare and contrast the beat-to-beat averaging methodology to cycle-averaging methodology.
In particular, we show that rather than introducing heuristic averaging during the model-building step,
as is done in existing non-pulsatile models, one can apply a short-term, cycle-averaging operation to
the differential equations of the underlying pulsatile model to obtain cycle-averaged models. The cycle-
averaging method preserves the dependence of the output variables on the model parameters. In particular,
we apply cycle-averaging to a simple pulsatile cardiovascular model to derive a cycle-averaged model for
cardiovascular dynamics. The resultant model captures the inter-cycle dynamics with relatively small
approximation errors for a large range of perturbations in important system parameters.
In Section 4.2, we describe the beat-to-beat averaging methodology and apply it to the well-known Wind-
kessel model and modified Windkessel models to derive beat-to-beat averaged Windkessel and modified
Windkessel models, respectively. Beginning in Section 4.3, we describe cycle-averaged models. In Sec-
tion 4.3.1, we describe the basic cycle-averaging methodology and also apply it to the Windkessel and
modified Windkessel models. In Section 4.3.3, we again describe the SPCVM. After some additional back-
ground on cycle-averaging in Section 4.3.4, we derive in Section 4.3.5 a cycle-averaged representation for
the SPCVM introduced in Chapter 3. Simulation results obtained using this cycle-averaged model are
1This chapter is partially based on two IEEE papers [15, 16]. The material has been reproduced with permission.
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Figure 4.1: Response of the SPCVM to a step change in total peripheral resistance at time t=5 s. Both
the pulsatile and continuous-time averaged ABP and LVP waveforms are shown.
presented and evaluated in Section 4.3.6. We conclude with a chapter summary.
4.1 Background
As mentioned in Chapter 1, integration and interpretation of hemodynamic data streams are particularly
important in the clinical environment of the intensive care unit. Given the vast and varied amount of
clinical information collected from each patient in intensive care, computational models have the potential
to play an important role in integrating a patient’s hemodynamic data streams into a common frame-
work, analyzing and interpreting the available information, and presenting resultant pathophysiological
hypotheses to the clinical staff in an efficient manner [7]. To employ computational physiological models
in such a way, one needs to match the model structure to the characteristics of the data streams collected
at the patient’s bedside. This matching must be done both in terms of the time scales involved and the
computational complexity of the forward and inverse problems to be solved. In developing discrete-time
beat-to-beat averaged and continuous-time cycle-averaged models of cardiovascular dynamics from pulsatile
ones, we aim to expand the repertoire of model structures available for matching to clinical data.
Unlike averaged models, non-pulsatile models simulate the time-average behavior of cardiovascular variables
and thus reduce the computational overhead associated with pulsatile models [89, 90]. In order to derive
non-pulsatile models, an implicit averaging step has to be taken to transform the pulsatile nature of cardiac
outflow to an average flow over the cardiac cycle. Kappel and Peer [90], for example, based on work by
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Grodins [89], used a heuristic formula to relate stroke volume to average ventricular end-diastolic volume,
which in turn they related to average pre- and after-load and average cardiac contractility. Similarly,
Boyers and co-workers [91] made stroke volume a function of average central blood volume and average
autonomic activity.
Similar to the pulsatile models described in Chapter 3, there are several simplifying assumptions we have
made in our models of cardiovascular dynamics. We, again, assume the elements of the systemic (or periph-
eral) circulation to be linear and time-invariant (LTI). Although LTI inertial and distributed-parameter
effects are easily incorporated into the averaging framework, we omit them as they are relatively insignifi-
cant for the slow inter-cycle variations we intend to capture with our beat-to-beat or cycle-averaged mod-
els. Similarly, we neglect the baroreflex and cardiopulmonary control mechanisms that, on an inter-beat
timescale, tightly control mean arterial blood pressure. These mechanisms act on time scales of a heart
cycle or longer. However, they typically use beat-to-beat-averaged rather than instantaneous (or pulsatile)
quantities as their inputs [92, 93]. Thus, it is not necessary to model them for purposes of deriving an
averaged model. Instead, once an averaged model has been obtained, the various control loops can be
wrapped around it if required.
4.2 Beat-to-Beat Averaged Models
Discrete-time beat-to-beat averaged models can be used to track the averages of the waveforms of an
underlying pulsatile model in discrete-time. To derive the beat-to-beat average model for a pulsatile
model, one simply finds the average of the pulsatile model over a single cardiac cycle, as we show below
with the Windkessel and modified Windkessel models.
4.2.1 Beat-to-Beat Averaged Windkessel Model
As mentioned in Chapter 3, the Windkessel model describes the beat-to-beat variations that occur in
arterial blood pressure. The differential equation representing the Windkessel circuit at time t is given by
Equation (3.3), repeated here for convenience:
Ca
dV (t)
dt
+
V (t)
Ra
= I(t) (4.1)
where, as before, I(t) is given by:
I(t) =
∑
n
SVn · δ(t− tn) . (4.2)
We define Tn to be the duration of the nth cardiac cycle (or beat), i.e.,the beat that begins at some
distinct time tn (which we take to be the end-diastolic minimum that precedes the cycle), and ends at the
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corresponding distinct time tn+1 of the next cycle:
Tn = tn+1 − tn . (4.3)
Average cardiac output in the nth cycle is then given by:
COn =
SVn
Tn
= Can
PPn
Tn
(4.4)
where Can is the lumped arterial tree compliance in the nth cardiac cycle.
Equation (4.4) can be used to estimate beat-to-beat values proportional to cardiac output, given pulse
pressure. However, we proceed here to derive an alternative expression – that for the beat-to-beat averaged
Windkessel model. The derivation proceeds as follows: as Ra and Ca are assumed to be constant within
each cardiac cycle, we may average Equation (4.1) from the onset of the beat at tn to the onset of the next
beat at tn+1 as follows:
Can
Tn
∫ tn+1
tn
dVa(t)
dt
dt+
1
TnRan
∫ tn+1
tn
Va(t)dt =
1
Tn
∫ tn+1
tn
I(t)dt . (4.5)
where the time constant τn equals Ran · Can and Ran is the lumped arterial tree resistance in the nth
cardiac cycle. (This application of beat-to-beat averaging is a simple example of a general method known
as the modulating function technique [94], first proposed by Shinbrot [95].) Since stroke volume in the nth
cycle is
SVn =
∫ tn+1
tn
I(t)dt (4.6)
and the average arterial blood pressure over the nth cycle is
Van =
1
Tn
∫ tn+1
tn
Va(t)dt (4.7)
Equation (4.5) reduces to
Can
∆Van
Tn
+
Van
Ran
= COn (4.8)
where ∆Van = Va(tn+1) − Va(tn). This model captures the dynamic evolution of the beat-to-beat (or
discrete-time) average arterial blood pressure, Van. Note that Equation (4.8) is a natural discrete-time
counterpart to Equation (4.1). We compare and contrast this model to the continuous-time cycle-averaged
Windkessel model below.
4.2.2 Beat-to-Beat Averaged Modified Windkessel Model
Along the same lines as above, we can also derive a beat-to-beat averaged modified Windkessel model in
Fig. 4.2.
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Figure 4.2: Analysis of the modified Windkessel circuit model, showing the supernode that includes Va,p,
La, and Va,d.
The derivation proceeds as follows. Using Kirchhoff’s current law to analyze the supernode that includes
Va,p, La, and Va,d in the modified Windkessel model circuit of Fig. 4.2 (marked in Fig. 4.2), we can write
the following relation:
Ca,p
dVa,p(t)
dt
+ Ca,d
dVa,d(t)
dt
+
Va,d(t)
Ra
= I(t) . (4.9)
By integrating (4.9) over a single cardiac cycle (or beat), we have:
Ca,pn
Tn
∫ tn+1
tn
dVa,p(t)
dt
dt+
Ca,dn
Tn
∫ tn+1
tn
dVa,d(t)
dt
dt+
1
TnRan
∫ tn+1
tn
Va,d(t)dt =
1
Tn
∫ tn+1
tn
I(t)dt (4.10)
where Tn is defined by (4.3), Ca,pn is the proximal arterial tree compliance, Ca,dn is the distal arterial tree
compliance, and Ran is the total peripheral resistance, all in the nth cardiac cycle.
Again, since stroke volume in the nth cycle is
SVn =
∫ tn+1
tn
I(t)dt (4.11)
and the average distal arterial blood pressure over the nth cycle is
Va,dn =
1
Tn
∫ tn+1
tn
Va,d(t)dt (4.12)
Equation (4.10) reduces to:
Ca,pn
∆Va,pn
Tn
+ Ca,dn
∆Va,dn
Tn
+
Va,dn
Ran
= COn . (4.13)
where ∆Va,pn = Va,p(tn+1) − Va,p(tn) and ∆Va,dn = Va,d(tn+1) − Va,d(tn). Note that (4.13) is the natural
discrete-time counterpart to (4.9).
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4.3 Cycle-Averaged Models
Cycle-averaged models can be used to track the averages of the waveforms of an underlying pulsatile
model in continuous-time. To do so, one applies a short-term, cycle-averaging operation to the differential
equations of the underlying pulsatile model. Such an approach, with certain systematic approximations,
leads to cycle-averaged models, and has found much applicability in the area of power electronics [96].
The cycle-averaging process preserves the dependence of the output variables on the model parameters,
which is a fundamental advantage over the a priori determination of such relationships during the model-
building step for non-pulsatile models. In some cases, linear and time-invariant cycle-averaged models can
be derived for nonlinear, time-varying pulsatile models [41]. A rich set of analysis tools can then be applied
to these cycle-averaged models.
4.3.1 Cycle-Averaged Windkessel Model
The In this section, we proceed to demonstrate our cycle-averaging methodology on the simple Windkessel
model [35, 36], whose circuit representation appears in Fig. 4.3.
To derive this cycle-averaged model, we assume that stroke volume, SVn, and the duration of the cardiac
cycle, Tn, are fixed such that SVn=SV and Tn=T . While these assumptions are not necessary, they make
it easier to understand our example here. It follows that I(t), still modeled as an impulsive current source,
given by
I(t) = SV
∑
n
δ(t− tn) . (4.14)
The state-space equation for the Windkessel circuit, repeated here for convenience, is as follows:
dVa
dt
+
Va
RaCa
=
I
Ca
, (4.15)
where the time argument t has been dropped for simplicity.
The pulsatile arterial blood pressure (ABP) waveform that results from simulating the model (4.15) with
Va(0)=0 is shown in Fig. 4.3. The pulse pressure in each cardiac cycle is given by
PP =
SV
Ca
. (4.16)
We now describe the basic cycle-averaged methodology (see [96, 97, 98]) and apply it to the Windkessel
model to derive the cycle-averaged Windkessel model. Our starting point is the complex Fourier series
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representation for a signal x(τ) on the interval [t− T, t], which can be written as
x(τ) =
∞∑
k=−∞
Xk(t)ejk
2pi
T
τ . (4.17)
The Xk(t) are the complex Fourier series coefficients, also referred to as the index-k cycle-averages of x(τ)
and thus denoted by 〈x〉k(t). These complex coefficients are given by
Xk(t) = 〈x〉k(t) = 1
T
∫ t
t−T
x(τ)e−jk
2pi
T
τ dτ (4.18)
due to the orthogonality properties of the basis functions {e−jk 2piT τ} on an interval of length T . For any
real signal x(t), Xk and X−k are complex conjugates:
Xk = XRk + jX
I
k = X
∗
−k (4.19)
where the superscripts R and I denote real and imaginary parts, and ∗ denotes complex conjugation.
If x(τ) were strictly periodic with period T , then the Xk(t) would be constants, independent of t. For
waveforms that deviate only slowly and/or slightly from such strict periodicity, it is reasonable to assume
that the Xk(t) will have only slow and/or slight departures from constant values. This can be exploited
when making modeling approximations.
From (4.18), with k=0, we obtain the standard formula for the cycle-average of the variable x(t), namely
X0(t) = 〈x〉0(t) = 1
T
∫ t
t−T
x(τ) dτ. (4.20)
This index-0 cycle-average is simply the dc term in the Fourier series (4.17). It is also the short-term
average of the variable x(t) that we wish to track in our cycle-averaged models, and we will often simply
write 〈x〉(t) for 〈x〉0(t). In the cardiovascular models in which we apply these expressions, T is the length
of the cardiac cycle, assumed to be known and essentially constant over the analysis interval of interest,
though possibly different from one analysis interval to another.
By differentiating (4.18) under the assumption of constant T and setting k=0, we obtain an expression for
the derivative of the index-0 cycle-average:
d
dt
X0(t) =
d
dt
〈x〉0(t) =
〈
dx
dτ
〉
0
(t) . (4.21)
By applying (4.20) and (4.21) to the state-space equation (4.15) for the Windkessel circuit, and taking
note of (4.14), we obtain the following index-0 cycle-averaged Windkessel model (one could also directly
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(b) Representative ABP waveforms – both pulsatile and cycle-averaged
– for circuit simulations with Va(0) =0 mmHg, SV=SVn = 100 ml, Tn=1
s, Ra= 1 mmHg/(ml/s), and Ca= 2 ml/mmHg.
Figure 4.3: Windkessel (top) and cycle-averaged Windkessel (bottom) model circuit representations with
representative pulsatile and cycle-averaged ABP waveforms.
average the circuit, see [99]):
dVa0
dt
+
Va0
RaCa
=
I0
Ca
=
SV
CaT
. (4.22)
It follows from (4.22) that in steady-state we have the following relation between SV and Va0:
SV =
Va0T
Ra
. (4.23)
It follows from (4.16) and (4.23) that PP in terms of Va0 is given by
PP =
Va0T
CaRa
. (4.24)
Because the pulsatile Windkessel model is LTI, the cycle-averaged Windkessel model (4.22) has the same
governing differential equation and circuit representation as the pulsatile Windkessel model (3.3). Of
interest is the fact that the time constant in both the pulsatile and the cycle-averaged Windkessel models
is RaCa.
Figure 4.3 shows the pulsatile ABP waveform from a simulation of the Windkessel model (an analytical
solution is also straightforward), along with the cycle-averaged ABP waveform obtained from a simulation
of the cycle-averaged Windkessel model. The time constant with which the average rises to its steady-state
equals the time constant of the decay on each pulse. It is clear that in order to capture the transient
dynamics in mean arterial blood pressure, Va0, it would for many purposes suffice to use a model that is
well-suited to efficiently representing the dynamics of the cycle-average.
Figure 4.4 shows how the ABP waveform from the continuous-time cycle-averaged Windkessel model differs
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Figure 4.4: Comparison of the outputs of the pulsatile, beat-to-beat averaged, and cycle-averaged Wind-
kessel models. The output of the beat-to-beat averaged model is a sampled version of the output of the
cycle-averaged model.
from that in the discrete-time beat-to-beat averaged Windkessel model. The beat-to-beat averaged ABP
(solid dots on Fig. 4.4) from the beat-to-beat averaged Windkessel model is a sampled version of the
cycle-averaged ABP (dotted line on Fig. 4.4) from the cycle-averaged Windkessel model, where samples
are taken at the end of each cardiac cycle.
4.3.2 Cycle-Averaged Modified Windkessel Model
We can easily apply the cycle-averaging methodology described above to the modified Windkessel model
from Chapter 3, repeated here for convenience:
d
dt
x =

0 − 1Ca,p 0
1
La
0 − 1La
0 1Ca,d − 1RaCa,d
x +

I
Ca,p
0
0
 (4.25)
where x=[Va,p IL Va,d]
′ is the vector of state variables.
By applying (4.20) and (4.21) to the state-space equation (4.25) for the modified Windkessel circuit, we
obtain the following index-0 cycle-averaged Windkessel model:
Ca,p
dVa,p0
dt
= −IL0 + I0 (4.26)
La
dIL0
dt
= Va,p0 − Va,d0 (4.27)
Ca,d
dVa,d0
dt
= −Va,d0
Ra
+ IL0 (4.28)
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(b) Representative proximal and distal ABP waveforms – both pul-
satile and cycle-averaged – for circuit simulations with Va,p(0) =0
mmHg, Va,d(0)= 0 mmHg, SV=SVn = 100 ml, T=Tn=1 s, Ra,p= 1
mmHg/(ml/s), La=0.025 mmHg/ml/s, Ca,p= 1.45 ml/mmHg, and
Ca,d= 0.15 ml/mmHg.
Figure 4.5: Modified Windkessel (top left) and cycle-averaged modified Windkessel (bottom left) model
circuit representations with representative pulsatile and cycle-averaged proximal (top right) and distal
(bottom right) ABP waveforms.
where Va,p0 is the index-0 cycle-average of the proximal ABP, Va,d0 is the index-0 cycle-average of the
distal ABP, IL0 is the index-0 cycle-average of the flow through the inductance La, and I0 is the index-0
cycle-average of the flow out of the impulsive source representing the heart.
Because the pulsatile modified Windkessel model is LTI, the cycle-averaged modified Windkessel model has
the same governing differential equations and circuit representation as the pulsatile modified Windkessel
model (3.11).
Figure 4.5 shows the pulsatile proximal and distal ABP waveforms from a simulation of the modified Wind-
kessel model (an analytical solution is also straightforward), along with the cycle-averaged proximal and
distal ABP waveforms obtained from a simulation of the cycle-averaged modified Windkessel model. In this
simulation, Va,p(0) =0 mmHg, Va,d(0)= 0 mmHg, SV=SVn = 100 ml, T=Tn=1 s, Ra,p= 1 mmHg/(ml/s),
La=0.025 mmHg/ml/s, Ca,p= 1.45 ml/mmHg, and Ca,d= 0.15 ml/mmHg.
4.3.3 The Simple Pulsatile Cardiovascular Model
Applying the cycle-averaging operator to the Windkessel and modified Windkessel models was straight-
forward as these models are LTI and cycle-averaging is an inherently linear operation. When a circuit
model has nonlinear and/or time-varying elements, such as the SPCVM, cycle-averaging is not as easily
applied. Heldt and co-workers [41] applied cycle-averaging methodology to a version of the CVSIMple
model of Chapter 3 assuming a piecewise constant ventricular elastance. However, this assumption led to
impulsive, and hence unrealistic, hemodynamic waveforms. Furthermore, the cycle-averaged model derived
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Figure 4.6: The simple pulsatile cardiovascular model (SPCVM) uses a 3-way switch which allows for
simpler analysis of the circuit. Vi and Vo are defined here for future reference. For simplicity, only one
diode is used to facilitate development of the averaged model.
there was dependent on the fine structure of the hemodynamic waveforms simulated by the pulsatile model.
Thus, if one were to change the elastance function for the ventricle for example, the cycle-averaged model
would have to be derived anew. The cycle-averaged model derived in this section remedies some of these
shortcomings.
As mentioned in the previous chapter, the SPCVM has a single ventricular compartment, and is useful
in studying systemic vascular conditions such as hemorrhaging in the peripheral circulation. Figure 4.6
illustrates the circuit representation for the SPCVM, but with two additional sources: Vzp and Vth. The
source Vzp is the zero-pressure filling volume for the body’s veins, while Vth is the pressure in the thoracic
cavity.
The elastance function Eh(t)=1/Ch(t) for the ventricular compartment in the SPCVM is taken to be the
piecewise linear periodic function of Equation (3.18). The parameters used in the SPCVM, including the
initial conditions for our simulations, are given in [16] and in Table 3.1 of Chapter 3. For simplicity, we
set Vzp and Vth equal to 0 mm Hg. The derivation of a cycle-averaged model with non-zero Vzp and/or Vth
would require only a trivial modification of the cycle-averaged model derived here.
The state space model for the SPCVM, repeated here for convenience is as follows:
dQh
dt
=
s1(Vv −EhQh)
R1
+
sD(Va − EhQh)
R2
(4.29)
Ca
dVa
dt
=
sD(EhQh − Va)
R2
+
(Vv − Va)
Ra
(4.30)
Cv
dVv
dt
=
s1(EhQh − Vv)
R1
+
(Va − Vv)
Ra
(4.31)
where the parameters p={R1, R2, Ra, Ca, Cv, Es, Ed, T} are fixed or slowly varying and we have again
dropped the time argument t for notational simplicity.
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The cycle-averaging methodology for this model, to which we turn next, is considerably more involved
than for the Windkessel or modified Windkessel models due to the presence of state-dependent switching
functions.
4.3.4 Cycle-Average Expressions for the SPCVM
To apply the cycle-average operators (〈•〉k) to our state-space model in (4.29)-(4.31), we need additional
expressions for derivatives of index-k cycle-averages and for the cycle-averages of the products of two
variables, such as sD(t)Va(t), or three variables, such as s1(t)Eh(t)Qh(t).
By differentiating (4.18) with T kept fixed, we easily obtain an expression for the derivative of the index-k
cycle-average:
d
dt
Xk(t) =
〈
dx
dτ
〉
k
(t)− jk2pi
T
Xk(t) . (4.32)
The index-k cycle-average of the product of two signals, x(t) and y(t), is given by the easily verified discrete
convolution formula for the product of the coefficients of two polynomials:
〈xy〉k =
∞∑
m=−∞
XmYk−m . (4.33)
The index-k cycle-average of the product of three signals, x(t), y(t), and z(t), can be obtained by applying
the discrete convolution relationship (4.33) to [x(t)y(t)](z(t)) to obtain:
〈xyz〉k =
∞∑
l=−∞
Zl〈xy〉k−l
=
∞∑
l=−∞
Zl
( ∞∑
m=−∞
Xk−l−mYm
)
. (4.34)
In our application, we can neglect many of the Fourier series coefficients as their magnitude is relatively
small, making these formulas much simpler to apply. Assuming only the index-0 and index-1 cycle-averages
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are significant, as is the case for the pulsatile SPCVM waveforms, we have:
〈xy〉0 = X0Y0 + 2(XR1 Y R1 +XI1Y I1 ) (4.35)
〈xy〉R1 = X0Y R1 +XR1 Y0 (4.36)
〈xy〉I1 = X0Y I1 +XI1Y0 (4.37)
〈xyz〉0 = X0〈yz〉0 + 2(XR1 〈yz〉R1 +XI1〈yz〉II)
(4.38)
〈xyz〉R1 = X0〈yz〉R1 +XR1 〈yz〉0 +XR1 (XR1 Y R1
−XI1Y I1 )−XI1(XR1 Y I1 +XI1Y R1 ) (4.39)
〈xyz〉I1 = X0〈yz〉I1 +XI1〈yz〉0 +XI1(XR1 Y R1
−XI1Y I1 ) +XR1 (XR1 Y I1 +XI1Y R1 ) . (4.40)
To obtain a cycle-averaged model, one can apply the formulas derived in Section 4.3.1 and in this section to
a state-space model. If we represent circuit variables by their index-0 and index-1 (and, where necessary,
their index-2) cycle-averages, but keep the index-1 and any index-2 cycle-averages constant, we end up
with what we shall call an index-0 cycle-averaged model.
4.3.5 The Index-0 Cycle-Averaged Model
To obtain an index-0 cycle-averaged model for the SPCVM, we begin by deriving an approximation for
the diode turn-on time tD. This approximation is important since we need develop a cycle-averaged model
in which all variables, including tD, depend only on index-0 cycle-averaged quantities.
4.3.5.1 An approximation for tD
We first need to express the index-0 cycle-average SD0 of the switching function sD for the diode D
in terms of cycle-averages of Va, Qh, and Vv. We do not require such an approximation for the other
switching functions because their index-0 cycle-averages are not state-dependent. An approximation for tD
can be obtained on examination of the relevant circuit waveforms in region I (see Table 3.3) of the model’s
operation.
Figure 4.7 shows the SPCVM circuit in region I, where the switch is in position 2 and the diode D is
open. In this region, the charge Qh is fixed, but pressure Vh is increasing since the elastance function Eh is
increasing linearly. At the same time, the arterial pressure Va is decreasing as Ca discharges into Cv. The
diode D begins conducting when Vh equals Va.
Since the capacitance Cv is very large, we can assume Vv is essentially constant, and hence that Vv = Vv0,
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Figure 4.7: Circuit representation for the SPCVM in region I.
where Vv0 is the index-0 cycle-average of Vv. Assuming region I begins at time t = 0, Vh in region I is
given by
Vh = QhEh = Qh(0)
(
(Es − Ed)
T
3
t+Ed
)
(4.41)
where we have used the fact that Qh=Qh(0) in region I.
At the beginning of region I, Vh ≈ Vv and Eh = Ed, so
Qh(0) ≈ Vv0
Ed
. (4.42)
If we assume the relative ripple on the arterial pressure Va to be small2, we can assume that Va = Va0.
The approximate diode turn-on time, tˆD, is then given by solving
Vh(tˆD) = Va(T + tˆD)
Vv0
Ed
(
3(Es −Ed)
T
tˆD +Ed
)
= Va0 (4.43)
for tˆD, which yields
tˆD =
EdT
3(Es −Ed)
(
Va0
Vv0
− 1
)
. (4.44)
Figure 4.8 plots both sides of (4.43) on the same axes along with the steady-state waveforms for Vh and Va
obtained with the nominal SPCVM parameters in [16]. The actual tD is given by the left-most intersection
of Vh and Va, while tˆD is given by the intersection of the lines representing the left- and right-hand sides of
(4.43). The error in approximating tD is only about 4% for the steady-state waveforms shown in Fig. 4.8.
The index-0 cycle-average of the sD waveform is then given by applying the index-0 cycle-averaging operator
2Other approximations for tD do not make this assumption; however, the improvement in results does not justify the added
complexity.
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Figure 4.8: The left and right hand side of the approximation of the equation defining tˆD. The left-most
intersection of Vh and Va defines tD, while the intersection of the LHS and RHS of (4.43) define tˆD.
to sD to obtain
SD0 =
1
T
∫ T
3
tD
sD(t)dt ≈ 13 −
Ed
3(Es − Ed)
(
Va0
Vv0
− 1
)
. (4.45)
If we were to approximate tD as a fixed constant, the resulting index-0 cycle-averaged model would be
linear and time-invariant. However, SD0 in (4.45) depends nonlinearly on state variables in the circuit,
making the cycle-averaged model nonlinear, though still time-invariant.
4.3.5.2 Fourier analysis
To derive an index-0 cycle-averaged model, one needs to find nominal values at which to fix the index-1
and higher cycle averages. From simulations of the SPCVM, we justified that the index-2 and higher
cycle-averages can be neglected for all the SPCVM waveforms except the ventricular volume, Qh, and
the ventricular elastance, Eh (see Appendix D.3 for derivations of the expressions we used). We then
numerically (or partially analytically in the case of s1 and Eh) calculated the relevant index-1 and index-2
cycle-averages using steady-state Fourier series representations of all the hemodynamic waveforms and
switching functions from our simulations. The steady-state SPCVM waveforms we used were obtained
from simulations with the nominal SPCVM parameters [16].
The results of this exercise are shown in Table 4.1. Since s1(t) is half-wave symmetric, it has no index-m
cycle-averages for m even (m ≥ 2). The first- and second-order Fourier series approximations we calculated
for the steady-state Va, Vh, and Qh waveforms are shown in Fig. 4.9.
As noted above, we used exact analytical expressions for switching functions s1(t), Eh(t), and sD(t). For
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Figure 4.9: First- and second-order Fourier-series approximations for the steady-state SPCVM waveforms
using the parameters in Table 3.1. Solid lines: actual waveforms; dash-dotted lines: Fourier series approx-
imations thereof.
Variable 〈•〉0 〈•〉R1 〈•〉I1 〈•〉R2 〈•〉I2
Vv 15.23 −0.09 −0.03 0.02 0.01
Va 100.54 −4.91 −3.59 −1.91 0.83
Qh 88.12 18.48 10.52 2.03 −2.52
Eh 0.70 −0.09 −0.47 −0.21 0.12
s1 0.50 0.00 0.32 0.00 0.00
sD 0.25 0.06 −0.22 −0.14 −0.08
Table 4.1: Values of cycle-averages in steady-state.
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the s1(t) waveform in Fig. 3.13, for example, it is easy to show that:
S10 =
T
2
. (4.46)
S1
R
1 = −
sin(2piS10)
2pi
. (4.47)
S1
I
1 = −
1
2pi
(
cos(2piS10)− 1
)
. (4.48)
Similarly, for the waveform for sD(t) displayed in Fig. 3.13, we could write:
SD
R
1 =
1
2pi
(
cos
(
2pitˆD
)
− cos
(
2pi
T
3
))
(4.49)
SD
I
1 =
1
2pi
(
sin
(
2pi
T
3
)
− sin
(
2pitˆD
))
(4.50)
where the expression for tˆD was derived in the previous section. In our simulations, however, we fixed SDR1
and SDI1 using tˆD=0.0822 seconds, which corresponds to the value of SD0 in Table 4.1.
Finally, Eh0 is given by:
Eh0 =
1
T
(∫ T
0
Eh(t)dt
)
=
1
4
Es +
3
4
Ed . (4.51)
and EhR1 and Eh
I
1 are given by finding the real and imaginary parts of:
Eh1 =
1
T
(∫ T
0
Eh(t)ej
2pit
T dt
)
. (4.52)
In addition, we implemented an index-0 dependence for the index-1 cycle-averages of the arterial blood
pressure, VaR1 and Va
I
1, and for the index-1 cycle-averages of the ventricular volume, Qh
R
1 and Qh
I
1. These
four index-1 cycle-averages were scaled by T and Va0, since (4.24) and (4.23) respectively show that pulse
pressure and stroke volume are proportional to Va0T in the Windkessel model. We therefore set:
Va
R
1 =
Va0
Va0nominal
T
Tnominal
(VaR1 )nominal (4.53)
Va
I
1 =
Va0
Va0nominal
T
Tnominal
(VaI1)nominal (4.54)
Qh
R
1 =
Va0
Va0nominal
T
Tnominal
(QhR1 )nominal (4.55)
Qh
I
1 =
Va0
Va0nominal
T
Tnominal
(QhI1)nominal (4.56)
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where the nominal values of the index-1 cycle-averages were taken from Table 4.1. (One could also consider
scaling the index-2 cycle-averages QhI2 and Qh
R
2 by the same factor as in Equations (4.53)-(4.56). However,
from simulations of the index-0 cycle-averaged model, we observed that such a scaling increases the resulting
error, perhaps because the phase relations of the index-1 and index-2 terms change in the pulsatile circuit
as conditions change.)
4.3.5.3 The index-0 cycle-averaged model
Using the values listed in Table 4.1 and applying the cycle-average operators from the previous section to
(4.29-4.31), we obtain an index-0 cycle-averaged model for the SPCVM:
d
dt
X0(t) =
d
dt
Qh0(t)Va0(t)
Vv0(t)
 =
−
〈s1EhQh〉0
R1
− 〈sDEhQh〉0R2 +
〈sDVa〉0
R2
+ 〈s1Vv〉0R1〈sDEhQh〉0
R1Ca
− (R2+Ra)Va0R2RaCa +
Vv0
RaCa〈s1EhQh〉0
R1Cv
+ Va0RaCv −
〈s1Vv〉0
R1Cv
− Vv0RaCv
 . (4.57)
Under our assumptions on the index-1 and higher cycle-averages, we can rewrite (4.57), using (4.35)-(4.40),
as
d
dt
X0(t) ≈ C(S10, SD0(t), p)X0(t) + d(S10, SD0(t), S11, SD1,X1,X2, p) (4.58)
where C(S10, SD0(t), p) is dependent on the index-0 cycle-averages of the switching functions and the
parameters p, and where d(S10, SD0(t), S11, SD1,X1,X2, p) is dependent on the index-0 and index-1 cycle-
averages of the switching functions, the index-1 cycle-averages, X1, the index-2 cycle-averages of Qh and
Eh, X2, and the parameters p. (Because of the index-1 adjustments in (4.53)-(4.56), X1 actually varies
with X0(t).) Exact expressions for C(S10, SD0(t), p) and d(S10, SD0(t), S11, SD1,X1,X2, p) are given in
Appendix D.1.
Note that the state variables in this cycle-averaged model are the index-0 cycle-averages of the state
variables in the SPCVM. Furthermore, it can be verified that the total charge in this cycle-averaged model
is conserved, and is equal to the total cycle-averaged charge in the SPCVM, as shown in Appendix D.2.
In steady-state, the matrix C has three eigenvalues: one that corresponds to a fast time constant (≈ 0.01
s), another that corresponds to a slower time constant (≈ 0.5 s), and one that is at zero3. Denoting the
eigenvector of C corresponding to this zero mode as v3, the index-0 cycle-averaged model state variables in
steady state are given by: Qh0Va0
Vv0
 = ζv3 − C‡d (4.59)
where ζ is a constant that is determined by equating the total charge in the SPCVM to the total charge
3The left eigenvector u of the steady state matrix C corresponding to this zero mode should be such that ud=0, otherwise
a steady state for (4.58) is not guaranteed.
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Figure 4.10: Index-0 cycle-averaged model with two-voltage dependent voltage sources and two current-
dependent voltage sources.
in the index-0 cycle-averaged model, and C‡ is the pseudo-inverse of the steady-state matrix C .
Initially, the parameters p in C and d are set to the nominal SPCVM parameters in Table 3.1 [15], which we
shall call the nominal parameter set pnom, and the index-1 and index-2 cycle-averages are fixed at the values
given in Table 4.1. To start the cycle-averaged model in steady-state, the initial conditions X0(0) for the
index-0 cycle-averaged model are set equal to the numerically calculated cycle-averages of the steady-state
simulated waveforms, xss, of the SPCVM using the parameters pnom.
Due to truncation error in the Fourier series approximations leading to (4.58)4, however, setting X0(0)=xss
in the index-0 cycle-averaged model leads to a non-zero value for
e = C(S10, SD0(0), pnom)xss + d(S10, SD0(0), S11, SD1,X1,X2, pnom) (4.60)
in the index-0 cycle-averaged model. This violates the assumption that the circuit starts in steady-state
with a certain fixed charge (or blood volume). To correct for this truncation error, we can subtract the
fixed correction term e from the right side of (4.58). The index-0 cycle-averaged model we propose is then
given by
d
dt
X0(t) = C(S10, SD0(t), p)X0(t) + d(S10, SD0(t), S11, SD1,X1,X2, p)− e . (4.61)
One alternative to using this correction term would be to use more index-2 Fourier series terms in (4.58);
however, such higher-order approximations were only used for expressions involving Qh and Eh.
We can also construct a circuit model that captures the dynamics of the index-0 cycle-averaged model
using voltage-dependent voltage sources and current-dependent current sources. Such an index-0 cycle-
averaged circuit, based on the SPCVM state space model in Equations (4.29) through (4.31) (or by direct
averaging of the circuit in Fig. 4.6, see [99]), is shown in Fig. 4.10. Note that the LTI components of the
4For a brief discussion of the modeling error that results from truncating these Fourier series, please see [100].
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Steady-state Error (%)
for specified values of Ra in:
Ra in PRU Va Qh Vv
1 0.00 0.00 0.00
0.6 0.54 0.55 0.04
1.4 1.33 0.86 0.14
Table 4.2: Steady-state error for the values of Ra from Fig. 4.11.
pulsatile circuit are unchanged by the cycle-averaging; they are in the same location, imposing the same
constraints, but now on the averaged rather than instantaneous quantities. In this averaged circuit, the
average compliance for the left ventricle, Ch,eff, is equal to 1/Eh0 (see [41] for a derivation), and the source
Vh,eff is introduced to properly convert Qh0 into Vh0. Using Vi and Vo from the circuit in Fig. 4.6, we can
write
Vi0 = S10Vh0 + (1− S10)Vv0 +Ki (4.62)
Vo0 = SD0Vh0 + (1− SD0)Va0 +Ko (4.63)
where Ki and Ko are variables that depend on the index-1 cycle-averages of sD, Vh, Va, and Vv, and fixed
index-2 cycle-averages of Eh and Qh.
4.3.6 Results and Discussion
Using the index-0 cycle-averaged model (4.61), we obtained simulation results for typical transient responses
to step changes in Ra, the systemic vascular resistance, and in T , the length of the cardiac cycle. We decided
on these two parameters because both are significant hemodynamic variables in the clinical setting, and
the cycle-averaged model is sensitive to both.
Figure 4.11 shows the transient responses of the index-0 cycle-averaged model for T=1s, during three
step changes in systemic vascular resistance Ra [in peripheral resistance units (PRU) or equivalently
mmHg/(ml/s)]: at t=15 s, Ra was stepped up to 1.4 PRU; at t=30 s, Ra was stepped down to 1 PRU;
and at t=45 s, Ra was stepped down to 0.6 PRU. In Fig. 4.11, the index-0 cycle-averaged model responses
are compared to the calculated index-0 cycle-averages from the SPCVM.
The errors inherent in the steady-state cycle-averaged waveforms for ABP, ventricular volume, and CVP
from this simulation are shown in Table 4.2. The maximum error in the steady-state cycle-averaged
waveforms (i.e.,after each transient step response has settled) was approximately 1.3%, which is acceptable
for the applications envisioned for this model. For this simulation, the transient error is lower than the
steady-state error and is therefore not reported here. There was no error for the nominal condition of
Ra=1 PRU because the initial conditions of the model (4.61) were set such that we began the simulation
at the calculated cycle-averages from a simulation of the SPCVM with p=pnom, and X1 and X2 set to the
values given in Table 4.1.
– 106 –
4.3 Cycle-Averaged Models
5 10 15 20 25 30 35 40 45 50 55
0
20
40
60
80
100
120
140
160
180
Time (s)
Vo
lu
m
e 
(m
l)
 
 
Calculated Cycle−Average Ventricular Volume
Ventricular Volume from Cycle−Averaged Model
(a) Ventricular Volume
5 10 15 20 25 30 35 40 45 50 55
0
20
40
60
80
100
120
140
160
180
Time (s)
Pr
es
su
re
 (m
m 
Hg
)
 
 Calculated Cycle−Average ABP
ABP from Cycle−Averaged Model
Calculated Cycle−Average CVP
CVP from Cycle−Averaged Model
(b) Arterial Blood Pressure and Central Venous Pressure
Figure 4.11: Comparison of the transient responses of the index-0 cycle-averaged model to the calculated
cycle-averaged SPCVM waveforms for several step changes in resistance Ra. At t=15 s, Ra was stepped
up to 1.4 PRU, at t=30 s, Ra was stepped down to 1 PRU, and at t=45 s, Ra was stepped down to 0.6
PRU.
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Analytical Calculated
Ra in PRU Time Constant Time Constant RaCa
1.4 1.21 s 1.17 s 2.8 s
1 1.05 s 1.06 s 2 s
0.6 0.82 s 0.98 s 1.2 s
Table 4.3: Time constants in steady-state for the transient responses for the values of Ra from Fig. 4.11.
In steady-state, the matrix C(S10, SD0(t), p) has three eigenvalues: one corresponding to a fast time constant
(≈ 0.02s), another to a slow time constant, and one that is zero [41]. The transient responses of our
simulation are governed by the slow time constant. For the simulation of transients in Ra in Fig. 4.11, we
determined the slow time constant both analytically and empirically in the neighborhood of steady-state.
We computed analytical time constants by calculating the eigenvalues of C(S10, SD0(t), p) at t=30 s (Ra=1.4
PRU), t=45 s (Ra=1 PRU), and t=60 s (Ra=0.6 PRU). We also computed empirical time constants by
fitting an exponential function to the calculated cycle-averaged ABP waveform for 24 < t < 30 s (Ra=1.4
PRU), 39 < t < 45 s (Ra=1 PRU), and 54 < t < 60 s (Ra=0.6 PRU). Table 4.3 compares these two
time constants to that obtained by estimating the time constant as RaCa, a reasonable assumption for the
SPCVM since Cv is large and the SPCVM spends most of the cardiac cycle with sD(t)=0. The empirical
time constant for Ra=0.6 PRU does not match the analytical one as well as the other cases because the
transient response for 45 < t < 60 s settles to steady-state very quickly, making it difficult to estimate the
time constant properly. Nonetheless, the analytical time constants we obtained are much more accurate
than simply estimating the time constant as RaCa.
Figure 4.12 shows the transient responses of the index-0 cycle-averaged model for three step changes in
cardiac cycle duration T : at t=15 s, T was stepped down to 0.5 s; at t=30 s, T was stepped back up to
its nominal value of 1 s; and at t=45 s, T was stepped up to 1.2 s. These values of T correspond to heart
rates of 50 beats/minute to 120 beats/min. In Fig. 4.12, the index-0 cycle-averaged model responses are
compared to the calculated index-0 cycle-averages from the SPCVM. The maximum error in the steady-
state cycle-averaged waveforms is larger than the simulation with transient changes in Ra – approximately
4%. This happens when the heart rate goes high, and where our approximation for tD is poorest. For
heart rate going low, the maximum error is 1.5%. Again, for this simulation, the transient error is lower
than the steady-state error.
There are significant computational savings obtained when using the index-0 cycle-averaged model. Ta-
ble 4.4 compares the CPU time for the simulation of Fig. 4.11 versus the time that it would take to simulate
the SPCVM for the transients in Ra, not including the computational time for the calculated averages in
Fig. 4.11. For the simulations, we used a Pentium M 1.7 GHz personal computer running Windows XP
and MATLAB 7.01 (The Mathworks Inc., Natick, MA) with the “ode23” differential equation solver (see
Appendix F). In the table, we also list the maximum step size limits that can be used in the simulations
before output waveform degradation occurs.
Finally, we note that systolic and diastolic ABP, both important variables in clinical settings, can be
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Figure 4.12: Comparison of the transient responses of the index-0 cycle-averaged model to the calculated
cycle-averaged SPCVM waveforms for several step changes in T . At t=15 s, T was stepped down to 0.5 s.
At t=30 s, T was stepped back up to its nominal value of 1 s, and at t=45 s, T was stepped up to 1.2 s.
Model CPU Time Max. Step Size Limit
SPCVM 6.05 s 0.004 s
Index-0 CAM 0.61 s 0.5 s
Table 4.4: Computational savings obtained using the index-0 cycle-averaged model.
– 109 –
Averaged Models of Cardiovascular Dynamics
5 10 15 20 25 30 35 40 45 50 55 60
40
60
80
100
120
140
AB
P 
(m
m 
Hg
)
 
 
ABP Waveform from index−0 Cycle−Averaged SCVM
Index−0 Cycle−Averaged ABP Waveform
5 10 15 20 25 30 35 40 45 50 55 60
40
60
80
100
120
140
Time (s)
AB
P 
(m
m 
Hg
)
 
 
ABP Waveform from Pulsatile SCVM
Calculated Cycle−Averaged ABP Waveform
Figure 4.13: Envelope of the ABP waveform from the cycle-averaged model (top) compared to that of the
SPCVM (bottom) for several step changes in peripheral resistance Ra. At t=15 s, Ra was stepped up to
1.4 PRU, at t=30 s, Ra was stepped down to 1 PRU, and at t=45 s, Ra was stepped down to 0.6 PRU.
estimated from the index-0 cycle-averaged model. Figure 4.13 is an example of such an approximation,
where the ABP waveforms from the cycle-averaged model and the SPCVM are compared for the same
transient as that in Fig. 4.11. The waveform in the top of Fig. 4.13 is sinusoidal, as it was calculated using
the formula
Va(t) ≈ Va0(t) + 2VaR1 cos
(
2pi
T
t
)
− 2VaI1 sin
(
2pi
T
t
)
, (4.64)
with VaR1 and Va
I
1 modulated as in (4.53) and (4.54), respectively.
We could also try to derive an index-1 cycle-averaged model to track the pulsatile arterial blood pressure
waveform. However, this would require six additional state equations for tracking the index-1 cycle-
averages.
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4.4 Chapter Summary
In this chapter, we presented both discrete-time beat-to-beat and continuous-time cycle-averaging method-
ologies applicable to dynamic systems in close to periodic operation, and illustrated their application to
the Windkessel, modified Windkessel, and, in the case of cycle-averaging, to a somewhat more elaborate
cardiovascular model – the SPCVM – that has nonlinear and time-varying components.
The beat-to-beat averaged models were obtained by integrating the differential equations of the underly-
ing pulsatile models over a single cardiac cycle. In Chapter 5, we show how the beat-to-beat averaged
Windkessel model (4.8) can be used to estimate cardiac output.
The cycle-averaged models were derived by applying short-term averaging operators to the differential
equations of the underlying pulsatile models. Despite the approximations needed to obtain the cycle-
averaged version of SPCVM, our cycle-averaged model captures the inter-cycle cardiovascular dynamics of
SPCVM with relatively small approximation errors for a large range of perturbations in important system
parameters.
Further simplifications of the SPCVM — for instance, replacing Vv by a constant source, eliminating the
remaining diode, and simplifying the logic for the switch — lead to pulsatile behavior that is still repre-
sentative of cardiovascular dynamics, but that may have a simpler averaged model. These simplifications,
and various extensions, and applications to fitting real data are beyond the scope of this thesis, but will
hopefully be explored in future research work in our group.
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Chapter 5
Continuous Monitoring of Cardiac Output and
Total Peripheral Resistance
CARDIAC output (CO) is an important hemodynamic variable that may be used to establish differ-ential diagnoses, monitor disease progression, and titrate therapy in many cardiovascular conditions.
CO can be measured in several ways, including echocardiography imaging studies, magnetic resonance
imaging studies, and ventricular impedance catheter-based volume measurements. Unfortunately, the
current clinical standard for measuring cardiac output is intermittent thermodilution – a highly invasive
procedure in which a Swan-Ganz catheter [9] is advanced to the pulmonary artery, a bolus of cold saline
is injected, and its mixing temperature with blood is observed over the time course of tens of seconds to
a minute. Because of its invasive nature (and some controversy surrounding its effect on patient outcome
[101, 102, 103, 104], thermodilution requires an expert operator and is usually reserved for only the sickest
of patients [3].
Rather than intermittently estimating average cardiac output invasively via thermodilution, many attempts
have been made to noninvasively obtain a continuous estimate of cardiac output from the arterial blood
pressure (ABP) waveform [37, 54, 60, 62, 64, 65, 72, 105, 106]. Some of these CO estimation methods have
since been deemed insufficiently reliable for clinical decision-making [107], while others claim to be reliable
[65]. Since stroke volume is related to the arterial pressure wavelet through the properties of the arterial
tree, realistic assumptions about the latter allow for the estimation of stroke volume, and thus cardiac
output, on a beat-to-beat basis. One of the most basic models for the arterial tree is a Windkessel [62]: a
single, leaky pressurized chamber that is filled intermittently with boluses of fluid. In fact, several methods
for estimating stroke volume from the arterial pressure waveform (so-called pulse contour methods) are
derivatives of the basic Windkessel model [37, 64, 65, 72]. Each of these methods assumes that the arterial
tree behaves like a Windkessel on a beat-to-beat basis, and cardiac output is estimated using morphological
features, e.g., systolic and/or diastolic values, of the arterial blood pressure waveform.
Recently, Mukkamala and co-workers [57, 58] pointed out that the arterial tree behaves like a Windkessel in
the limit of inter-beat time scales, but not over intra-beat time scales, as wave reflections significantly distort
the individual pressure wavelets, and therefore negatively affect stroke volume estimates derived using
the Windkessel model. Other researchers disagree with this proposition [108]. Nonetheless, Mukkamala
and co-workers intermittently, i.e.,every 3 minutes, and with clinically acceptable precision, estimated
relative changes in cardiac output from inter-cycle variations of the ABP waveform by finding the impulse
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response function of the Windkessel model and, from it, the time constant of arterial outflow. Knowing
the latter enables one to estimate proportional cardiac output, from which absolute CO can be obtained
via calibration with true CO measurements.
The work by Mukkamala and co-workers on the problem of estimating cardiac output from beat-to-beat
variations in ABP is consistent with our motivation in developing the averaged models of the cardiovascular
system of Chapter 4. These models are capable of dynamically tracking the time-averaged behavior of
various hemodynamic waveforms on a beat-to-beat basis.
5.1 Outline
This chapter is comprised of two parts: one describing our novel CO estimation method [109], and the
second describing the application of this method to two animal and two human data sets. A full analysis
of the errors obtained on application of our method is reported for one of the animal data sets.
In the first part of this chapter, we review the Windkessel model (Section 5.2), and then derive our beat-
to-beat averaged Windkessel model-based CO estimation method (Section 5.3). We show that, following
the example of Mukkamala and co-workers, we can directly apply the discrete-time beat-to-beat averaged
Windkessel model of Chapter 4 to estimate the Windkessel model arterial time constant. In doing so, we
exploit the beat-to-beat variability in arterial blood pressure and heart rate. Cardiac output estimates can
then be calculated using this time constant and a value for the corresponding arterial compliance that is
obtained via calibration with reference cardiac output measurements. This estimation method has a clear
physiological basis, and is simple to understand and implement.
Calibration methods are discussed in detail in Section 5.4. In particular, unlike Mukkamala and co-workers,
but consistent with other researchers [65, 110], we investigate the use of a parabolic arterial volume-mean
pressure relationship, and compare this compliance to a constant arterial tree compliance. This compliance
is the calibration factor for our CO estimate.
Error criteria used to compare our estimate to the reference cardiac output measurements are discussed in
Section 5.5. We use these criteria to evaluate how our estimation method compares to several other model-
based CO estimation methods when applied to animal and human data. Central to our CO estimation
method are the notions of inter-beat and intra-beat arterial blood pressure variability. In Section 5.6, we
discuss CO variability and some na¨ıve CO estimators, as the estimation error that results from applying a
na¨ıve CO estimator is a strong indicator of CO variability.
In the second part of this chapter, we show the results obtained by applying our method to a porcine
(Section 5.8), a canine (Section 5.9), and two human (Sections 5.10 and 5.11) ICU data sets. We also
compare our results to those we obtained by applying a number of other CO estimation methods to the
same data sets. We show that our method consistently outperforms all other methods we chose to apply
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Figure 5.1: Circuit representation for the Windkessel model.
to the various data sets presented in this chapter. We conclude the chapter with Section 5.12 which
summarizes the main results and presents some ideas for future work.
5.2 The Windkessel Model Revisited
In this section we revisit the discrete-time beat-to-beat averaged Windkessel model which is the basis of
our CO estimation method described in Section 5.3.
5.2.1 Model Description
As mentioned in Chapters 3 and 4, the Windkessel model describes the basic phenomenon of an arterial
pressure pulse [62]. It lumps the distributed resistive and capacitive properties of the entire arterial tree
into two elements, as seen in the electrical circuit analog in Fig. 5.1: a single resistor, Ra, represents
total peripheral resistance (TPR), and a single capacitor, Ca, represents the aggregate elastic properties
of all arteries. Though Ca is expected to show a nonlinear dependence on arterial blood pressure, here we
take this dependence to be on mean arterial blood pressure, Va. Equivalently, we assume pulse pressure
is small relative to MAP, and the incremental compliance evaluated around MAP provides a sufficient
approximation of the compliance characteristic for the entire ABP waveform over the cycle. Furthermore,
we assume Va changes slowly enough that Ca may be assumed essentially constant over any window of a
few beats duration.
The state space equation for the Windkessel model, repeated here for convenience, is:
Ca
dV (t)
dt
+
V (t)
Ra
= I(t) (5.1)
In addition, the pulse pressure-stroke volume relationship for the Windkessel model, assuming impulsive
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cardiac ejection, is as follows:
PPn = SAPn −DAPn = SVn
Can
(5.2)
where Can is the lumped arterial tree compliance in the nth cardiac cycle.
5.2.2 Arterial Tree Compliance
As mentioned above and in Chapter 3, the arterial tree compliance Ca is perhaps better modeled as a
function of arterial blood pressure, rather than as a constant. We observe below that a constant compliance
is a reasonable assumption for modeling animal data, but a pressure-dependent compliance may be more
relevant for ICU patients.
We mentioned several studies on arterial tree compliance in Section 3.4.2. Of particular relevance in terms
of CO estimation, is the arctangent volume-pressure curve proposed by Langewouters et al. [110] based
on ex vivo studies of human thoracic and abdominal aortas. Their work was further strengthened by the
work of Tardy et al. [111] who describe in vivo studies on the mechanical properties of human peripheral
arteries. The relationship proposed by Langewouters and co-workers, and used by Wesseling et al. [65] in
their CO estimation method, yields the following (incremental) compliance:
Ca =
α1
α2 + α3(Va − V ∗)2 (5.3)
where α1, α2, and α3 are constants, and V ∗ is the inflection point of their arctangent aortic volume-pressure
relationship. In humans, a value V ∗=40 mmHg is suggested [65]. The constants α1, α2, and α3 depend
on patient gender and age; nominal values of these constants can be extracted from regression analyses
described in [110]. The CO estimation approach in [65] allows a further adjustment of α1 when calibrating
against available CO measurements.
There are other pressure-dependent compliances that have been used in CO estimation methods, e.g., the
pressure-dependent compliances of Godje et al. [112] and Liljestrand and Zander [64]. In [64], compliance
is simply modeled as being inversely proportional to the sum of the beat-to-beat systolic and diastolic
arterial blood pressures, while in [112], compliance is modeled using a complicated expression that involves
both mean and instantaneous arterial blood pressure.
In our work, we attempt to use either a linear arterial tree compliance:
Can = γ1 + γ2Van (5.4)
where γ1 and γ2 are constants, Can is arterial tree compliance and Van is mean arterial blood pressure,
both in the nth cardiac cycle (or beat), or a constant arterial tree compliance:
Can = γ1 (5.5)
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which arises naturally from its linear counterpart as the special case of γ2=0.
The function (5.4) corresponds to a parabolic volume-mean pressure relationship in the arterial tree, is
simpler than the one used in [65], and facilitates estimation of patient- or animal-specific parameters
from calibration data. A review of the literature (see Section 3.4.2) shows no significant advantages of a
logarithmic or arctangent volume-mean pressure relationship over one that is parabolic or one that uses
instantaneous arterial blood pressure. In our work, we compare the calibrated CO estimates obtained
using (5.5) to those obtained using (5.4). We also allow for the total peripheral resistance to vary from
cycle to cycle, denoting its value in the nth cardiac cycle Ran.
5.3 Using the Beat-to-Beat Averaged Windkessel Model to Estimate
Cardiac Output
In this section we work with the beat-to-beat averaged Windkessel model (4.8) from Chapter 4 and show
how we use it to estimate cardiac output. It would also be possible to use the beat-to-beat averaged
modified Windkessel model (4.13) to do such estimation; this is the subject of current research in our
group [17].
5.3.1 Model Description
As derived in Chapter 4, the discrete-time beat-to-beat averaged Windkessel model equation is:
Can
∆Van
Tn
+
Van
Ran
= COn (5.6)
where ∆Van = Va(tn+1)− Va(tn). Note that (5.6) is a natural discrete-time counterpart to (5.1).
Average cardiac output in the nth cycle is given by:
COn =
SVn
Tn
= Can
PPn
Tn
(5.7)
where we have invoked (5.2) to obtain the second equality.
Although, equation (5.7) can be used to estimate CO given pulse pressure, we proceed here to derive
alternative expressions for cardiac output. As we show below, one such expression, Equation (5.9), results
in much lower estimation error when applied to various human and animal data sets. Combining (5.7) and
(5.6), we obtain
∆Van
Tn
+
Van
τn
=
PPn
Tn
, (5.8)
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Figure 5.2: Porcine radial arterial blood pressure waveform showing quantities that are used, on a beat-
to-beat basis, to estimate the time constant τn in Equation (5.8). Mean arterial blood pressure in beat n
is the area under the pressure waveform in the nth cardiac beat.
where τn=RanCan is the only unknown. Thus, Equation (5.8) can be used to estimate τn from knowledge
of the remaining quantities, most of which are illustrated in Fig. 5.2.
COn can then be estimated from (5.6), rewritten below to show dependence on τn:
COn = Can
(
∆Van
Tn
+
Van
τn
)
. (5.9)
In steady-state, the first term on the right hand side of (5.9) vanishes and the equation reduces to:
COn =
Van
Ran
(5.10)
which is simply the relation governing average flow through the resistor Ran given the mean pressure
Van. The vanishing term
∆Van
Tn
in (5.9), represents the average flow through Can. It is a measure of the
beat-to-beat variability in CO and allows us to refine the estimate of τn.
5.3.2 Linear Least-Squares Estimation Scheme
In going from (5.8) to (5.9), we assume that τn varies slowly from beat-to-beat. Inherent in this assumption
is that Can, and hence Van, do not vary too much over the course of a few beats. Had we not assumed
an impulsive cardiac ejection in Equation (5.2), we would have had two unknowns in Equation (5.8), and
would have had to make the assumption that both τn and SVnCan vary slowly from beat-to-beat. Such an
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assumption is invalid for stroke volume as it can change rapidly from one beat to the next. In addition, it
turns out that for the human and animal data sets used in this chapter, the resulting two-parameter (SVn
and τn) least-squares estimation problem is ill-conditioned.
We estimated CO directly from (5.8) by computing a least-squares estimate of τn over a fixed-length data
window, i.e., we calculated a least-squares estimate of τn for the nth beat using a window comprising the
b/2 adjacent beats on each side of this beat. This results in a total of b (even) equations in one unknown,
a very well-conditioned least-squares estimation problem.
−Van
.
.
.
−Vab+n

[
1
τ
n−1+ b2
]
=

∆Va(n)
Tn
− PP(tn)Tn
.
.
.
∆Va(b+n)
Tb+n
− PP(tb+n)Tb+n
 (5.11)
Note that we assign the estimated τn from each window to the midpoint of that window, and that in (5.11),
n > b2 . We then estimated the uncalibrated beat-to-beat CO estimate, UCOn, in the n
th window as:
UCOn =
(
Van
τn
+
∆Van
Tn
)
, (5.12)
from which the calibrated beat-to-beat CO estimate, ECOn, is:
ECOn = CanUCOn . (5.13)
The calibration factor Can can be determined using one or more true or reference CO measurements,
TCOn, as described in Section 5.4.
5.3.3 Calculation of Pulse Pressure
The pulse pressure needed represented in the Windkessel model is that measured at the aortic root. Thus,
calculation of PPn from (5.2) for peripheral pressure waveforms can be problematic because these waveforms
can exhibit pressure wave reflections leading to overestimation of SAPn. Some of these reflections occur
because of the tapering of vessels at the lower levels of the arterial tree. In addition, (5.2) assumes an
impulsive model for cardiac ejection and thus (5.1) simulates blood pressure waveforms that morphologically
do not represent real blood pressure waveforms. In previous work on SV estimation, Herd et al. [106]
suggested using the following estimate for PPn:
PPn = α
(
Van −DAPn
)
(5.14)
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where α is a constant. Their expression for estimated CO is:
COn = α
Van −DAPn
Tn
. (5.15)
Herd et al. [106] argue that Equation (5.14) is more accurate than the usual expression for pulse pressure
because it takes into account not only the blood volume ejected into the arterial tree, but also the additional
blood volume which “leaves the arterial tree during systole.” They also argue that their pulse pressure
estimate is not confounded by wave reflections in the ABP wavelet.
In the results described in this thesis, we compare our estimate (5.13) to (5.15) – the Herd estimate for
cardiac output. Herd et al. compared (5.14) to several other expressions for PPn by performing canine
experiments in which they measured ABP at the ascending aorta.
After we applied (5.2) and visually inspected the reflection-induced morphologies in the peripheral ABP
waveforms in the two animal data sets used in this thesis, we decided to use (5.14) to calculate PPn. We
used α=2 in (5.14) because for high enough HR (i.e., Tn ¿ τn) in the nth cardiac cycle of the Windkessel
model (5.1), a reasonable assumption for the representative values of Tn and τn observed in both animal
data sets, we see that in the (n+ 1)st cardiac cycle, diastolic ABP is given by
DAPn+1 = SAPne
−Tn
τn ≈ SAPn
[
1− Tn
τn
]
(5.16)
such that the MAP in the nth cardiac cycle can be approximated as
Van ≈
1
Tn
[
DAPn+1Tn +
1
2
Tn(SAPn −DAPn)
]
(5.17)
which yields the following formula for pulse pressure in the nth cardiac cycle:
PPn = SAPn −DAPn ≈ 2
(
Van −DAPn
)
. (5.18)
For the human data sets, we used (5.2) to approximate pulse pressure.
5.3.4 Estimation of Total Peripheral Resistance
Total peripheral resistance is an important cardiovascular variable; it is used along with CO and mean ABP
to generate differential diagnoses and monitor disease progression. TPR is especially useful in tracking
conditions that affect the systemic vasculature such as septic shock. Even in conditions that do not affect
the vasculature directly, e.g., hypovolemic shock, a patient’s TPR can change significantly. In the case of
hypovolemic shock, it rises to compensate for blood loss. An estimate of TPR also allows clinicians to infer
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the effects of any vasoactive medications. In the clinical setting, TPR is commonly defined as the ratio of
mean arterial blood pressure to cardiac output:
TPRn =
Van
TCOn
, (5.19)
which is essentially a rearrangement of Equation (5.10), with ∆Van set to zero.
There are two ways in which we can obtain an estimate of TPRn, or Ran, in our beat-to-beat averaged
Windkessel model. First, given beat-to-beat estimates of τn and Can, we can estimate TPR using:
Ran =
τn
Can
. (5.20)
Both τn and Can are outputs of our estimation method, making (5.20) particularly easy to implement.
This estimate is relatively smooth given that τn and Can are usually estimated in a least-squares sense
over a window of many beats.
Second, similar to the Windkessel model-based formula used by Toorop and co-workers [77], we can cal-
culate Ran by subtracting from ECOn the proportion of ECOn that goes into Can and use this flow to
estimate Ran:
Ran =
Van
ECOn − Can∆VanTn
. (5.21)
Since this formula uses beat-to-beat variations in the flow to Can, it tends to be noisier than the estimate
in (5.20).
For the results presented in this thesis, we use (5.21) to estimate TPR, though both (5.20) and (5.21) give
acceptable TPR estimates.
5.4 Calibration Methods
The purpose of calibrating the UCO is to determine an appropriate value of Can such that we can compare
our CO estimate to the true or reference CO. If we did not calibrate, we would only be able to report relative
changes in our CO estimate, i.e.,how relative changes in ECO (or equivalently, how absolute changes in
UCO) track relative changes in TCO, as opposed to how absolute changes in ECO track absolute changes
in TCO.
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5.4.1 Least-Squares Calibration
A natural calibration criterion is the root-mean-square-normalized error (RMSNE), in which we seek an
optimal Can such that we minimize √
sumn
²n
TCOn
(5.22)
This is equivalent to minimizing the commonly-used weighted least-squares error criterion. Specifically, we
want to find a value for Can such that the CO estimation error, ²n, in
TCOn = ECOn + ²n = CanUCOn + ²n (5.23)
is minimized. For example, one can find Can such that the root-mean-square-normalized-error (RMSNE),
described in the Section 5.5, is minimized, i.e., find the optimal Can such that ²nTCOn in
1 =
CanUCOn
TCOn
+
²n
TCOn
(5.24)
is minimized, in the least-squares sense, for all n of interest.
Note that this kind of least-squares calibration is easily done with (5.5) – a constant calibration factor.
For instance, given a set of TCO measurements {TCOpi} at points {p1, . . . , pm}, to find the least-squares
optimal γ1 in (5.5), we need to solve (5.24) using at least one reference TCO measurement, i.e.,we need to
solve: 
UCOp1
TCOp1
.
.
.
UCOpm
TCOpm
 γ1
=

1
.
.
.
1
 . (5.25)
The resulting value for γ1 minimizes the RMSNE between ECO and TCO at points {p1, . . . , pm}.
It is also straightforward to extend this method in order to find the least-squares optimal γ1 and γ2 in
(5.4) – a state-dependent calibration factor as it depends on mean arterial blood pressure. To do so, one
needs to solve (5.24) using at least two reference TCO measurements:
UCOp1
TCOp1
Vap1
UCOp1
TCOp1
. .
. .
. .
UCOpm
TCOpm
Vapm
UCOpm
TCOpm

[
γ1
γ2
]
=

1
.
.
.
1
 (5.26)
for m ≥ 2. For (5.26) to be well-conditioned, there must be a sufficient degree of variation in mean pressure
Van.
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If we solve (5.26) using all the available TCO measurements, we call this a state-dependent calibration
with all points. If we choose to solve (5.26) using an equally-spaced fixed number p of the available TCO
measurements, we call this a state-dependent calibration with p points. From the perspective of condi-
tioning of (5.26), it makes more sense to do a state-dependent calibration with p points since it is unlikely
that Van will be varying drastically from one beat to the next. Furthermore, a state-dependent calibration
with p points is more realistic in settings such as the ICU where CO is measured only intermittently.
5.4.2 State-Dependent Least-Squares Calibration with Updates
It is also possible to carry out state-dependent (or even constant, though we don’t discuss this here)
calibrations on smaller windows of data, and update the calibration constants γ1 and γ2 in successive
windows. This kind of calibration would also be particularly applicable in the ICU, where CO is measured
only intermittently. If we use non-overlapping windows and re-calibrate the CO estimate in every window
using an equally-spaced fixed number of the available TCO measurements in that window, we call this
a repeated state-dependent calibration with p points. If instead, we use overlapping windows, we call
this an overlapping repeated state-dependent calibration with p points. Finally, if we use exponentially-
shaped overlapping windows such that older calibration data is emphasized more (and we solve a weighted
least-squares calibration with tapering windows instead of (5.25) or (5.26)), we call this an exponentially-
weighted overlapping repeated state-dependent calibration with p points. Repeatedly calibrating on over-
lapping or non-overlapping windows results in much lower RMSNEs, however, instead of reporting results
with these low RMSNEs in Section 5.8, we report those obtained with state-dependent calibration with p
points.
5.4.3 Constant Calibration Factors
The results reported by Mukkamala et al. [57] and some of the results quoted by Sun et al. [113] were
generated using a Can that is not optimal in the sense of (5.24). In [57], a mean calibration was done, i.e.,
Can was estimated by dividing the mean of the true CO waveform by that of the estimated CO waveform
as follows:
Can =
mean (TCO)
mean (ECO)
=
∑m
i=1TCOi∑m
i=1 ECOi
. (5.27)
Mean-calibrated CO estimates allow one to determine, in some sense, relative errors for the CO estimates,
i.e.,percent changes in TCO to percent changes in ECO after scaling one of these two waveforms to have the
same mean as the other. Thus, the mean calibration errors reported in this document can be interpreted
as relative errors in ours and others’ estimation methods.
In some of the results in Sun et al. [113], a single point calibration was used i.e.,estimate the calibration
constant Can by dividing a single point p in the true CO waveform by the corresponding point in the
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estimated CO waveform as follows:
Can =
TCOp
ECOp
. (5.28)
We do not quote results using single point calibration in this chapter, however, we do compare results
obtained with mean calibration and results obtained with state-dependent calibration. Note that the mean
or single point calibration methods can only be used if one assumes that Can is given by (5.5) for all n.
5.5 Error Criteria
In evaluating the goodness-of-fit of our calibrated CO estimates, i.e., to compare true cardiac output (TCO)
to estimated cardiac output (ECO), we used the RMSNE criterion. For a particular subject or animal, s,
given ns points at which TCO was measured and ECO was estimated, the RMSNE (in %) for the ECO
for subject or animal s, denoted RMSNEs, is given by:
RMSNEs =
√√√√ 1
ns
ns∑
n=1
(
100(TCOn − ECOn)
TCOn
)2
. (5.29)
Within each data set, the subject or animal data records are of varying lengths, and thus the aggregate
RMSNE over all subjects or animals is calculated as the weighted mean of the individual RMSNEs. As-
suming that a particular data set has NS total data points across all the subjects or animals, the aggregate
RMSNE is given by:
Aggregate RMSNE =
√
1
NS
∑
s
ns
(
RMSNEs2
)
. (5.30)
In the literature, for example in [57, 58], instead of the weighted mean (5.30), the following expression is
used to compute RMSNE over all S subjects or animals:
Mean RMSNE =
1
S
∑
s
RMSNEs . (5.31)
Such amean RMSNE can be skewed if a particular subject or animal record within a data set is significantly
larger (or smaller) or error-ridden (or error-free) compared to others in the same data set. In this chapter,
unless we are doing direct comparisons with the results in [57], we use the aggregate RMSNE expression
(5.30).
RMSNE, even for a particular subject or animal, is an average measure of performance. While it represents
how the TCO and ECO compare in an average sense, it does not classify the CO estimation error with
regard to the particular values of CO, ABP, or HR, or even the particular interventions being performed
on the animals. A linear regression of TCO versus ECO with a reported correlation coefficient would also
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only be an aggregate measure of performance, as would a Bland-Altman (see [114, 115]) plot of CO error
versus the mean of TCO and ECO.
While we use RMSNEs, linear regressions, and Bland-Altman plots to visualize our CO estimation error
and do useful comparisons of our estimation method to other methods, wherever appropriate, we also
present plots of our estimate to visualize how the time series for the estimate and the reference waveform
compare. A measure that is less sensitive to outliers and perhaps better matched to the visual impression
in the graphical plots would be the mean absolute normalized error (MANE) for a particular animal or
subject s:
MANEs =
1
ns
ns∑
n=1
100|TCOn − ECOn|
|TCOn| , (5.32)
however, we do not use this criterion in this thesis.
5.6 CO Variability and Na¨ıve CO Estimators
As a metric for the degree of variability in the TCO waveform, i.e.,a measure of how variable TCO is and
how well our CO estimation method captures this variability, we implemented two na¨ıve CO estimators,
one for the porcine data set, and another for the canine and human data sets. Neither of these estimators
needs to be calibrated.
For the porcine data set, the na¨ıvely estimated CO, NECO, for swine s is simply the mean of the beat-to-
beat TCO values:
NECOn = NECO =
1
ns
ns∑
n=1
TCOn , (5.33)
such that the normalized error at each estimation point is simply the normalized standard deviation of the
TCO at that point. If the RMSNE for the NECO is smaller than that of our ECO, it implies that our
method does not add more information than can be naively obtained from the TCO values.
For the canine and human data sets, since we only have intermittent echocardiography- or thermodilution-
based cardiac output measurements, we used a sample-and-hold na¨ıve estimator, SHNECO, given by:
SHNECOn+1 = TCOn , (5.34)
for n ≥ 2 and SHNECO1 = TCO1. Again, if the RMSNE for the SHNECO is smaller than that of the
ECO, it implies that our ECO does not add more information than can be obtained by simply holding the
value of the previous TCO sample until the next time instant TCO is measured.
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5.7 Sensitivity to Window Size and α
We used various window sizes (i.e.,number of beats) – ranging from about 6 seconds to 12 minutes of data
– to estimate τn, and hence ECOn in our data sets. We observed that aggregate RMSNEs do not increase
significantly for window sizes above 50 beats, implying that we do not seem to need variability beyond
the range of 50 beats (30 seconds at a resting porcine or canine heart rate of 100 bpm, or approximately
1 minute at a resting human heart rate of 60 bpm) to obtain reasonable estimates. These observations,
however, could be strongly dependent on the particular data sets used. For the results on the porcine data
set, for example, we used a window size of 360 beats. For the canine data set, we used a window size of
100 beats, while in the two human ICU patient data sets, we used a window size of 360 beats.
We also used various values for α in (5.14) to estimate CO in our animal data sets. We observed that mean
RMSNEs in the animal data sets are not too sensitive to α except for small values of α. For example, with
a window size equal to 360 beats, the aggregate RMSNE taken over the porcine data set for each value
of α were about the same for α ranging from 1.5 to 100. For small α, e.g., α ≈ 0.01 – 0.9, the aggregate
RMSNE is much higher than with α ≥ 1.5. For other window sizes, the same result holds for this data
set, i.e., the aggregate RMSNE is not sensitive to the value of α except for small α. From a least-squares
estimation point of view this is not surprising as the constant α must be large enough such that the term
1
Tn
PPn in (5.8) is of the same order of magnitude, i.e., as significant, as the term − 1τnVan. For the results
presented in this thesis, we use α=2 in both the porcine and the canine data sets, as described above.
5.8 Results and Discussion with Porcine Data
In this section, we describe a porcine data set, and describe how we estimate cardiac output for the animals
in this data set. We also describe the errors obtained using our method and present a comparison of these
errors to those obtained with other model-based CO estimation methods.
5.8.1 Porcine Data Set
The estimation methods were tested on the same animal data set used by Mukkamala et al. [57] – a
study on nine Yorkshire swine (weighing 30–34 kg) approved by the MIT Committee on Animal Care. The
animals were intubated under anesthesia and mechanically ventilated. Once intubated, the animals’ chests
were opened, pressure transducers and an ultrasonic flow probe were placed, and over the course of 2-3
hours, CO, ABP, and HR were varied by one or more of the following interventions: volume infusions, slow
hemorrhage, intravenous (IV) drugs (one or more of phenylephrine, isoproterenol, esmolol, nitroglycerine,
or dobutamine).
The resulting data set is comprised of measurements of ECG, central arterial blood pressure (cABP)
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Swine CO (l/min) HR (bpm) Mean cABP (mmHg) Duration of record
Range Range Range (min)
4 1.5-5.6 43-190 40-115 118
5 2.4-5.0 100-210 45-162 112
6 2.2-6.1 63-192 55-120 94
7 1.2-4.8 56-250 36-123 140
8 2.5-5.9 49-208 40-117 104
9 1.3-6.3 51-192 45-130 72
Table 5.1: Population statistics for the porcine data set. The data was obtained from Professor Ramakr-
ishna Mukkamala at Michigan State University [57].
measured at the thoracic aorta, approximate “radial” 1 arterial blood pressure (rABP), femoral arterial
blood pressure (fABP), and aortic flow (AF), all sampled at 250 Hz with 16 bit amplitude resolution.
The results from swines 1–3 are not reported here (or in [57]) due to insufficiencies in the experimental
data. The cABP waveform for swine 4 and the fABP waveform for swine 7 were corrupted because the
corresponding pressure transducers were mis-calibrated during the experimental protocol. In addition, as
was done in [57], data points at the end of each record, after progressive hemorrhages were started, were
neglected as TCO was too low in these regions for any serious analysis. Table 5.1 gives a summary of
population statistics for the six swine we used in this thesis.
Using a standard open-source algorithm [116] on the AF waveform, we derived onset times for each cardiac
beat and HR. We also calculated systolic and diastolic cABP, systolic and diastolic rABP, systolic and
diastolic fABP, mean cABP, mean rABP, and mean fABP for each swine. True or reference beat-to-beat
CO was calculated by integrating the AF waveform over each beat, and then applying a 50-beat median
filter to the resulting output. All the data processing and cardiac output estimation algorithms were
implemented in MATLAB R14 (Mathworks Inc., Natick, MA).
5.8.2 RMSNEs and Individual Porcine ECO Waveforms
We applied our method to each of the six swine in several experiments, i.e., the cABP, rABP, and fABP
waveforms were used independently in the linear least squares estimation scheme described in the previous
section to obtain an uncalibrated estimate of CO. This estimate was calibrated using the methods described
in Section 5.4, and the resulting ECO waveform was filtered using a 50-beat median filter. We tried using
both the end-diastolic and the peak-systolic pressures in ∆Van. All the results reported in this paper were
obtained using the end-diastolic pressures in ∆Van as the end-diastolic pressure points are less affected by
wave reflection phenomena. We tried various values of α and window size, as well the different calibration
methods mentioned in Section 5.4. Unless noted otherwise, results reported in this section were generated
with a 100-point state-dependent calibration, i.e., 100 beats (1% or less of each swine record) evenly-
1This pressure was measured using a transducer placed as distal as possible from the brachial artery.
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Swine Number of RMSNE (%) RMSNE (%) RMSNE (%) RMSNE (%)
comparisons for NECO using cABP using rABP using fABP
4 14604 36.8 – 15.4 10.2
5 14404 17.6 8.7 10.6 9.4
6 12088 23.2 8.8 9.7 8.8
7 18155 33.7 13.1 11.1 –
8 14113 24.4 10.6 8.4 12.6
9 9370 44.6 21.7 15.8 19.5
Aggregate 82734 30.8 12.8 11.9 12.1
Table 5.2: RMSNEs for a 360 beat window size with α=2 in equation (5.14) and a 100-beat state-dependent
calibration.
spaced throughout a particular swine’s record, were used in (5.26) for calibration. (The aggregate RMSNEs
reported here do not change more than 1% if we use as few as 10 beats, or even as many as 1000 beats,
for calibration.)
Table 5.2 summarizes the results obtained for a window size of 360 beats (or, approximately 6 minutes at
a HR of 100 bpm) for the cABP, rABP, and fABP waveforms. Results obtained with window sizes ranging
from 20 to 800 beats yield similar RMSNEs. We also list the RMSNEs for the NECO estimate described
in Section 5.5. These RMSNEs reflect the high CO variability in the porcine data set. Were this not the
case, it would be difficult to argue that the low RMSNEs obtained using our method are an improvement
over the na¨ıve CO estimate (5.33).
Figures 5.3, 5.4, 5.5, 5.6, 5.7, and 5.8 show results for each of the six swine – Swines 4, 5, 6, 7, 8, and
9, respectively. Note that the spikes in the HR and Ra waveforms are a result of not filtering either Van,
Tn or ∆Van to generate these results. Note that there are sections where our estimate performs very
well, while there are sections in each record where our estimate performs poorly. Whenever our estimate
performs poorly, it is the result of over- or underestimating the time constant τ . For instance, for a single
cardiac beat, assuming ∆Van=0, Equation (5.8) can be rewritten to reflect the components of τn:
τn =
Van
PPn
Tn , (5.35)
from which it is clear that τn depends on the relative magnitudes and variability in mean ABP, PP, and
HR. For example, in data sections where ABP and PP are not varying much, τn depends strongly on
HR, e.g., between t=2000 s and t=3000 s in Fig. 5.5. On the other hand, in sections of data where HR
is constant, τn depends on the ratio of mean ABP to pulse pressure – and if mean ABP is low, e.g., 50
mmHg, τn will vary primarily with pulse pressure, e.g., see the first and last 500 s of data in Fig. 5.4 and
between t=3800 s and t=4200 s in Fig. 5.5.
Our results with 100-point state-dependent calibration have mean RMSNEs of 11–13% which is lower than
the 15% reported in the literature [58] as being acceptable for clinical purposes. The CO estimate tracks
all major transitions in TCO over a wide range of values for mean ABP and HR. In addition, across
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Figure 5.3: True and estimated CO (using rABP), HR, mean rABP, true and estimated TPR, and IV
drugs for swine 4 with window size = 360 beats and a 100-beat state-dependent calibration.
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Figure 5.4: True and estimated CO (using cABP), HR, mean cABP, true and estimated TPR, and IV
drugs for swine 5 with window size = 360 beats and a 100-beat state-dependent calibration.
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Figure 5.5: True and estimated CO (using fABP), HR, mean fABP, true and estimated TPR, and IV drugs
for swine 6 with window size = 360 beats and a 100-beat state-dependent calibration.
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Figure 5.6: True and estimated CO (using rABP), HR, mean fABP, true and estimated TPR, and IV
drugs for swine 7 with window size = 360 beats and a 100-beat state-dependent calibration.
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Figure 5.7: True and estimated CO (using cABP), HR, mean fABP, true and estimated TPR, and IV
drugs for swine 8 with window size = 360 beats and a 100-beat state-dependent calibration.
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Figure 5.8: True and estimated CO (using fABP), HR, mean fABP, true and estimated TPR, and IV drugs
for swine 9 with window size = 360 beats and a 100-beat state-dependent calibration.
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– ECO (for cABP) ECO (for rABP) ECO (for fABP)
TCO 0.917±0.001 0.9325 ± 0.005 0.887 ± 0.002
Table 5.3: Correlation coefficients for linear regressions of ECO versus TCO. The results are for a 360 beat
window size and a 100-beat state-dependent calibration.
– TCO-ECO (for cABP) TCO-ECO (for rABP) TCO-ECO (for fABP)
Va 0.072±0.006 0.051 ± 0.007 0.009 ± 0.007
HR -0.470±0.005 -0.488 ± 0.005 -0.127 ± 0.006
TCO -0.102±0.006 -0.198 ± 0.007 0.049 ± 0.007
Table 5.4: Correlation coefficients for linear regressions of estimation error (TCO-ECO) versus Va, HR,
and TCO. The results are for a 360 beat window size and a 100-beat state-dependent calibration.
the entire data set, the estimated TPR, Ra, tracked the true TPR for a wide variety of pharmacological
interventions, e.g., in Fig. 5.3, when phenylephrine is infused, we see a large increase in estimated TPR
and a slight increase in HR. In Fig. 5.4, we again see larger estimated TPR when phenylephrine is infused.
If we allowed for updates in the calibration factor, e.g., with an exponentially-weighted repeated overlapping
state-dependent calibration with 10 points in every window of 1000 points, as shown in Fig. 5.9, the ECO
and Ra waveforms track the TCO and TPR waveforms, respectively, extraordinarily well. In the region
around 6800s, the calibration factor is not updated as fast as the transient in TCO, and we see a spike in
the ECO waveform.
5.8.3 CO Error Visualization and Analysis
Figure 5.10 shows a linear regression visualizing the CO estimation error. This plot is an aggregate of all
82, 734 comparisons listed in Table 5.2 using the rABP waveform.
The correlation coefficients for ECO versus TCO (with 95% confidence intervals) are summarized in Ta-
ble 5.3, while the the correlation coefficients of the estimation error versus mean pressure, heart rate, and
TCO, with 95% confidence levels, are summarized in Table 5.4. These correlation coefficients show that
the estimation error is not strongly correlated with mean ABP, HR, or TCO.
Figure 5.11 is a Bland-Altman plot for the CO estimation error using rABP. Again, this plot is an aggregate
of all 82734 comparisons listed in Table 5.2. Note that in both the regression and the Bland-Altman plots,
there is a discernible path traced by the error in the plane showing some correlation between error and the
underlying TCO waveform. Given our state-dependent calibration, this time correlation is expected.
From the Bland-Altman plot, we see that the mean estimation error (or bias) is 18 ml/min, while the
1-standard deviation (SD) of the estimation error is 429 ml/min. The flow probe (T206 with A-series
attachment, Transonic Systems Inc., Ithaca, NY) used in the animal experiments had a relative precision
of ±2%, which at the instrument scale of ±20 l/min is approximately 1 l/min. The 2-SD line for our
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Figure 5.9: True and estimated CO (using rABP), HR, mean rABP, estimated and true TPR, and IV drugs
for swine 4 with window size = 360 beats, and a 10-beats of every 1000-beat window exponentially-weighted
overlapping repeated state-dependent calibration.
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Figure 5.10: Linear regression of TCO versus ECO (using rABP) over all six swine with window size =
360 beats, and a 100-beat state-dependent calibration.
estimate lies 860 ml/min from the line representing mean estimation error, showing that, according to the
criterion outlined in [114, 115], our estimated CO compares well with the reference aortic flow probe CO
measurements.
5.8.4 Comparison to Mukkamala and Co-workers Method
Mukkamala et al. [57] reported the results shown in Table 5.5, where we calculated the aggregate RMSNEs
using (5.30). They re-sampled the 250Hz data at 90 Hz, and used a 6-minute window size, with a 3-minute
overlap between successive windows. In each 6-minute window, they estimated the time constant τ of the
Windkessel model by assuming it could be represented by a 23-coefficient ARMA model [57].
Our results are significantly different by swine and are, in an aggregate sense, much better than those
reported in [57]. In addition, instead of 6-minute windows, our method can use much less data, e.g., 10–50
beats to obtain an estimate of τn. A criticism of Mukkamala et al. put forward by van Lieshout et al. [108],
and contended in [118] is that while CO estimates produced every 3 minutes may be good enough to track
slower patient dynamics, they may not be good enough for large, sudden changes in CO, as is evident from
patient data in the literature [119]. Furthermore, Mukkamala and co-workers’ estimate assumes a constant
arterial tree compliance, which is not necessarily a valid assumption, but does allow for the possibility of
using only one TCO point for calibration.
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Figure 5.11: Bland-Altman plot of CO estimation error versus the mean of TCO and ECO (using rABP)
over all six swine with window size = 360 beats, and a 100-beat state-dependent calibration. The horizontal
lines in the plot are the mean error, and the 1-SD and 2-SD lines.
Swine Number of comparisons RMSNE (%) using rABP RMSNE (%) using fABP
4 38 19.1 29.9
5 37 16.0 10.2
6 31 16.7 8.8
7 46 12.3 –
8 34 8.0 10.2
9 24 14.7 17.1
Aggregate 210 14.8 17.6
Table 5.5: RMSNEs reported in Mukkamala et al. [57] with aggregate RMSNEs calculated based on (5.30).
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CO Estimation Method RMSNE (%) RMSNE (%)
(calibration method) using rABP using fABP
Ours* 13.3 13.9
(state-dependent using 3-minute sampled TCO points)
Ours 13.5 14.0
(state-dependent using half of 3-minute sampled TCO points)
Mukkamala et al. [57] 13.9 15.0
(mean using 3-minute sampled TCO points)
Sample-and-hold version of * 18.5 19.2
Table 5.6: RMSNEs for the porcine data set (using the rABP waveform) comparing our 3-minute ECO to
Mukkamala and co-workers CO estimate, as well as our sample-and-hold ECO. Errors for the first three
estimates were compared to 3-minute samples of TCO, while that for the sample-and-hold estimate was
compared to the entire TCO waveform.
For a better comparison with Mukkamala et al. [57], we implemented our method using 6-minute windows
to estimate the time constant and produced estimates of CO every 3 minutes. We compared this 3-minute
CO estimate to the 3-minute samples of the TCO waveform. For our estimate, we performed a state-
dependent calibration in two ways – using all the available 3-minute TCO points, and using only half
of these points. We also computed a sample-and-hold 3-minute estimate and compared it to the TCO
waveform. Table 5.6 presents the results of these analyses.
Fig. 5.12 is a plot of our 3-minute estimated CO (using rABP) and the sample-and-hold version of this
3-minute estimated CO versus true CO for swine 4. Note that the sample-and-hold version of the 3-minute
estimated CO performs much worse than our beat-to-beat CO estimate.
5.8.5 Comparison to other CO Estimation Methods
We compared our and Mukkamala and co-workers’ methods to several other static intra-beat Windkessel-
based CO estimation methods. We refer to these methods as static since they estimate CO at each beat
using only information encoded in the pressure wavelet of that particular beat. To come up with a fair
comparison, we used a mean calibration (5.27), as used by Mukkamala and co-workers, to calibrate all the
estimates. In addition, as was done in [57], we calculated mean RMSNEs for each estimation method using
(5.31), i.e., without weighting the individual swine RMSNEs by the number of comparisons in each swine
record. The results of this analysis, for the fABP and rABP waveforms2, are shown in Table 5.7.
From these results we can conclude that for this particular porcine data set, the Herd estimate performs
quite well, while the other static estimation methods tend to perform quite poorly. Using rABP, the Herd
estimate performs as well as the dynamic estimation method of Mukkamala et al. [57], and is comparable to
our CO estimate. For the fABP waveform-based results, our method, Mukkamala and co-worker’s method,
2We do not report results with the cABP waveform here because they were not reported in [57].
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Figure 5.12: True CO, 3-minute estimated CO (using rABP), and a sample-and-hold (S/H) version of the
3-minute estimated CO, HR, and mean rABP. 3-minute ECO was calculated with window size = 6 minutes
and α=2 in (5.14), and a state-dependent calibration using all available 3-minute samples of TCO.
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CO Estimation Uncalibrated RMSNE (%) RMSNE (%)
Method COn = using rABP using fABP
Our Method (5.13) 13.5 15.2
Mukkamala et al. [57] ARMA model 14.0 15.0
Herd [106] HRn ·
(
Van −DAPn
)
14.0 15.9
Modified Mean Pressure HRn · Van 18.6 20.0
Static Windkessel [37] HRn · (SAPn −DAPn) 21.1 18.8
Liljestrand and Zander [64] HR ·
(
SAPn−DAPn
SAPn+DAPn
)
30.0 25.1
Mean Pressure [113] Van 31.6 33.6
Table 5.7: Mean RMSNEs for various static and dynamic CO estimates. Each estimate was calibrated
using a mean calibration (5.27). Note that Mukkamala’s results are based on intermittent CO estimates
i.e., every 3 minutes, while the others are continuous CO estimates.
In the next section, we show that if we apply the same 100-point state-dependent calibration to the
Herd estimate, we obtain aggregate RMSNEs similar to those in Table 5.2. On the other hand, results
obtained using human ICU data [113] show that the method of Liljestrand and Zander [64] outperforms
the Herd estimate (we apply our method to human data in Sections 5.10 and 5.11). Our method, however,
consistently outperforms all other methods we chose to apply to the various data sets presented in this
chapter.
5.8.6 Comparison of Mean and State-Dependent Calibration Factors
At the outset, we wanted to investigate the use of both a constant and a mean pressure-dependent compli-
ance Ca as the calibration factor for our CO estimates. While there is much disagreement in the research
community, CO estimation methods exist which assume a constant arterial compliance, and there are
others which assume a pressure-dependent compliance function – whether linear or nonlinear.
We applied our method and other methods from the literature to the porcine data set using both a 100-
point state-dependent calibration, and a 100-point mean calibration. In each case, the points were spread
evenly throughout each swine record. The results of this experiment are shown in Table 5.8. It is clear
that a state-dependent calibration, even on just 100 points out of 10, 000-15, 000, yields better results than
a mean calibration. It is also clear that for the Liljestrand and Zander, mean pressure, and modified mean
pressure methods, the state-dependent calibration significantly reduces the aggregate RMSNEs.
In addition to calibrating the CO estimates with TCO points spread evenly through the entire length of
each swine record, we also applied each CO estimation method from Table 5.8 to swine records in which
half the data was used for calibrating (or “training”), and half was used for testing the predictive value of
the calibration factor (or “testing”).
Table 5.9 shows the resulting RMSNEs for each of the CO estimation methods when 10 points out of the
first half of each swine record were used for training, and the second half of each swine record was used for
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CO Estimation Method Aggregate RMSNE (%) Aggregate RMSNE (%)
using rABP using rABP
state-dependent calibration mean calibration
Ours 11.8 13.5
Herd [106] 12.0 13.9
Mukkamala et al. [57] N/A 14.0
Liljestrand and Zander [64] 14.6 30.0
Modified Mean Pressure 14.5 18.6
Mean Pressure [113] 26.6 31.6
Table 5.8: Aggregate RMSNEs for the porcine data set (using the rABP waveform) with either mean
calibration using all available TCO points or state-dependent calibration using 100 TCO points evenly-
spaced throughout each record. Results obtained with the fABP waveform follow the trends in this table.
CO Estimation Method Aggregate RMSNE (%) Aggregate RMSNE (%)
using rABP using rABP
state-dependent calibration mean calibration
Ours 19.8 18.3
Herd [106] 20.8 19.3
Liljestrand and Zander [64] 28.9 57.8
Modified Mean Pressure 19.8 21.1
Mean Pressure [113] 35.3 41.1
Table 5.9: Aggregate RMSNEs for the porcine data set (using the rABP waveform) with either mean or
state-dependent calibrations using 10 points out of the first half of the available TCO points to calibrate,
and the second half of the records to test the predictive value of the calibration factor. Results obtained
with the fABP waveform follow the trends in this table.
testing.
Table 5.10 shows the resulting RMSNEs for each of the CO estimation methods when 10 points out of the
central half of each swine record were used for training, and the outer quarters of the records were used
for testing.
Table 5.11 shows the resulting RMSNEs for each of the CO estimation methods when 10 points out of the
second half of each swine record were used for training, and the first half of each swine record was used for
testing.
In all three scenarios described above, we tried the same analysis using 50 points or all points for calibration
in the training set and observed similar results.
From Tables 5.8, 5.9, 5.10, and 5.11, it is evident that when the data records were divided into training
and test sets, mean calibration resulted in lower RMSNEs than state-dependent calibration for the top
two estimation methods, but when the records were not split in this manner, state-dependent calibration
resulted in lower RMSNEs. While there may be some data dependency in these results, it is also clear
that whatever data set we use for training/testing, our method is robust in the sense that it is consistently
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CO Estimation Method Aggregate RMSNE (%) Aggregate RMSNE (%)
using rABP using rABP
state-dependent calibration mean calibration
Ours 17.9 15.2
Herd [106] 19.2 15.1
Liljestrand and Zander [64] 22.3 30.0
Modified Mean Pressure 21.6 18.9
Mean Pressure [113] 38.2 33.1
Table 5.10: Aggregate RMSNEs for the porcine data set (using the rABP waveform) with either mean or
state-dependent calibrations using 10 points out of the central half of the available TCO points to calibrate,
and the outer fourths of the records to test the predictive value of the calibration factor. Results obtained
with the fABP waveform follow the trends in this table.
CO Estimation Method Aggregate RMSNE (%) Aggregate RMSNE (%)
using rABP using rABP
state-dependent calibration mean calibration
Ours 20.2 13.5
Herd [106] 22.3 14.0
Liljestrand and Zander [64] 23.1 32.7
Modified Mean Pressure 22.4 19.9
Mean Pressure [113] 46.7 52.8
Table 5.11: Aggregate RMSNEs for the porcine data set (using the rABP waveform) with either mean or
state-dependent calibrations using 10 points out of the second half of the available TCO points to calibrate,
and the first half of the records to test the predictive value of the calibration factor. Results obtained with
the fABP waveform follow the trends in this table.
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a top performer in each of the evaluations. Since these conclusions were true for both the fABP and the
rABP waveform, we can conclude that our observations are not measurement site-dependent.
We analyzed our linear mean pressure-dependent arterial tree compliance for each of the six swine and
discovered that, apart from swine 4, all the swines have an almost-constant, i.e., pressure-independent,
arterial compliance. Figures 5.13 and 5.15(a) show a time series of our fit for the arterial compliance, and
a plot of TCOECO and our fit for the arterial compliance versus mean pressure, respectively, for swine 4. Note
that in Fig. 5.15, we used 100 points spread evenly throughout each swine record to compute our fit for the
arterial compliance Ca. Figures. 5.14 and 5.15e) show a time series of our fit for the arterial compliance,
and a plot of TCOECO and our fit for arterial compliance versus mean pressure, respectively, for swine 8. Plots
of TCOECO and our fits for the arterial compliance versus mean pressure for all six swine appear in Fig. 5.15.
It is clear from Figs. 5.13, 5.14, and 5.15, that the arterial tree compliance is essentially constant for all
but one of the swine in this data set, i.e., that γ2 in (5.4) can be assumed to be zero for all except swine
4. This may not be the case for the canine and human data sets as we discuss below, and thus, more
investigation is needed to ascertain the need for a mean pressure-dependent compliance.
5.8.7 Results on the Effect of Beat-to-Beat Variability
We conclude this section with a brief discussion on beat-to-beat variability. While Tables 5.7, 5.8, 5.9, 5.10,
and 5.11, all seem to imply that the static Herd estimate and our dynamic CO estimate are, in an aggregate
sense, equivalent, the same is not true if we take a closer look at the TCO and ECO waveforms. Our
dynamic CO estimation method incorporates beat-to-beat variability and we assumed therefore from the
outset that it must produce more fine-tuned CO estimates than those produced by static estimation
methods. If this assumption is valid, we can infer that the performance of the static Herd estimation
method relative to our method may be because there is not enough beat-to-beat variability in these
animals’ ABP and/or HR.
To test the hypothesis, i.e., that beat-to-beat variability improves our CO estimate, we defined a beat-to-
beat variability index, B2BVIb (%), in each 360-beat window as follows:
B2BVIb =
1
360
b+360∑
n=b
(
100
∆Van
PPn
)
. (5.36)
We then calculated RMSNEs only using points on the ECO waveform where τn was calculated on windows
where B2BVIb ≥ 5%. The results obtained are summarized in Tables 5.12 and 5.13, where, for the rABP
waveform, we compare our estimate to the Herd estimate. It is clear that on windows with high beat-to-
beat variability, our dynamic CO estimate performs either comparably (in the case of swine 5) or somewhat
better than the static Herd estimate.
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Figure 5.13: True and estimated CO (using cABP), HR, mean cABP, calibration factor Ca, and its compo-
nents γ1 and γ2Va, and IV drugs for pig 4 with window size = 360 beats, and a 100-point state-dependent
calibration.
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Figure 5.14: True and estimated CO (using cABP), HR, mean cABP, calibration factor Ca, and its compo-
nents γ1 and γ2Va, and IV drugs for pig 8 with window size = 360 beats, and a 100-point state-dependent
calibration.
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Figure 5.15: Plots of TCOECO and our fit for the calibration factor Ca versus mean pressure Va for all six swine.
The results were obtained using a window size = 360 beats and a 100-point state-dependent calibration.
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Swine Number RMSNE (%) for Herd RMSNE (%) for our
of comparisons estimate using rABP estimate using rABP
4 3256 17.1 14.9
5 2608 5.1 5.2
6 0 – –
7 6847 14.8 14.2
8 0 – –
9 514 9.3 7.1
Aggregate 13225 13.9 12.9
Table 5.12: RMSNEs for the rABP waveform-based estimate taken over points at which the beat-to-beat
variability index was larger than 5%. 100-point state-dependent calibrations were used for our estimate
and for the Herd estimate.
Swine Number RMSNE (%) for Herd RMSNE (%) for our
of comparisons estimate using rABP estimate using rABP
4 3256 26.4 24.7
5 2608 5.5 6.0
6 0 – –
7 6847 17.1 15.7
8 0 – –
9 514 8.6 6.6
Aggregate 13225 18.2 16.9
Table 5.13: RMSNEs for the rABP waveform-based estimate taken over points at which the beat-to-beat
variability index was larger than 5%. Mean calibrations were used for our estimate and for the Herd
estimate.
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We applied this variability index to all our data sets, but only report results with the porcine data set
here. The beat-to-beat variability in the canine data set described below was less than the variability in
the porcine data set.
Results in the literature imply that the performance of many CO estimation methods may be extremely
data-dependent [65, 113]. In the next three sections, as encouraged in editorials by Mukkamala et al. [118]
and van Lieshout et al. [108], we apply our estimation method to canine and human ICU patient data.
5.9 Results and Discussion with Canine Data
In this section, we describe a canine data set, and describe how we estimate cardiac output for the animals
in this data set. We also describe the errors obtained using our method and present a comparison of these
errors to those obtained with other model-based CO estimation methods.
5.9.1 Canine Data Set
The canine data set was obtained from Professor Ramakrishna Mukkamala of Michigan State University,
and was the result of a study on three beagles (weighing 10–15 kg) approved by the Michigan State
University All-University Committee on Animal Use and Care. Dog 1 was intubated under anesthesia and
mechanically ventilated. Once intubated, the dog underwent a thoracotomy and an aortic flow transducer
was placed. This dog was allowed ten days to recover from this major surgery.
The same experimental protocol was then applied to each of the three dogs – one with the chronic in-
strumentation described above, and two others. Each animal was anesthetized, but not mechanically
ventilated. Catheters were placed in the thoracic aorta to measure cABP, and in the femoral artery to
measure fABP. A syringe pump catheter was placed into a cephalic vein for drug administration, and ECG
leads were placed on the animal. In each animal, over the course of approximately 1 hour, CO, EF, ABP,
and HR were varied by one or more of the following interventions: volume infusions, fast hemorrhage, and
intravenous (IV) drug infusions (one or more of phenylephrine, nitroprusside, or dobutamine).
Table 5.14 summarizes the population statistics for the canine data set. It is important to note that for
dog 3, the variability in CO, HR, and mean cABP is particularly small. In fact, the beat-to-beat variability
as measured by the index (5.36) does not exceed 1% for the entire record for dog 3. Furthermore, it does
not exceed 3% for the entire record for dog 2, and only exceeds 5% for a few windows of data for dog 1,
with most variability seen with the fABP waveform.
For dog 1, the data set is comprised of measurements of central arterial blood pressure (cABP) measured
at the aorta, carotid arterial blood pressure (carABP), femoral arterial blood pressure (fABP), and aortic
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Dog Weight (kg) CO (l/min) HR (bpm) Mean cABP (mmHg) Duration of record
Range Range Range (min)
1 14.5 0.9-6.7 94-181 50-160 92
2 10.5 0.7-3.9 88-179 56-99 49
3 12.5 1.8-3.5 142-197 57-120 74
Table 5.14: Population statistics for the canine data set. The data was obtained from Professor Ramakr-
ishna Mukkamala at Michigan State University.
flow (AF), all sampled at 250 Hz with 16 bit amplitude resolution. In addition, there are intermittent
echocardiography measurements of heart rate, left ventricular end-systolic volume (LVESV) and left ven-
tricular end-diastolic volume (LVEDV), from which one can compute both CO and left ventricular ejection
fraction (EF).
For dogs 2 and 3, the data set is comprised of measurements of central arterial blood pressure (cABP)
measured at the aorta sampled at 250 Hz with 16 bit amplitude resolution. Similar to dog 1, there are
intermittent echocardiography measurements of heart rate, left ventricular end-systolic volume (LVESV)
and left ventricular end-diastolic volume (LVEDV), from which one can compute CO and EF. There are
no peripheral arterial blood pressure waveforms available for dogs 2 and 3.
Using a standard open-source algorithm [117] on the cABP waveforms, we derived onset times for each
cardiac beat and thus derived HR. We calculated systolic and diastolic cABP, and mean cABP for all
three dogs. For dog 1, we also calculated systolic and diastolic carABP, systolic and diastolic fABP, mean
carABP, and mean fABP. For dog 1, true or reference beat-to-beat CO was calculated by integrating the
AF waveform over each beat, and applying a 50 beat median filter to the resulting TCO waveform. In
addition, the intermittent echocardiography measurements were also used as reference CO measurements.
For dogs 2 and 3, we used the echocardiography measurements of cardiac output as the reference or true
CO. For dog 3 we averaged every three echocardiography CO measurements. All the data processing and
cardiac output estimation algorithms were implemented in MATLAB R14 (Mathworks Inc., Natick, MA).
5.9.2 Results
The arterial blood pressure waveforms that were available were used independently in the linear least
squares estimation scheme described in Section 5.3.2 to obtain an uncalibrated estimate of CO. This
estimate was calibrated using a state-dependent calibration using all available echocardiography CO mea-
surements.
Table 5.15 summarizes the results obtained for a window size of 100 beats (or, approximately 1 minute at
a HR of 100 bpm) for the cABP, carABP, and fABP waveforms. Results obtained with other window sizes
yield similar RMSNEs. In the table, we also list the RMSNEs for the SHNECO estimate (5.34) described
in Section 5.5. The SHNECO RMSNEs reflect fairly low CO variability for dogs 2 and 3.
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Dog Number of RMSNE (%) RMSNE (%) RMSNE (%) RMSNE (%)
comparisons for SHNECO using cABP using fABP using carABP
1 7 (10636) 31.6 (0.0) 11.2 (9.7) 9.0 (6.3) 13.7 (14.9)
2 30 19.0 11.7 – –
3 7 15.1 9.1 – –
Aggregate 44 20.8 11.1 – –
Table 5.15: Aggregate RMSNEs for the dog data set with a 100 beat window size, α=2 in Equation (5.14),
and a state-dependent calibration using all available echocardiography TCO points in each record. The
parenthetical numbers in the first row are those obtained from comparisons to TCO from the aortic flow
probe using a 10 point state-dependent calibration.
Our results are comparable to results in the literature, e.g., in [120], Mukkamala and co-workers obtained
a RMSNE of 10% for dog 1, but did not report errors for dogs 2 or 3.
Figures 5.16 and 5.17 show results for dogs 1 and 2, respectively. Note that the spikes in the HR and Ra
waveforms are a result of not filtering either Van, Tn or ∆Van to generate these results.
Note that there are sections where our estimate performs very well, while there are sections in each dog
record, where we are over- or underestimating the time constant τ , as explained in (5.35). Our results with
state-dependent calibration have aggregate RMSNEs of 11% which is much below the 15% reported in the
literature [58] as being acceptable for clinical purposes. The CO estimate tracks all major transitions in
TCO over the ranges of mean ABP and HR.
In addition, across the entire canine data set, the estimated TPR, Ra, tracked the true TPR for all the
pharmacological interventions, e.g., in Fig. 5.16, when dobutamine is infused, estimated TPR decreases,
while when phenylephrine is infused, estimated TPR increases. In the case of dog 2 in Fig. 5.17, we see a
rapid rise in estimated TPR subsequent to the progressive hemorrhage procedure.
Figure 5.18 is a Bland-Altman plot for the CO estimation error using the cABP waveform. From the
Bland-Altman plot, we see that the mean estimation error (or bias) is 53 ml/min, while the 1-standard
deviation (SD) of the estimation error is 343 ml/min. The 2-SD line for our estimate lies 686 ml/min from
the line representing mean estimation error, showing that, according to the criterion outlined in [114, 115],
our estimated CO compares well with the reference echocardiography CO measurements.
5.9.3 Comparison to Other CO Estimation Methods
We compared the estimates produced by our CO estimation method for the canine data set to estimates
produced by other methods. Table 5.16 shows the results of this exercise with either a state-dependent
or a mean calibration using all available TCO points. Again, we see that our method outperforms the
other CO estimation methods listed, and that state-dependent calibration yields better results than mean
calibration.
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Figure 5.16: True (intermittent echocardiography and flow probe measurements) and estimated CO (using
cABP), HR, mean cABP, true and estimated TPR, and IV drugs for dog 1 with window size = 100 beats
and a state-dependent calibration using all available echocardiography TCO measurements.
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Figure 5.17: True (intermittent echocardiography measurements) and estimated CO (using cABP), HR,
mean cABP, true and estimated TPR, and IV drugs for dog 2 with window size = 100 beats and a
state-dependent calibration using all available echocardiography TCO measurements.
– 155 –
Continuous Monitoring of Cardiac Output and Total Peripheral Resistance
0 0.5 1 1.5 2 2.5 3 3.5 4 4.5 5
−1
−0.8
−0.6
−0.4
−0.2
0
0.2
0.4
0.6
0.8
1
Estimated CO+True CO
2
(l/min)
C
O
E
rr
or
(l
/
m
in
)
n = 44, µ(error) = 0.053 l/min, σ(error) = 0.343 l/min
Figure 5.18: Bland-Altman plot of CO estimation error versus the mean of TCO and ECO (using cABP)
over the three dogs with window size = 100 beats and a state-dependent calibration using all available
echocardiography TCO measurements. The horizontal lines in the plot are the mean error, and the 1-SD
and 2-SD lines.
CO Estimation Method Aggregate RMSNE (%) Aggregate RMSNE (%)
using cABP using cABP
state-dependent calibration mean calibration
Ours 11.1 13.3
Herd [106] 13.7 17.2
Liljestrand and Zander [64] 11.3 19.6
Modified Mean Pressure 25.6 39.9
Mean Pressure [113] 34.3 56.5
Table 5.16: Aggregate RMSNEs for the canine data set with either mean or state-dependent calibrations
using all available echocardiography TCO points.
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CO Estimation Method Aggregate RMSNE (%) Aggregate RMSNE (%)
using cABP using cABP
state-dependent calibration mean calibration
Ours 32.0 11.1
Herd [106] 16.0 15.9
Liljestrand and Zander [64] 24.2 20.3
Modified Mean Pressure 66.7 75.0
Mean Pressure [113] 93.7 119.7
Table 5.17: Aggregate RMSNEs for the canine data set with either mean or state-dependent calibrations
using the first half of the available echocardiography TCO points to calibrate, and the second half to test
the predictive value of the calibrated CO estimate.
CO Estimation Method Aggregate RMSNE (%) Aggregate RMSNE (%)
using cABP using cABP
state-dependent calibration mean calibration
Ours 13.3 12.2
Herd [106] 16.2 18.8
Liljestrand and Zander [64] 13.4 18.3
Modified Mean Pressure 45.7 41.0
Mean Pressure [113] 36.0 48.9
Table 5.18: Aggregate RMSNEs for the canine data set with either mean or state-dependent calibrations
using the second half of the available echocardiography TCO points to calibrate, and the first half to test
the predictive value of the calibrated CO estimate.
5.9.4 Comparison of Mean and State-Dependent Calibration Factors
To further investigate the efficacy of a state-dependent arterial compliance calibration factor, we applied
each CO estimation method from Table 5.16 to dog records in which half the data was used for calibrating
(training set), and half was used for testing the predictive value of the calibration factor (testing set).
Table 5.17 shows the resulting RMSNEs for each of the CO estimation methods when all points in the
first half of each dog record were used for training, and the second half of each dog record was used for
testing. Since the RMSNEs for the state-dependent calibrated estimates nearly doubled for all except the
Herd estimate, we can infer that this particular training/testing data split was not rich enough for fitting
the state-dependent compliance parameters.
Table 5.18 shows the resulting RMSNEs for each of the CO estimation methods when all points in the
second half of each dog record were used for training, and the first half of each dog record was used for
testing.
Again, as was the case with the porcine data set, it is evident that when the data records were divided into
training and test sets, mean calibration resulted in lower RMSNEs than state-dependent calibration, but
when the records were not split in this manner, state-dependent calibration resulted in lower RMSNEs. It
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is also clear that whatever data set split we use for training/testing, our method is robust in the sense that
it is consistently a top performer in the numerical experiments (except for Table 5.17 which was discussed
above).
5.10 Results and Discussion with MIMIC I Human ICU Data
In this section, we describe the multi-parameter intelligent monitoring in intensive care (MIMIC) I database,
and describe how we estimate cardiac output for some patients in this database.
5.10.1 MIMIC I Data Set
The MIMIC I database is freely available from an internet physiological signal database3. Based on the
work of Lu et al. [58], we selected a set of 12 MIMIC I patients of different clinical classes. In Lu et al.
[58], three more patients (ID 055, ID 410, and ID 480) were used, but we found the available data for these
patients to be too noisy to be included in our analysis.
Each of the patients in this data set had 2 or more CO measurements obtained via thermodilution (giving
a total of 124 reference or true CO measurements), a radial arterial blood pressure waveform, and two
or more frontal electrocardiogram signals. In addition to these signals, some patients had a pulmonary
arterial blood pressure waveform or pulmonary capillary wedge pressure measurements. While it would
have been possible to use pulmonary signals to estimate CO as in [19], we did not do this as the goal of
our work is to use signals that can be obtained less invasively than with right-heart catheterization.
It is commonly known that an average of 3 thermodilution CO measurements obtained in close succession
constitutes the current clinical gold-standard for evaluating CO estimation methods on human ICU data
[3]. In the case of the MIMIC I patient data set, and the MIMIC II patient data set that we use below,
this averaging was rarely performed.
Table 5.19 summarizes the population statistics for the patients chosen from the MIMIC I database. It
is important to note that the variability in CO, and the beat-to-beat variability in MAP for almost all of
these patients is very low.
Using a standard open-source algorithm [117] on the rABP waveforms, we derived onset times for each
cardiac beat and HR. We calculated systolic and diastolic rABP, and mean rABP for each of the 12 patients.
All the data processing and cardiac output estimation algorithms were implemented in MATLAB R14
(Mathworks Inc., Natick, MA). For both the MIMIC I and MIMIC II data sets, we used PP=SAP-DAP
to calculate pulse pressure for our least-squares estimation scheme.
3The database can be accessed at http://www.physionet.org.
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MIMIC I Clinical Number of CO (l/min) HR (bpm) MAP (mmHg)
Patient ID Class TCO points Mean ± SD Range Range
041 Hemorrhage 2 8.98± 0.728 78-104 74-81
281 NA 5 4.37± 0.438 100-114 94-99
411 Respiratory Failure 6 3.84± 0.582 50-61 84-94
451 Congestive Heart Failure 6 5.18± 0.583 74-84 51-58
453 Heart Valve Surgery 14 4.08± 0.457 50-89 60-79
454 Heart Valve Surgery 11 4.18± 0.398 49-70 67-74
456 Coronary Artery Bypass Graft 14 5.92± 1.301 67-108 57-100
474 NA 6 4.21± 0.414 86-94 72-79
476 Coronary Artery Bypass Graft 11 4.42± 0.331 90-105 58-71
477 Coronary Artery Bypass Graft 10 5.40± 0.554 79-111 54-75
484 NA 12 6.56± 0.743 79-96 62-78
485 NA 27 3.54± 0.562 94-126 69-87
Table 5.19: Population statistics and clinical class (if available) for our set of MIMIC I patients; NA=not
available. The data was obtained from http://www.physionet.org. More descriptions of the data set are
given in [58], where two more patients were used.
5.10.2 Results and Comparisons to other Methods
We applied our CO estimation method (using PP=SAP-DAP) to the available peripheral arterial blood
pressure waveforms in the data set. We used the linear least squares estimation scheme described in
Section 5.3.2 to obtain an uncalibrated estimate of CO. This estimate was calibrated with a state-dependent
calibration using all available reference or true thermodilution CO measurements.
Table 5.20 summarizes the results obtained for a window size of 360 beats (or, approximately 3.5 minutes
at a HR of 100 bpm). Results obtained with other window sizes yield similar RMSNEs – something to be
expected given the lack of beat-to-beat variability in the ABP waveforms of the patients in this data set.
In the table, we also list the RMSNEs for the SHNECO estimate (5.34) described in Section 5.5, and the
errors reported by Lu et al. in [58].
From Table 5.20, we can see that for many patients, the SHNECO does better than both our method and
the Mukkamala’s method. This is not surprising given the low CO variability in many of these patients.
Figures 5.19 and 5.20 are plots of true and estimated CO, mean rABP, HR, and true and estimated TPR
for MIMIC I patients 411, and 451, respectively. In both figures, the estimated CO coincides quite well
with the reference thermodilution TCO points. The accuracy of our estimate between two consecutive
thermodilution measurements cannot be determined. In addition, we have marked the obvious artifacts
in the rABP and HR waveforms in Fig. 5.19. There is very little variability in the thermodilution CO
measurements for both these patients. Medication data was not available for the MIMIC I patients, so we
were not able to verify medication-induced changes in hemodynamic variables.
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Figure 5.19: True and estimated CO, mean rABP, HR, and true and estimated TPR for patient 411
with window size = 360 beats and a state-dependent calibration using all available thermodilution TCO
measurements.
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Figure 5.20: True and estimated CO, mean rABP, HR, and true and estimated TPR for patient 451
with window size = 360 beats and a state-dependent calibration using all available thermodilution TCO
measurements.
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MIMIC I Number of RMSNE (%) RMSNE (%) RMSNE (%)
Patient ID Comparions Our Method SHNECO reported in [58]
041 2 0.0 7.7 0.5
281 5 6.2 10.2 6.8
411 6 9.3 17.8 14.4
451 6 6.3 13.0 15.0
453 14 8.8 9.5 10.7
454 11 25.1 8.7 5.4
456 14 15.2 25.0 22.5
474 6 15.8 11.7 15.6
476 11 12.3 9.7 11.2
477 10 12.2 11.5 10.6
484 12 9.7 14.2 12.4
485 27 18.4 10.3 23.0
Aggregate 124 14.8 14.3 15.3
Table 5.20: Aggregate RMSNEs for the MIMIC I data set comparing our method to the SHNECO, and
to Mukkamala’s method [58], for which the mean RMSNE for their selection of 15 patients was 15.3%.
We calibrated our estimates with a state-dependent calibration using all available thermodilution TCO
measurements.
Figure 5.21 is a Bland-Altman plot for the CO estimation error using our CO estimation method. From
Fig. 5.21, we see that the mean estimation error (or bias) is 119 ml/min, while the 1-standard deviation
(SD) of the estimation error is 667 ml/min. While we do not know the inherent error in thermodilution CO
measurements, we can assume it to be small (< 1 l/min), the 2-SD line for our estimate lies 1.334 l/min from
the line representing mean estimation error, showing that, according to the criterion outlined in [114, 115],
our estimated CO compares reasonably well with the reference thermodilution CO measurements.
Figure 5.22 is a Bland-Altman plot for the CO estimation error on the MIMIC I patients using the SHNECO
estimation method. From Fig. 5.21, we see that the mean estimation error (or bias) is -24 ml/min, while
the 1-standard deviation (SD) of the estimation error is 691 ml/min. From this plot, we can infer that the
SHNECO estimator works almost as well as our CO estimation method.
Nevertheless, in an ICU setting where we expect a minimally-invasive CO estimation method to be useful,
there would be few to no reference thermodilution measurements taken, making it difficult to make use of
the SHNECO estimate.
5.11 Results and Discussion with MIMIC II Data
In this section, we describe the MIMIC II data set, and describe how we estimated cardiac output for our
set of MIMIC II patients.
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Figure 5.21: Bland-Altman plot of our method’s CO estimation error versus the mean of TCO and ECO
over the set of MIMIC I patients with window size = 360 beats and a state-dependent calibration using
all available thermodilution TCO measurements. The horizontal lines in the plot are the mean error, and
the 1-SD and 2-SD lines.
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Figure 5.22: Bland-Altman plot of the SHNECO estimation error versus the mean of TCO and ECO over
the set of MIMIC I patients. No calibration was necessary for this estimate. The horizontal lines in the
plot are the mean error, and the 1-SD and 2-SD lines.
5.11.1 MIMIC II Data
The MIMIC II database is not yet publicly available, though we expect parts of it to be publicly available
by June 2008. We obtained a de-identified4 MIMIC II data set from researchers at the Laboratory for
Computational Physiology at MIT. Based on the work of Sun et al. [113], we selected a set of 120 MIMIC
II patients, each of which had 2 or more CO measurements obtained via thermodilution (giving a total
of 1378 reference or true CO measurements) and a radial arterial blood pressure waveform. Sun et al.
[113] showed that on this set of ICU patients, the CO estimation method of Liljestrand and Zander [64]
outperformed 10 other CO estimation methods, including the static Windkessel and the Herd estimates.
It is important to note three problems with the MIMIC II data set. First, as mentioned above, we note
that the average of 3 consecutive thermodilution CO measurements constitutes the current clinical gold-
standard for evaluating CO estimation methods on human ICU data. In the case of the MIMIC II data set
this averaging was rarely performed. Second, based on the TCO ranges for each patient, we inferred that
there is little to no CO variability in the MIMIC II data set. Finally, there was little to no beat-to-beat
variability in other hemodynamic variables in the MIMIC II data set.
Table 5.21 summarizes the population statistics for the MIMIC II patients, some of which were adopted
4All protected health information (PHI) was removed.
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Variable Mean ± SD
Age (years) 69±12
TCO (l/min) 5±2
∆TCO (l/min) 2.5±1.2
HR (bpm) 90±20
MAP (mmHg) 75±10
Number of TCO measurements 1378
Table 5.21: Population statistics for the MIMIC II patients some of which were adapted from [113]. ∆TCO
signifies the mean of the maximum deviation of each subject’s TCO measurements. The data was obtained
via a personal communication from researchers at the Laboratory for Computational Physiology at MIT.
from [113].
Using a standard open-source algorithm [117] on the rABP waveforms, we derived onset times for each
cardiac beat and thus derived HR. We calculated systolic and diastolic rABP, and mean rABP for each of
the 120 patients. In addition, we implemented a signal quality index developed by Sun et al. [121, 122]
on each rABP waveform, neglecting all low quality rABP wavelets, e.g., wavelets which had values beyond
physiologically-possible values. All the data processing and cardiac output estimation algorithms were
implemented in MATLAB R14 (Mathworks Inc., Natick, MA). For both the MIMIC I and MIMIC II data
sets, we used PP=SAP-DAP to calculate pulse pressure for our least-squares estimation scheme.
5.11.2 Results and Comparisons to other CO Estimation Methods
We applied our CO estimation method to the rABP waveforms (using PP=SAP-DAP) to our MIMIC II
patient data set. We used the linear least squares estimation scheme described in Section 5.3.2 to obtain
an uncalibrated estimate of CO. This estimate was calibrated using a state-dependent calibration using all
available reference or true thermodilution CO measurements.
For the MIMIC II patients, we were able to obtain information on IV and provider-order-entry (POE)
medications for most of the 120 patients; we used this information to correlate our estimates of CO and
TPR to changes in medications. While this analysis was conclusive for some patients, for many others it
was too difficult to determine the effect of a particular medication.
Table 5.22 summarizes the results obtained for a window size of 360 beats (or, approximately 3.5 minutes
at a HR of 100 bpm). Results obtained with other window sizes yield similar RMSNEs – something to be
expected given the lack of beat-to-beat variability in the ABP waveforms of the patients in this data set.
In Table 5.22, we also list the RMSNEs and 1-SD Bland-Altman error for three other estimates: the
SHNECO estimate (5.34), which performs quite well, and the two best-performing CO estimation meth-
ods: the Liljestrand and Zander [64] method, and the Modified Mean Pressure method, in which CO is
proportional to the product of MAP and HR. Both these methods performed almost as well as our CO
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CO Estimation Number of σ(error) Aggregate
Method Comparisons l/min RMSNE (%)
Our Method 1378 0.906 17.4
SHNECO (no calibration) 1378 0.906 17.2
Modified Mean Pressure 1378 1.027 19.8
Liljestrand and Zander [64] 1378 1.041 19.7
Table 5.22: Aggregate RMSNEs for the MIMIC II ICU patient data set comparing our method to the
best-performing of the other methods. We calibrated each estimate with a state-dependent calibration
using all available thermodilution TCO measurements. The SHNECO estimator does not need calibration.
estimation method. Note that we do not include the results for the Herd estimation method here because
this method performed poorly on the MIMIC II data set.
While our method performs well on this ICU patient data set, the fact that the SHNECO estimator
performs as well as our method implies that there is very little CO variability in the data set – something
that discounts the performance of any CO estimation method on this data set.
Figure 5.23 is a plot of estimated and true waveforms for MIMIC II patient b75092. There were only two
thermodilution CO measurements taken on this patient. Fortunately, these coincide with the infusion of
levophed, which acts to increase TPR. Both the true and estimated TPR increase during the period of
levophed infusion, something that is more clear in the Fig. 5.24, where only the period of levophed infusion
is plotted.
Figure 5.25 is a plot of estimated and true waveforms for MIMIC II patient b63047, where we have marked
a HR artifact at t ≈ 900 minutes which affects both our CO and TPR estimates. There were 14 thermodi-
lution CO measurements taken on this patient, all of which coincide with the infusion of neosynephrine (or
phenylephrine), which acts to increase TPR. The estimated TPR tracks the neosynephrine infusion rate
quite well for most of the patient data shown in the figure. Both the true and estimated TPR increase
during the period of neosynephrine infusion, something that is more clear in the Fig. 5.26, where we zoom
in on part of Fig. 5.25. Of more clinical relevance is the fact that in Fig. 5.26, the estimated TPR tracks
the neosynephrine infusion rate, even between the intermittent thermodilution CO measurements.
Figure 5.21 shows Bland-Altman plots of CO estimation error using our CO estimation method, the
Liljestrand and Zander method [64], the Modified Mean Pressure method, and the SHNECO estimator.
From Fig. 5.27, we see that the mean estimation error in our method is 226 ml/min, in Liljestrand’s and
Zander’s method is 292 ml/min, for the SHNECO estimator is 42 ml/min, and for the Modified Mean
Pressure method is 325 ml/min. The 1-SD of our method’s estimation error is 906 ml/min, the same as
that for the SHNECO estimator. The 1-SD error for the other two methods is about 100 ml/min more.
(In an ICU setting, however, where we expect a minimally-invasive CO estimation method to be useful,
there would be few to none reference thermodilution measurements taken, making it difficult to make use
of the SHNECO estimate.)
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Figure 5.23: True and estimated CO, mean rABP, HR, true and estimated TPR, and IV levophed infusion
for patient b75092 with window size = 360 beats and a state-dependent calibration using the two available
thermodilution TCO measurements. Data during the early parts of the patient’s ICU stay are not plotted
here.
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Figure 5.24: True and estimated CO, mean rABP, HR, true and estimated TPR, and IV levophed infusion
for patient b75092 with window size = 360 beats and a state-dependent calibration using the two available
thermodilution TCO measurements. Only the patient data during the IV levophed infusion have been
plotted.
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Figure 5.25: True and estimated CO, mean rABP, HR, true and estimated TPR, and IV neosynephrine
infusion for patient b63047 with window size = 360 beats and a state-dependent calibration using the two
available thermodilution TCO measurements.
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Figure 5.26: True and estimated CO, mean rABP, HR, true and estimated TPR, and IV neosynephrine
infusion for patient b63047 with window size = 360 beats and a state-dependent calibration using the two
available thermodilution TCO measurements.
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(a) Our method
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(b) Mean Pressure * Heart Rate
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(c) Liljestrand and Zander
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(d) Sample-and-hold
Figure 5.27: Bland-Altman plots of CO estimation error versus the mean of TCO and ECO over the set
of MIMIC II patients. The horizontal lines in the plots are the mean error, and the 1-SD and 2-SD lines.
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While we do not know the inherent error in the reference thermodilution CO measurements, if we assume
it to be small (< 1 l/min), then the 2-SD lines for all four of the estimates presented here lie at least 1.8
l/min from the lines representing mean estimation errors, showing that, according to the criterion outlined
in [114, 115], these estimates can probably not be used to robustly detect changes in true CO of magnitude
< 1 l/min.
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5.12 Summary and Conclusions
In this chapter, we described a novel beat-to-beat averaged model-based method for continuously estimating
cardiac output from arterial blood pressure waveforms. This continuous cardiac output estimation method
can easily be implemented in real time, works well on different window lengths of data, and is model-based,
giving it a clear physiological basis. The method exploits the beat-to-beat variability in heart rate and
arterial blood pressure to estimate the time constant for the Windkessel model. We applied the method to
porcine, canine, and human data sets in which reference CO measurements were available. The resulting
errors on each of the data set showed that our method is robust i.e., it performs well on each data set we
used.
We investigated the use of both a constant and a mean pressure-dependent compliance when we applied
our method. We observed that errors obtained using each of these compliance functions depend on the
method used to obtain the results. In particular, when the data records were divided into training and test
sets, mean calibration proved superior to state-dependent calibration. However, when the records were not
split in this manner, state-dependent calibration resulted in lower RMSNEs. More investigation is needed
to ascertain the need for a mean pressure-dependent compliance, possibly with more animal and human
subject experiments.
Using the porcine central or peripheral arterial blood pressure waveforms, the aggregate RMSNE was at
most 15-18%. Using the canine central or peripheral arterial blood pressure waveforms, the aggregate
RMSNE was at most 13% (except for one case), while the aggregate RMSNE was at most 18% in the two
human ICU patient data sets. These errors are on the order of those obtained using another beat-to-beat
variability-based method in the literature [57], as well as some static intra-beat CO estimation methods.
In addition, in the case of the animal data sets, we observed that the total peripheral resistance calculated
from this estimate tracked the animals’ expected hemodynamic responses to the intravenous drugs quite
well. For the human data sets, it is more difficult to correlate the infusion of intravenous drugs to changes
in patient hemodynamics as we discuss below.
We did not use the mean absolute normalized error criterion to evaluate our CO estimates, but this criterion
could be used in future evaluations of our method as the MANE criterion does not exaggerate the effects
of estimates that are outliers.
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Chapter 6
Continuous Monitoring of Left Ventricular
Ejection Fraction and End-Diastolic Volume
LEFT ventricular ejection fraction (EF) and left ventricular end-diastolic volume (LVEDV) are clinicallyimportant variables that, together with cardiac output (CO) and total peripheral resistance (TPR),
allow clinicians to make early diagnoses, track disease progression, and decide on therapeutic interventions.
Of particular relevance in the ICU is distinguishing between cardiogenic, septic, and hypovolemic shock,
which could potentially be done using continuous measurements of EF, LVEDV, and CO. Given the
projected shortage of nurses in the coming decade [6], and the aging US population, it is essential that
automated, continuous, and minimally-invasive methods for monitoring CO, TPR, EF, and LVEDV are
developed.
In Chapter 5, we discussed a novel model-based method for continuously estimating CO and TPR from
arterial blood pressure waveforms. In this chapter we describe two other novel, model-based methods, this
time for continuously estimating EF and LVEDV [123]. We show how these methods work in practice
on the canine data set we presented in Chapter 5. We conclude this chapter with a discussion on how
we envision combinations of our CO, TPR, EF, and LVEDV estimates to make clinical assessments of
hemodynamic state.
6.1 Background
Left ventricular ejection fraction (EF) is defined the ratio of stroke volume (SV) to LVEDV. Since SV can
be written as the difference between left ventricular end-systolic and end-diastolic volumes, the following
equality holds:
EF =
SV
LVEDV
=
LVEDV− LVESV
LVEDV
. (6.1)
EF is usually expressed as a percentage, with typical normal values ranging from 40–60%. Left ventricular
ejection fraction is a strong indicator of heart function – perhaps the most significant index that is currently
in clinical use [27]. Low ejection fraction is indicative of compromised heart function or coronary artery
disease [124, 125, 126]. Monitoring EF, even for outpatients, can thus be quite useful. For instance,
Curtis and co-workers (see [28]) describe a powerful relationship between EF and mortality in heart failure
outpatients – the lower the EF, the worse the patient outcome.
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If the left-ventricular end-diastolic compliance is assumed to be large and constant, LVEDV is proportional
to left ventricular end-diastolic pressure (LVEDP). LVEDP, usually approximated in the ICU by Pulmonary
Capillary Wedge Pressure (PCWP) measurements, is a strong indicator of congestive heart failure [127,
128, 129, 130]. Hence, LVEDV, a quantity proportional to LVEDP, is also an important indicator of
ventricular function, namely the left ventricular preload.
Although many techniques exist to measure ventricular volumes, e.g., magnetic resonance imaging (MRI),
the current clinical gold-standard for determining ventricular volumes, i.e., LVEDV and LVESV, is echocar-
diography imaging [131, 132, 133]. While this is a noninvasive procedure, it is quite expensive because it
requires an expert operator to perform the measurement and interpret the image. As a result, ventricular
volumes are infrequently measured. While there are non-imaging methods, e.g., thermodilution-based EF
mentioned in Chapter 2, one could use to continuously monitor ventricular volumes, these methods are
highly invasive and would therefore only be used on the sickest of patients.
We propose that ventricular volumes, and hence EF, can be estimated from central or peripheral arterial
blood pressure waveforms. Our estimation method would therefore allow for continuous, minimally-invasive
measurements of EF and LVEDV. While Mukkamala and co-workers have successfully estimated EF using
a central arterial blood pressure waveform [27, 120], they did so by assuming a particular ventricular
elastance function and performing an intra-beat fit of this function to the central arterial blood pressure
(cABP) waveform. Their method is thus still quite invasive. However, it does not require calibration
against true or reference EF measurements.
Consistent with our development of beat-to-beat averaged cardiovascular models, instead of fitting an
intra-beat cABP waveform, we propose a model-based method that used inter-beat information from the
arterial blood pressure waveform – central or peripheral – to estimate EF and LVEDV. Such a method does
not require one to assume a particular ventricular elastance function; it exploits the inter-beat variability in
systolic and diastolic blood pressures to estimate important left ventricular parameters. To our knowledge,
our method is the only inter-beat method for estimating EF and LVEDV.
6.2 Using Beat-to-Beat Variability to Estimate EF and LVEDV
In this section, we give a detailed description of our model-based technique for estimating EF and LVEDV.
In the next section we discuss a linear least-squares estimation scheme based on the model of this section.
The starting point for this method is the left-ventricular pressure-volume loop shown in Fig. 6.1. In
the figure, we have labeled straight lines defining the end-diastolic (Cd), before-ejection (Cbe), peak-
systolic (Cs), and end-systolic (Ces) compliances, as well as SAP, DAP, LVEDP, and LVESP. We have also
exaggerated the distance between SAP and LVESP to emphasize the key elements in our method. Qd is
the ventricular dead volume during either systole or diastole; Vth is intrathoracic pressure.
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Figure 6.1: Left ventricular pressure-volume loop showing the straight lines defining the end-diastolic,
before-ejection, peak-systolic, and end-systolic compliances, as well as SAP, DAP, and the preload and
afterload pressures. Note that the pressures in this graphic are measured with respect to intrathoracic
pressure.
In steady-state, ejection fraction can be computed as follows:
EF ≡ SV
LVEDV
=
Cd(LVEDP− Vth)− Ces(LVESP− Vth)
Cd(LVEDP− Vth) +Qd (6.2)
where steady-state stroke volume is given by:
SV = Cd(LVEDP− Vth)− Ces(LVESP− Vth) (6.3)
Note the prominence of both Qd and Vth in Equation (6.2). The intrathoracic pressure variations during
the respiratory cycle modulate left-ventricular and arterial blood pressures, LVP and ABP, respectively,
and cause beat-to-beat variations in SV, which in turn cause beat-to-beat variations in EF [3].
If we assume Vth=0, we can (see Fig. 6.1) approximate stroke volume by:
SV′ = CbeDAP− CsSAP (6.4)
and thus EF simplifies to:
EF ≈ SV
′
LVEDV′
=
CbeDAP− CsSAP
CbeDAP+Qd
, (6.5)
and LVEDV is approximated by:
LVEDV′ ≈ CbeDAP . (6.6)
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Given beat-to-beat measurements of SAP, DAP, and SV and assuming a nominal value for Qd, we can use
Equation (6.5) to compute beat-to-beat estimates of Cbe and Cs – the essence of our method for continuously
estimating beat-to-beat EF from the ABP waveform. Furthermore, given beat-to-beat estimates of Cbe
and DAP, Equation (6.6) can be used to estimate LVEDV.
The main problem with this approach is that SV′ does not in general equal SV (though we believe SV′
may be proportional to SV), leading to bias errors in the estimates of Cbe and Cs. We discuss calibration
methods to correct for the inequality of the SV estimate (6.4) in Section 6.4.
If a measurement of SV is not available, one can use a proportional estimate of SV, e.g., SVCa , such that
(6.4) reduces to:
SV′
Ca
=
Cbe
Ca
DAP− Cs
Ca
SAP (6.7)
and approximate EF is computed using:
EF ≈
Cbe
Ca
DAP− CsCaSAP
Cbe
Ca
DAP+ QdCa
, (6.8)
from which the proportionality constant Ca cancels out [27, 120]. Note that one now has to assume assume
a nominal value for QdCa in (6.8), and that to obtain LVEDV
′, one needs to perform a calibration.
We implemented least-squares estimation schemes in which we used absolute estimates of SV, and thus
(6.4)-(6.6), as well as relative estimates of SV, and thus (6.7)-(6.8), but only present results using absolute
SV estimates in this thesis.
6.3 Linear Least-Squares Estimation Scheme
In doing EF estimation from (6.5), we assume that Cbe and Cs vary slowly from beat-to-beat. Thus, we
ensure that the window size in our linear least-squares estimation scheme does not exceed half a minute
(30 beats at a heart rate of 60 beats/min), which is probably slightly larger than the timescale on which
Cbe and Cs change. We estimated EF directly from (6.5) by computing least-squares estimates of Cben and
Csn over a fixed-length data window, i.e., we calculated least-squares estimates of Cben and Csn for the nth
cardiac beat using a window comprising every mth beat of the b/2 adjacent beats on each side of this beat.
This results in a total of b2m (even) equations in two unknowns, leading to a reasonably well-conditioned
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least-squares estimation problem:
SAPn DAPn
. .
. .
. .
SAPb+n DAPb+n

[
Cben−1+ b
2
Csn−1+ b
2
]
=

SVn
.
.
.
SVb+n
 (6.9)
where we estimated absolute SV estimates using the CO estimation method of Chapter 5. The end-result
presented here does not change if we use proportional SV estimates, i.e., SVnCan , instead of absolute SV
estimates.
Furthermore, we assign the estimated Cben and Csn from each window to the midpoint of that window,
and assume that in (6.9), n > b2m , such that ejection fraction in the n
th cardiac cycle, EFn, is given by:
EFn ≈ SV
′
n
LVEDVn
≈ CbenDAPn − CsnSAPn
CbenDAPn +Qdn
(6.10)
and estimated LVEDV in the nth cycle, LVEDV′n is given by:
LVEDV′n ≈ CbenDAPn . (6.11)
It is important to note that we could use the definition of SV from (6.4) in Equation (5.8) of Chapter 5
and attempt to compute beat-to-beat estimates of Cbe, Cs, and τ in a three-parameter linear least-squares
estimation scheme of the form:
∆Van
Tn
+
Van
τn
=
CbenDAPn
Tn
− CsnSAPn
Tn
, (6.12)
where Cben and Csn are the before-ejection and end-diastolic compliances in the nth cardiac cycle. Such a
scheme, however, turns out to be severely ill-conditioned as there is an insufficient degree of variability in
the data. In addition, this approach would also suffer from the modeling assumption above, namely that
SV′ does not in general equal SV, leading to bias errors in the estimates of Cbe and Cs.
6.4 Calibration Methods
The formulae for EF and LVEDV in (6.10) and (6.11) seem to require no calibration to true or reference
measurements. Once Cben and Csn are estimated, the only unknown in (6.10) is Qd, for which we can
assume a nominal value.
There are three problems with this approach, though, and we list them here in order of importance. First,
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as mentioned above, SV′ does not equal SV (though we believe SV′ may be proportional to SV), leading
to bias errors in the estimates of Cbe and Cs. Second, it is difficult to assume a good value for Qd, as
it can vary from between 5 ml to 200 ml depending on ventricular disease state. Third, because we are
assuming Vth=0 and using (6.4) to estimate SV based on SAP and DAP, instead of LVESP and LVEDP,
respectively, there will be an additional component to the bias errors in our estimates of Cbe and Cs, and
thus, in our EF and LVEDV estimates.
To attempt to correct for these bias errors, we use a constant calibration factor to relate estimated and
reference EF or LVEDV, such that our estimate of EF in the nth cardiac cycle, EFn, is given by:
EFn = δ
SV′n
LVEDVn
= δ
CbenDAPn − CsnSAPn
CbenDAPn +Qdn
(6.13)
and our estimate of LVEDV in the nth cardiac cycle, LVEDV′n, is given by:
LVEDV′n = ²CbenDAPn . (6.14)
We could select the constants δ or ² to minimize the RMSNE between the true and estimated EF (or
LVEDV). However, in this chapter we use two types of calibration: mean and single-point calibration. In
mean calibration, we set δ (or ²) to be the ratio of the mean of the reference EF (or LVEDV) to the mean
of the estimated EF (or LVEDV) waveform. In single-point calibration, we set δ (or ²) to be the ratio
of a single reference EF (or LVEDV) point to the corresponding point in the estimated EF (or LVEDV)
waveform.
6.5 Error Criteria
In evaluating the goodness-of-fit of our calibrated EF or LVEDV estimates, i.e., to compare reference EF or
LVEDV to estimated EF or LVEDV, we used the root-mean-square-normalized-error criterion introduced
in Chapter 5. For a particular animal, s, given ns points at which EF (or LVEDV) was measured and
estimated, the RMSNE (in %) for the EF (or LVEDV) for animal s, denoted RMSNEs, is given by:
RMSNEs =
√√√√ 1
ns
ns∑
n=1
(
100(True Xn − Estimated Xn)
True Xn
)2
, (6.15)
where X denotes either EF or LVEDV.
Within the data set, the animal records contain varying numbers of reference EF or LVEDV measurements,
and thus the aggregate RMSNE over all animals is calculated as the weighted mean of the individual dog
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RMSNEs. Assuming that there are NS reference measurements, the aggregate RMSNE is given by:
Aggregate RMSNE =
√
1
NS
∑
s
ns
(
RMSNEs2
)
. (6.16)
In the literature [27, 120], instead of the weighted mean (6.16), the following expression is used to compute
RMSNE over all S animals:
Mean RMSNE =
1
S
∑
s
RMSNEs . (6.17)
Such a mean RMSNE can be skewed if a particular animal record within the data set has a large number
of reference EF or LVEDV measurements or is relatively error-ridden (or error-free) compared to others
in the same data set. In this chapter, unless we are doing direct comparisons with the results in [120], we
use the aggregate RMSNE expression (6.16).
RMSNE, even for a particular animal, is an average measure of performance. While it represents how
the true and estimated quantities compare in an average sense, it does not classify the EF or LVEDV
estimation error with regard to the particular values of ABP, HR, or even the particular interventions
being performed on the animals. A linear regression of true EF (or LVEDV) versus estimated EF (or
LVEDV) with a reported correlation coefficient would also only be an aggregate measure of performance,
as would a Bland-Altman (see [114, 115]) plot of estimation error versus the mean of the reference and
estimated quantities.
In this chapter, while we use RMSNEs and Bland-Altman plots to visualize our estimation error, wherever
appropriate, we also present plots of our EF and LVEDV estimates to visualize how the time series for the
estimates and the reference measurements compare. A measure that is less sensitive to outliers and perhaps
better matched to the visual impression in the graphical plots would be the mean absolute normalized error
(MANE) for a particular animal or subject s:
MANEs =
1
ns
ns∑
n=1
100|True Xn − Estimated Xn|
|True Xn| , (6.18)
where X denotes either EF or LVEDV. We do not use this criterion in this thesis.
6.6 Naive Sample-and-Hold Estimators for EF and LVEDV
As a metric for the quality of the estimated EF (or LVEDV) waveforms, i.e., a measure of how variable
EF (or LVEDV) is and how well our EF (or LVEDV) estimation method captures this variability, we
implemented a na¨ıve sample-and-hold EF (or LVEDV) estimator.
For the canine data set, since we only had intermittent echocardiography-based EF (or LVEDV) measure-
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Dog EF (%) LVEDV (ml) LVESV (ml) HR (bpm) cABP (mmHg)
Range Range Range Range Range
1 53-90 28-46 3-20 94-181 50-160
2 30-86 17-30 3-21 88-179 56-99
3 55-76 19-28 6-11 142-197 57-120
Table 6.1: Population statistics for the canine data set. The data was obtained from Professor Ramakrishna
Mukkamala at Michigan State University and was also used in [120].
ments, we used the following sample-and-hold na¨ıve estimator given by:
SH Xn+1 = True Xn , (6.19)
where n ≥ 2, SH X1 = True X1, and where X denotes either EF or LVEDV. Again, if the RMSNE for the
sample-and-hold na¨ıve estimator is smaller than that of the estimated quantity itself, it implies that our
estimate does not add more information than can be obtained by simply holding the value of the previous
sample.
6.7 Canine Data Set
As described in Chapter 5, the canine data set was the result of a study on three beagles (weighing 10–
15 kg) approved by the Michigan State University All-University Committee on Animal Use and Care.
Dog 1 was intubated under anesthesia and mechanically ventilated. Once intubated, the dog underwent a
thoracotomy and an aortic flow transducer was placed. This dog was allowed ten days to recover from this
major surgery.
The same experimental protocol was then performed on each of the three dogs – one with the chronic
instrumentation described above, and two others. Each animal was anesthetized, but not mechanically
ventilated. Catheters were placed in the thoracic aorta to measure cABP, and in the femoral artery to
measure fABP. A syringe pump catheter was placed into a cephalic vein for drug administration, and
ECG leads were placed on the animal. In each animal, over the course of approximately 1 hour, CO,
EF, ABP, and HR were varied by one or more of the following interventions: volume infusions, fast
hemorrhage, intravenous (IV) drugs (one or more of phenylephrine, nitroprusside, or dobutamine). During
the experiment, 2-dimensional echocardiography measurements [132] were intermittently used so as to
obtain reference LVEDV, LVESV, and thus, EF measurements.
Table 6.1 summarizes the population statistics for the canine data set. It is important to note that for
dog 3, the variability in HR and mean cABP is particularly small. In fact, the beat-to-beat variability as
measured by the index (5.36) does not exceed 1% for the entire record for dog 3, does not exceed 3% for
the entire record for dog 2, and only exceeds 5% for a few windows of data for dog 1, with most variability
seen with the fABP waveform.
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For dog 1, the data set is comprised of measurements of central arterial blood pressure (cABP) measured at
the aorta, carotid arterial blood pressure (carABP), and femoral arterial blood pressure (fABP), all sampled
at 250 Hz with 16 bit resolution. In addition, there are intermittent echocardiography measurements of
heart rate, left ventricular end-systolic volume and left ventricular end-diastolic volume, from which one
can compute left ventricular ejection fraction using (6.1).
For dogs 2 and 3, the data set comprised of measurements of central arterial blood pressure (cABP) mea-
sured at the aorta sampled at 250 Hz with 16 bit resolution. Similar to dog 1, there are intermittent
echocardiography measurements of heart rate, left ventricular end-systolic volume (LVESV) and left ven-
tricular end-diastolic volume (LVEDV), from which one can compute left ventricular ejection fraction (EF)
using (6.1). There are no peripheral arterial blood pressure waveforms available for dogs 2 and 3. For dog
3, we averaged every 3 echocardiography measurements since they were taken very close together.
Using standard open-source algorithms [117] on the cABP waveforms, we derived onset times for each
cardiac beat and HR. We calculated systolic and diastolic cABP, and mean cABP for all three dogs.
For dog 1, we also calculated systolic and diastolic carABP, systolic and diastolic fABP, mean carABP,
and mean fABP. We computed EF using the intermittent echocardiography measurements. For dog 3 we
averaged every three EF (or LVEDV) measurements as each consecutive set of three measurements was
taken at about the same time instant. All the data processing and EF and LVEDV estimation algorithms
were implemented in MATLAB R14 (Mathworks Inc., Natick, MA).
6.8 Results on EF Estimation
We first used the available ABP waveforms in the canine data set to estimate beat-to-beat stroke volume
using our CO estimation method from Chapter 5, and then used the estimated SV in the linear least squares
estimation scheme (6.9), with a window size of 50 beats and two evenly spaced points per window1, to
obtain beat-to-beat estimates of Cbe and Cs. We then computed an uncalibrated EF estimate assuming
Qd=5 ml, a plausible value for the animals in our data set [27, 120]. Note that other values of Qd could
have been used since an error in Qd can to some extent be corrected by calibration. Varying Qd from 5 to
150 ml only moderately affected the estimation results.
Table 6.2 summarizes the results obtained for a window size of 50 beats (or, approximately half a minute
at a HR of 100 bpm) for the cABP, carABP, and fABP waveforms, using a mean calibration. In the
table, we also list the RMSNEs for the SH EF estimate (6.19) described above. The RMSNEs for the SH
EF estimate reflect fairly low EF variability for dogs 2 and 3. We believe that these low RMSNEs are
sufficiently low to make our EF estimation method useful in clinical applications. In addition, the fact that
results are reasonable whether we use the cABP, fABP or carABP waveforms for dog 1 implies that our
method could be used in a minimally-invasive manner.
1We used two beats per 50 beat window to improve the conditioning of the least-squares problem (6.9).
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Dog Number of RMSNE (%) RMSNE (%) RMSNE (%) RMSNE (%)
comparisons for SH EF using cABP using fABP using carABP
1 7 20.3 14.0 11.5 16.0
2 29 13.7 12.1 – –
3 7 6.8 13.2 – –
Aggregate 43 13.9 12.7 – –
Table 6.2: RMSNEs for our mean-calibrated EF estimate using cABP, fABP, or carABP, with window size
= 50 beats (using 2 points in each window) and Qd=5ml.
Dog Number of RMSNE (%) RMSNE (%) RMSNE (%)
comparisons using cABP using fABP using carABP
1 7 14.1 11.6 16.1
2 29 11.7 – –
3 7 13.6 – –
Aggregate 43 12.6 – –
Table 6.3: RMSNEs for our single-point calibrated EF estimate, with window size = 50 beats and Qd=5ml.
In each record, the second reference EF measurement was used for calibration.
Figure 6.2 shows the true and estimated EF for dog 2 using a mean calibration. Note that the estimated
EF tracks the true EF quite well during the infusions of dobutamine, which increases EF by decreasing
Ces, and volume changes (hemorrhage results in a controlled response to lower Ces, while volume infusion
results in a controlled response to increase Ces).
Figure 6.3 is a Bland-Altman plot for the EF estimation error across all three dogs using the cABP
waveform with window size = 50 beats (using 2 points in each window) and a mean calibration.
From the Bland-Altman plot, we see that the mean estimation error (or bias) is 0%, while the 1-standard
deviation (SD) of the estimation error is 8.2%. A review of the literature [132, 131] suggests that 2-
dimensional echocardiography measurements of ventricular volumes, as were performed on the dogs of
the canine data set, have a 13% root-mean-square error, which is approximately what our EF RMSNE
is in Table 6.2. (3-dimensional echocardiography measurements have approximately 5% root-mean-square
error.) Since the 2-SD line for our estimate lies 16.4% from the line representing mean estimation error,
showing that, according to the criterion outlined in [114, 115], our estimated EF could be used to estimate
EF changes of magnitude larger than ±10%.
Table 6.3 summarizes the results obtained for a window size of 50 beats for the cABP, carABP, and fABP
waveforms, by performing a single-point calibration using the second EF measurement in each canine
record. We believe that these low RMSNEs are sufficiently low to make our estimation method useful in
clinical applications, especially given that these results were obtained with only one reference measurement
used for calibration. Note that the results in Table 6.3 are reasonable whether we use the cABP, fABP
or carABP waveforms for dog 1, which implies that our method could be used in a minimally-invasive
manner.
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Figure 6.2: True and estimated CO (using cABP), HR, mean cABP, true and estimated EF (using cABP),
and IV drugs for dog 2 with window size = 50 beats (using 2 points in each window), and a mean calibration.
In the estimation, Qd=5ml.
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Figure 6.3: Bland-Altman plot of EF estimation error (using cABP and mean calibration) versus the mean
of true and estimated EF (using cABP) over the three dogs. The horizontal lines in the plot are the mean
error, and the 1-SD and 2-SD lines.
Figure 6.4 shows the true and estimated EF for dog 1 with a single-point calibration (using the second
EF measurement). Note that the estimated EF tracks the true EF quite well during the infusions of
dobutamine and phenylephrine (which increase EF by decreasing Ces).
Figure 6.3 is a Bland-Altman plot for the EF estimation error across all three dogs using the cABP
waveform with window size = 50 beats (using 2 points in each window) and a single-point calibration using
the second reference EF measurement in each record.
From the Bland-Altman plot, we see that the mean estimation error (or bias) is 2.7%, while the 1-standard
deviation (SD) of the estimation error is 8.2%. The 2-SD line for our estimate lies 16.4% from the line
representing mean estimation error, showing that, according to the criterion outlined in [114, 115], our
single-point calibrated estimated EF could be used to estimate true EF changes larger than ±10%.
In [120], Mukkamala and co-workers describe the results shown in Table 6.4. Note that these results
were obtained without any calibration. However, this method cannot be implemented except on cABP
waveforms2. Our results from Tables 6.2 and 6.3 compare favorably to Mukkamala’s results, but are not
as good, especially for dog 3. However, considering that we only use beat-to-beat values of DAP and SAP
to compute our EF estimate, our method performs very well.
2Prof. Mukkamala obtained RMSNEs of > 20% when using the fABP waveform in dog 1 (personal communication, March
2007)
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Figure 6.4: True and estimated CO (using cABP), HR, mean cABP, true and estimated EF (using cABP),
and IV drugs for dog 1 with window size = 50 beats (using 2 points in each window), and a single-point
calibration.
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Figure 6.5: Bland-Altman plot of EF estimation error (using cABP and single-point calibration) versus
the mean of true and estimated EF (using cABP) over the three dogs. The horizontal lines in the plot are
the mean error, and the 1-SD and 2-SD lines.
Dog Number of RMSNE (%)
comparisons using cABP
1 7 9.2
2 9 12.1
3 10 6.9
Mean 26 8.5
Table 6.4: RMSNEs for Mukkamala and co-workers’ EF estimate using cABP and Qd=5ml [120].
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Dog Number of RMSNE (%) RMSNE (%) RMSNE (%) RMSNE (%)
comparisons for SH LVEDV using cABP using fABP using carABP
1 7 17.5 14.3 15.5 15.4
2 29 14.0 9.8 – –
3 7 6.1 14.0 – –
Aggregate 43 13.3 11.9 – –
Table 6.5: RMSNEs for our mean-calibrated LVEDV estimate, for which EF was calculated with window
size = 50 beats and Qd=5ml.
6.9 Results on LVEDV Estimation
Using the available ABP waveforms in the canine data set, we obtained beat-to-beat estimates of Cbe, and
used these estimates to compute beat-to-beat estimates of LVEDV using (6.14).
Table 6.5 summarizes the results obtained for the cABP, carABP, and fABP waveforms, using a mean
calibration. In the table, we also list the RMSNEs for the SH LVEDV estimate (6.19) described above.
The RMSNEs for the SH EF estimate reflect very low LVEDV variability for dogs 2 and 3. We believe
that these low RMSNEs are sufficiently low to make our LVEDV estimation method useful in clinical
applications. In addition, the fact that results are reasonable whether we use the cABP, fABP or carABP
waveforms for dog 1 implies that our method could also be used in a minimally-invasive manner.
Figure 6.6 shows the true and estimated LVEDV for dog 2 with a mean calibration. Note that the estimated
LVEDV tracks the true LVEDV quite well during the infusions of dobutamine (which indirectly increases
LVEDV by reducing TPR) and volume changes (hemorrhage results in lower LVEDV, while volume infusion
results in higher LVEDV).
Figure 6.7 shows the true and estimated LVEDV for dog 3 with a mean calibration. Note that the true
LVEDV is essentially constant for this dog, making it difficult to conclude much about the estimated
LVEDV.
Figure 6.8 is a Bland-Altman plot for the LVEDV estimation error across all three dogs using the cABP
waveform and a mean calibration.
From the Bland-Altman plot, we see that the mean estimation error (or bias) is −0.01 ml, while the 1-
standard deviation (SD) of the estimation error is 3.2 ml. The 2-SD line for our estimate lies 6.4 ml from
the line representing mean estimation error, showing that, according to the criterion outlined in [114, 115],
our mean-calibrated estimated LVEDV compares quite well with the reference echocardiography LVEDV
measurements.
– 189 –
Continuous Monitoring of Left Ventricular Ejection Fraction and End-Diastolic Volume
500 1000 1500 2000 2500
0
2
4
Fl
ow
 (l/
mi
n)
 
 
500 1000 1500 2000 2500
0
100
200
H
R
 (b
pm
)
500 1000 1500 2000 2500
40
60
80
100
M
ea
n 
cA
BP
 (m
mH
g)
500 1000 1500 2000 2500
0
20
40
Vo
lu
m
e 
(m
l)
 
 
500 1000 1500 2000 2500
0
10
20
30
Time (secs)D
os
e 
(m
cg
/kg
/m
in)
    
    
o
r 
Bl
oo
d 
(m
l/1
0 o
r m
l/1
8)
 
 
dobutamine
hemorrhage
infusion
Figure 6.6: True and estimated CO (using cABP), HR, mean cABP, true and estimated LVEDV (using
cABP), and IV drugs for dog 2 with a mean calibration.
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Figure 6.7: True and estimated CO (using cABP), HR, mean cABP, true and estimated LVEDV (using
cABP), and IV drugs for dog 3 with a mean calibration.
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Figure 6.8: Bland-Altman plot of LVEDV estimation error (using cABP and mean calibration) versus the
mean of true and estimated LVEDV (using cABP) over the three dogs. The horizontal lines in the plot
are the mean error, and the 1-SD and 2-SD lines.
6.10 Combining Estimates of CO, TPR, EF, and LVEDV
In the ICU, we envision providing beat-to-beat estimates of CO, TPR, EF, and LVEDV to clinicians,
allowing them to quickly decide on therapeutic interventions, particularly for hypotensive ICU patients
with a combination of hypovolemia, sepsis, or cardiac failure.
We plot time series of estimated CO, TPR, EF, and LVEDV for dogs 1, 2, 3, in Figs. 6.9, 6.10, and 6.11,
respectively. Each estimate was obtained under conditions described in this chapter and in Chapter 5.
In Fig. 6.9, when dobutamine is infused, we see a rapid increase in EF and a rapid decrease in both true
and estimated TPR, while LVEDV stays approximately constant. Later in the record, when phenylephrine
is infused, TPR increases, and as a result LVEDV increases.
In Fig. 6.10, when dobutamine is infused, we see a rapid increase in EF and a rapid decrease in TPR, while
LVEDV stays approximately constant. Later in the record, during the progressive hemorrhage, TPR and
LVEDV increase very rapidly. During the volume infusion, TPR and LVEDV gradually increase. During
the hemorrhage and volume infusion portions of data, EF stays approximately constant.
In Fig. 6.11, it is very difficult to make reasonable deductions about the dog’s cardiovascular state given
that CO, mean cABP, EF, and LVEDV do not vary much during the experiment.
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Figure 6.9: True and estimated CO, HR, mean cABP, true and estimated TPR, true and estimated EF,
true and estimated LVEDV, and IV infusions for dog 1. The cABP waveform was used for each estimate.
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Figure 6.10: True and estimated CO, HR, mean cABP, true and estimated TPR, true and estimated EF,
true and estimated LVEDV, and IV infusions for dog 2. The cABP waveform was used for each estimate.
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Figure 6.11: True and estimated CO, HR, mean cABP, true and estimated TPR, true and estimated EF,
true and estimated LVEDV, and IV infusions for dog 3. The cABP waveform was used for each estimate.
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6.11 Conclusions and Future Work
In this chapter, we described a novel beat-to-beat model-based method for continuously estimating left
ventricular ejection fraction and left ventricular end-diastolic volume from central or peripheral arterial
blood pressure waveforms. Our estimation methods require at least a single-point calibration to a reference
EF or LVEDV measurement. Nevertheless, the methods have clear physiological bases, can be implemented
using minimally-invasive arterial blood pressure measurements, and are computationally efficient making
it easily implementable in real time.
We applied the method to a canine data set in which reference echocardiography-based ventricular volume
measurements were available. The resulting RMSNEs on the data set, 13% for left ventricular ejection
fraction, and 12% for left ventricular end-diastolic volume, are quite reasonable, especially given that our
method does not require the entire arterial blood pressure wavelet in each beat. These errors are on the
order of those obtained using another EF estimation method [27, 120], however, that method does not
require a calibration factor. In future work, we intend to explore the bias errors that creep into our EF
and LVEDV estimates, and we hope that this exploration will result in a calibration-free methods for
estimating EF and LVEDV.
We concluded this chapter with a preview of one of the research directions we would like to pursue, namely,
combining our estimates of CO, TPR, EF, and LVEDV to make sense of ICU patient data. As we lack
the gold-standard annotated data for doing this research in a meaningful way, it would be prudent to
carry out mammalian experiments in the laboratory through which more cardiac output, ejection fraction,
left-ventricular end-diastolic volume, and arterial blood pressure data could be collected. This data could
be collected for a variety of disease states and therapeutic interventions. Our model-based estimation
methods would be even more strongly validated.
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Chapter 7
Conclusions
MODERN intensive care units suffer from an information overload problem, in which a vast andvaried amount of physiological data is collected but little effort is placed in organizing, integrating,
and interpreting the wealth of data. The clinician’s task of data interpretation and integration is further
complicated by the highly dynamic physiological state of ICU patients and the fact that the clinicians
cannot devote too much time to any one ICU patient.
The research presented in this thesis attempted to address this information overload problem by using
cardiovascular dynamics models and model-based estimation schemes to track important clinical variables.
By tracking these variables, some of which are currently not continuously monitored in the ICU, we hope to
present information to clinicians in a more organized manner, and also to reduce the frequency of invasive
measurements performed on ICU patients. In particular, our hope was to be able to track variables that
would help us distinguish between sepsis, hypovolemia, and cardiac problems.
We have come a long way towards estimating clinically important variables – cardiac output (CO), total
peripheral resistance (TPR), left ventricular ejection fraction (EF), and left ventricular end-diastolic volume
(LVEDV) – especially in terms of validating our model-based estimation methods with animal and human
data. Yet, as with many theses, the research presented here generated more questions that need to be
addressed, while providing answers to only some of those we posed earlier.
In this chapter, we conclude this report with a summary of the thesis contributions and a description of
future research directions.
7.1 Summary of Contributions
The main contributions described in this thesis report are:
1. The development and application of averaging methodology to existing lumped-parameter pulsatile
electrical circuit models of cardiovascular dynamics. The resulting averaged models – discrete-time beat-
to-beat averaged and continuous-time cycle-averaged models – are capable of tracking cardiovascular
dynamics on timescales larger than a single cardiac beat.
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2. The development and application of the beat-to-beat averaged Windkessel model to estimate cardiac
output and total peripheral resistance from a central or peripheral arterial blood pressure waveform.
We validated this estimation method on two animal data sets – a porcine data set and a canine data
set. In addition, we validated the method on two human ICU data sets – a MIMIC I patient data set
with 12 patients and a MIMIC II patient data set with 120 patients. The errors obtained on application
of our CO estimation method are well within the margin of clinically-acceptable error.
3. The use of the steady-state ventricular pressure-volume relationship in the development and application
of a novel method for estimating left ventricular ejection fraction and left ventricular end-diastolic
volume from a central or peripheral arterial blood pressure waveform. We applied these estimation
methods to a canine data set, again obtaining errors that are clinically-acceptable.
7.2 Summary of Thesis Document
In Part I (Chapters 1 and 2) of this thesis, we gave an introduction to, and background for, the thesis
research. In Chapter 1, we placed the thesis research in context, and provided a description of the thesis
aims and contributions. We gave an overview of the MIT BRP and the MIMICU group within that
partnership. We also included details on the MIMIC II ICU patient database, explaining which signals are
routinely collected and the potential implications for researchers who might use these signals. We ended
the chapter with the specific aims and contributions of this thesis research, and an outline of the thesis
document. In Chapter 2 we gave a brief overview of cardiovascular physiology. In particular, we gave a
brief description of the circulatory system and the mechanisms which control mean arterial blood pressure.
In Part II (Chapters 3 and 4), we described lumped-parameter electrical circuit models of cardiovascular
dynamics. In particular, we described pulsatile, discrete-time beat-to-beat averaged, and continuous-time
cycle-averaged models, many of which we developed. In Chapter 3 we described pulsatile models of car-
diovascular dynamics. The well-known Windkessel model was introduced in this chapter. We showed how
electrical circuit analogs for the cardiovascular system can be used to create models such as the modified
Windkessel model, the cardiovascular simulator (CVSIM), and its derivatives – the simple cardiovascular
simulator (CVSIMple) and the simple pulsatile cardiovascular model (SPCVM). We introduced the av-
eraging methodology in Chapter 4 and applied it to some of these pulsatile models to obtain averaged
models of cardiovascular dynamics. We illustrated these averaging techniques on the linear, time-invariant
Windkessel model and also showed how one could cycle-average a nonlinear time-varying model such as
the SPCVM.
In Part III (Chapters 5,and 6), we described our model-based estimation methods for cardiac output,
total peripheral resistance, left-ventricular ejection fraction, and left-ventricular end-diastolic volume. In
Chapter 5, we showed how the beat-to-beat averaged Windkessel model from Chapter 4 can be used to
estimate cardiac output and total peripheral resistance. We validated this method using two animal and
two human ICU patient data sets. The method was shown to be robust i.e., in all the data sets, our
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method performed better than all the other CO estimation methods implemented, with a mean RMSNE
of at most 15%. We presented a novel method for estimating left ventricular ejection fraction based on
the steady-state left ventricular pressure-volume relationship in Chapter 6. As an extension of our EF
estimation method, we also estimated left ventricular end-diastolic volume. Both methods were tested on
a canine data set with three dogs and 43 reference echocardiography-based EF and LVEDV measurements.
The resulting mean RMSNE of at most 13% is within the margin of clinically-acceptable error.
Part IV (Chapters 7 and the Appendices) concludes this thesis with a summary of the thesis research,
main contributions, and potential avenues for further research. In the appendices, we give a description
of the notation used in this thesis (Appendix A), and have placed ancillary material, such as derivations
(Appendices B, C, D), and programming scripts (Appendices E and F).
7.3 Suggestions for Future Work
While we have come a long way towards demonstrating the benefits of computational models of cardiovas-
cular dynamics in the ICU, there are many possible future research directions that we motivated through
the research presented in this report. We describe some of these below.
Model-Based Estimation Methods Our model-based estimation methods for CO, EF, and LVEDV still
need to be perfected. As mentioned in Chapters 5, we need to evaluate our results using the mean absolute
normalized error criterion. In addition, as we mentioned in Chapter 6, the bias errors in our EF and
LVEDV estimates need to be carefully analyzed. This analysis could potentially lead to the discovery of a
calibration-free model-based method for estimating EF and LVEDV. While our estimation methods could
easily report relative changes in these three variables, clinicians will be more accepting of our estimates if
we provided absolute values of CO, EF, and LVEDV without any calibration.
Animal Studies There is a lack of gold-standard (appropriately measured and recorded) CO, EF, and
LVEDV data in the MIMIC II database, something that we did not foresee at the beginning of this
project. It would be prudent to carry out animal experiments in the laboratory through which more
ejection fraction and left-ventricular end-diastolic volume and pressure data could be collected. In the
same spirit, more animal data on cardiac output and ejection fraction and left-ventricular end-diastolic
volume (and pressure) for various pathologies and therapeutic interventions should be collected. Our
model-based estimation methods would then be more strongly validated.
Clinical Studies Before our CO estimation method progresses to a clinical setting, we need to perform
studies with human subjects in which we determine how exactly to set nominal values for the calibration
constants (γ1, γ2) for our CO estimate. This study would, hopefully, take into account some of the
pathologies we would encounter in the ICU, perhaps by using human subjects who suffer from cardiovascular
disease.
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Averaged Models While we have demonstrated the beat-to-beat and cycle-averaging methodologies in
simple pulsatile models, it would be beneficial if we could show how to modularize our averaging methods,
i.e., apply the methods in a modular fashion to linear or even nonlinear circuit elements. This would make
the method more applicable to multi-compartment models, such as CVSIM. In addition, in the case of
cycle-averaged models, other system identification techniques, such as adaptive observers and identifiers
should be investigated.
Fluid Responsiveness One of the key problems in the ICU is determining a patient’s fluid responsiveness,
i.e., how well a patient will respond to a bolus fluid infusion, or to the administration of a drug that
reduces the body’s circulating blood volume. Fluid infusion is the main intervention for hypovolemia, while
fluid removal is a key intervention for congestive heart failure [3]. We have performed some preliminary
animal experiments in which we tried to determine how changes in the animals’ fluid balance relate to the
respiratory modulation of the arterial blood pressure waveform [134]. Much work remains to be done – at
the very least more animal studies could be performed to more carefully collect data on the respiratory
modulation of ABP.
Clinical Reasoning Systems The emphasis in this thesis was on lumped-parameter electrical circuit
models of cardiovascular dynamics. Very little work has been done on how to combine the outputs of our
models and model-based estimation schemes to generate pathophysiological hypotheses in the ICU. This
model integration step is essential, and a large part of our group’s future research effort would be best
focused on this project.
We hope that our results will encourage other researchers to perform the studies suggested, and that the
results in this thesis will contribute to the development of a next-generation patient monitoring system.
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Appendix A
Nomenclature
A.1 Chapter 1
ICU Intensive care unit
U.S. United States of America
ABP Arterial Blood Pressure
ECG Electrocardiogram
BRP Bioengineering Research Partnership
MIT Massachusetts Institute of Technology
MIMIC Multi-parameter Intelligent Monitoring for Intensive Care
LCP Laboratory for Computational Physiology
CSAIL Computer Science and Artificial Intelligence Laboratory
PHI Protected Health Information
CVP Central Venous Pressure
PAP Pulmonary Artery Pressure
HR Heart Rate
MAP Mean Arterial Blood Pressure
SAP Systolic Arterial Blood Pressure
DAP Diastolic Arterial Blood Pressure
DPAP Diastolic Pulmonary Artery Blood Pressure
PCWP Pulmonary Capillary Wedge Pressure
CO Cardiac Output
CHF Congestive Heart Failure
TPR Total Peripheral Resistance
SVR Systemic Vascular Resistance
MIMICU Model-based Monitoring for the Intensive Care Unit
LEES Laboratory for Electromagnetic and Electronic Systems
AI Artificial Intelligence
BBN Bayesian Belief Network
HMM Hidden Markov Model
EF Left ventricular Ejection Fraction
LVEDV Left Ventricular End-Diastolic Volume
LVEDP Left Ventricular End-Diastolic Pressure
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A.2 Chapter 2
A.2 Chapter 2
CV Cardiovascular
CVS Cardiovascular System
SA Sino-Atrial
AV Atrio-Ventricular
MI Myocardial Infarction
EDV End-Diastolic Volume
ESV End-Systolic Volume
EDP End-Diastolic Pressure
ESP End-Systolic Pressure
Preload Pressure at the inlet of an atrium in the heart
Afterload Pressure at the outlet of a ventricle in the heart
LV Left Ventricular
RV Right ventricular
SV Stroke Volume
Cd End-diastolic ventricular compliance
Ces End-systolic ventricular compliance
LVESP Left Ventricular End-Systolic Pressure
Qd Ventricular dead volume
Vth Intrathoracic pressure
RVEDP Right Ventricular End-Diastolic Pressure
VR Venous Return
Va Arterial blood pressure
NTS Nucleus tractus solitarius
ANS Autonomic nervous system
RAP Right Atrial Transmural Pressure
NO Nitric Oxide
GTP Guanosine triphosphate
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A.3 Chapter 3
A.3 Chapter 3
I Blood flow
V Blood pressure
Q Blood volume
D Heart valve
R Vascular or valvular resistance
C Vascular or ventricular compliance
L Blood inertia
E Elastance
Ra Arterial resistance or TPR
Ca Arterial compliance in Windkessel model
PP Pulse Pressure
T (or Tn) Duration of (nth) cardiac cycle
f (or fn) Heart rate (in nth cardiac cycle) in beats/min
tn Onset time of nth cardiac cycle
Ca,p Proximal arterial compliance in the modified Windkessel model
Ca,d Distal arterial compliance in the modified Windkessel model
La Blood inertia in modified Windkessel model
Va,p Proximal arterial blood pressure in the modified Windkessel model
Va,d Distal arterial blood pressure in the modified Windkessel model
IL Blood flow through La in the modified Windkessel model
CVSIM Cardiovascular Simulator
CVSIMple Simple cardiovascular simulator
SPCVM Simple Pulsatile Cardiovascular Model
Qh Ventricular volume in CVSIMple or SPCVM
Vv Venous blood pressure in CVSIMple or SPCVM
Va Arterial blood pressure
I1 Blood flow through R1 in CVSIMple or SPCVM
I2 Blood flow through R2 in CVSIMple or SPCVM
Ia Blood flow through Ra
Cv Venous compliance in CVSIMple or SPCVM
R1 Inlet valve resistance in CVSIMple or SPCVM
R2 Outlet valve resistance in CVSIMple or SPCVM
Eh Ventricular elastance in CVSIMple or SPCVM
Es End-systolic elastance in CVSIMple or SPCVM
Ed End-diastolic elastance in CVSIMple or SPCVM
Td Duration of diastole
Ts Duration of systole
s1 switching function for position 1 for the SPCVM switch
s2 switching function for position 2 for the SPCVM switch
s3 switching function for position 3 for the SPCVM switch
sD switching function for the diode in the SPCVM
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A.4 Chapter 4
A.4 Chapter 4
LVP Left Ventricular Pressure
LTI Linear and Time-Invariant
τ (or τn) Time constant in Windkessel-type models (in the nth cardiac cycle)
T (or Tn) Duration of (nth) cardiac cycle
f (or fn) Heart rate (in nth cardiac cycle) in beats/min
tn Onset time of nth cardiac cycle
Xn X in the nth cardiac cycle
Van Mean ABP in the nth cardiac cycle in the Windkessel model
∆Van Equal to Va(tn+1)− Va(tn) where n refers to the nth cardiac cycle
Va,pn Mean proximal ABP in the n
th cardiac cycle of the modified Windkessel model
∆Va,pn Equal to Va,p(tn+1)− Va,p(tn) where n refers to the nth cardiac cycle
Va,dn Mean distal ABP in the n
th cardiac cycle of the modified Windkessel model
∆Va,dn Equal to Va,d(tn+1)− Va,d(tn) where n refers to the nth cardiac cycle
Xak Index-k cycle-average of Xa or 〈Xa(t)〉k
Xa
R
k Real part of Index-k cycle-average of Xa or 〈Xa(t)〉Rk
Xa
I
k Imaginary part of Index-k cycle-average of Xa or 〈Xa(t)〉Ik
tD Diode turn-on time in the SPCVM
Xa0 Index-0 cycle-average of Xa
Va0 Index-0 arterial blood pressure in the cycle-averaged Windkessel model
Va,p0 Index-0 proximal arterial blood pressure in the cycle-averaged modified Windkessel model
Va,d0 Index-0 distal arterial blood pressure in the cycle-averaged modified Windkessel model
IL0 Index-0 blood flow through La in the cycle-averaged modified Windkessel model
Qh0 Index-0 ventricular volume in the Index-0 CAM
Vv0 Index-0 venous blood pressure in the Index-0 CAM
Va0 Index-0 arterial blood pressure in the Index-0 CAM
CAM Cycle-Averaged Model
VP Ventricular Pressure
PRU Peripheral Resistance Unit (=1 mmHg/(ml/s))
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A.5 Chapter 5
A.5 Chapter 5
CO Cardiac Output
ABP Arterial Blood Pressure
ECG Electrocardiogram
TPR Total Peripheral Resistance
HR Heart Rate
MAP Mean Arterial Blood Pressure
SAP Systolic Arterial Blood Pressure
DAP Diastolic Arterial Blood Pressure
TPR Total Peripheral Resistance
Ra Arterial resistance or TPR
Ca Arterial compliance in Windkessel model
PP Pulse Pressure
T (or Tn) Duration of (nth) cardiac cycle
tn Onset time of nth cardiac cycle
Ca,p Proximal arterial compliance in modified Windkessel model
Ca,d Distal arterial compliance in modified Windkessel model
La Blood inertia in modified Windkessel model
Va,p Proximal arterial blood pressure in modified Windkessel model
Va,d Distal arterial blood pressure in modified Windkessel model
IL Blood flow through La in the modified Windkessel model
Va Arterial blood pressure in the Windkessel model
Ia Blood flow through Ra
LTI Linear and Time-Invariant
τ (or τn) Time constant in Windkessel-type models (in the nth cardiac cycle)
Xn X in the nth cardiac cycle
Van Mean ABP in the nth cardiac cycle in the Windkessel model
Va,pn Mean proximal ABP in the n
th cardiac cycle of the modified Windkessel model
Va,dn Mean distal ABP in the n
th cardiac cycle of the modified Windkessel model
∆Van Equal to Va(tn+1)− Va(tn) where n refers to the nth cardiac cycle
UCO Uncalibrated Cardiac Output
ECO Estimated Cardiac Output
TCO True (or reference) Cardiac Output
RMSNE Root-Mean-Square-Normalized-Error
MANE Mean Absolute Normalized Error
cABP central Arterial Blood Pressure
rABP radial Arterial Blood Pressure
fABP femoral Arterial Blood Pressure
IV Intravenous
B2BVI Beat-to-Beat Variability Index
NECO Na¨ıve Estimated Cardiac Output
SHNECO Sample-and-Holde Na¨ıve Estimated Cardiac Output
LVESV Left Ventricular End-Systolic Volume
LVEDV Left Ventricular End-Diastolic Volume
∆TCO Range of True Cardiac Output measurements
POE Provider-Order-Entry (medications)
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A.6 Chapter 6
A.6 Chapter 6
EF Left ventricular Ejection Fraction
LVEDV Left Ventricular End-Diastolic Volume
CO Cardiac Output
TPR Total Peripheral Resistance
SV Stroke Volume
PCWP Pulmonary Capillary Wedge Pressure
MRI Magnetic Resonance Imaging
Echo Echocardiography image
ICU Intensive Care Unit
Cd End-diastolic ventricular compliance
Cbe Before-ejection ventricular compliance
Cs Peak-systolic ventricular compliance
Ces End-systolic ventricular compliance
Vth Intrathoracic pressure
SAP Systolic Arterial Blood Pressure
DAP Diastolic Arterial Blood Pressure
SV′ Estimated stroke volume
Ca Arterial compliance in the Windkessel-type models
LVEDV′ Estimated left ventricular end-diastolic volume
Qd Ventricular dead volume
LVEDP Left Ventricular End-Diastolic Pressure
LVESP Left Ventricular End-Systolic Pressure
Xn X in the nth cardiac cycle
T (or Tn) Duration of (nth) cardiac cycle
tn Onset time of nth cardiac cycle
Van Mean ABP in the nth cardiac cycle in the Windkessel model
τ (or τn) Time constant in Windkessel-type models (in the nth cardiac cycle)
∆Van Equal to Va(tn+1)− Va(tn) where n refers to the nth cardiac cycle
RMSNE Root-Mean-Square-Normalized-Error
MANE Mean Absolute Normalized Error
SH X Sample-and-Hold Estimator for quantity X
δ calibration constant for ejection fraction
² calibration constant for left ventricular end-diastolic volume
cABP central Arterial Blood Pressure
carABP carotid Arterial Blood Pressure
fABP femoral Arterial Blood Pressure
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A.7 Chapter 7
A.7 Chapter 7
ICU Intensive Care Unit
CO Cardiac Output
TPR Total Peripheral Resistance
EF Left Ventricular Ejection Fraction
LVEDV Left Ventricular End-Diastolic Volume
MIMIC Multi-parameter Intelligent Monitoring for Intensive Care
BRP Bioengineering Research Partnership
CVSIM Cardiovascular Simulator
CVSIMple Simple Cardiovascular Simulator
SPCVM Simple Pulsatile Cardiovascular Model
RMSNE Root-Mean-Square-Normalized-Error
MANE Mean Absolute Normalized Error
γ1 first calibration constant for the pressure-dependent arterial compliance
γ2 second calibration constant for the pressure-dependent arterial compliance
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Appendix B
CVSIM Equations and Parameters
The equations for the CVSIM model corresponding to Fig. 3.7 are as follows:
dQh,l
dt
= Iil − Iol (B.1)
dVa
dt
=
Iol − Ia
Ca
(B.2)
dVv
dt
=
Ia − Iir
Cv
(B.3)
dQh,r
dt
= Iir − Ior (B.4)
dVpa
dt
=
Ior − Ipa
Cpa
(B.5)
dVpv
dt
=
Ipa − Iil
Cpv
(B.6)
where the various flow rates are given by:
Iil =

Vpv−Vh,l
Ril
if Vpv > Vh,l
0 otherwise
(B.7)
Iol =

Vh,l−Va
Rol
if Vh,l > Va
0 otherwise
(B.8)
Ia =
Va − Vv
Ra
(B.9)
Iir =

Vv−Vh,r
Rir
if Vv > Vh,r
0 otherwise
(B.10)
Ior =

Vh,r−Vpa
Ror
if Vh,r > Vpa
0 otherwise
(B.11)
Ipa =
Vpa − Vpv
Rpv
. (B.12)
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Description Parameter Nominal Value
Systemic vascular resistance Ra 1.0 mmHg/(ml/s) or PRU
Inflow resistance for right ventricle Rir 0.01 PRU
Outflow resistance for right ventricle Ror 0.003 PRU
Pulmonary arterial resistance Rpa 0.08 PRU
Inflow resistance for left ventricle Ril 0.01 PRU
Outflow resistance for left ventricle Rol 0.006 PRU
Systemic arterial compliance Ca 1.6 ml/mmHg
Systemic venous compliance Cv 100 ml/mmHg
Pulmonary arterial compliance Cpa 4.3 ml/mmHg
Pulmonary venous compliance Cpv 8.4 ml/mmHg
Left ventricular end-diastolic elastance Ed,l 0.1 mmHg/ml
Left ventricular end-systolic elastance Es,l 2.5 mmHg/ml
Right ventricular end-diastolic elastance Ed,r 0.1 mmHg/ml
Right ventricular end-systolic elastance Es,r 56 mmHg/ml
Zero-pressure filling volume in left ventricular compartment Qh,l(0) 15 ml
Zero-pressure filling volume in right ventricular compartment Qh,r(0) 15 ml
Zero-pressure filling volume in systemic arterial compartment Qa(0) 715 ml
Zero-pressure filling volume in systemic venous compartment Qv(0) 2500 ml
Zero-pressure filling volume in pulmonary arterial compartment Qpa(0) 90 ml
Zero-pressure filling volume in pulmonary venous compartment Qpv(0) 400 ml
Length of one heart beat T 56 s
Intrathoracic Pressure Vth -4 mmHg
Total Blood Volume Qtot 5000 mL
Table B.1: Nominal parameters of the CVSIM model. These parameters are based on a literature review
in [49]. Ranges for these parameters can be found in [34].
The elastance of the left and right ventricles, respectively, are given by:
Eh,l(t) =

1
2(Es,l − Ed,l)
(
1− cos
(
pit
0.3
√
T
))
+ Ed,l for 0 ≤ t ≤ 0.3
√
T
1
2(Es,l − Ed,l)
(
1− cos
(
2pi(t−0.3√T )
0.3
√
T
))
+Ed,l for 0.3
√
T ≤ t ≤ 0.9
√
T
2
Ed,l for 0.9
√
T
2 ≤ t ≤ T
(B.13)
Eh,r(t) =

1
2(Es,r − Ed,r)
(
1− cos
(
pit
0.3
√
T
))
+Ed,r for 0 ≤ t ≤ 0.3
√
T
1
2(Es,r − Ed,r)
(
1− cos
(
2pi(t−0.3√T )
0.3
√
T
))
+ Ed,r for 0.3
√
T ≤ t ≤ 0.9
√
T
2
Ed,r for 0.9
√
T
2 ≤ t ≤ T
(B.14)
The nominal CVSIM parameters (see [8, 49]) are as follows:
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Appendix C
Circuit Analysis for the SPCVM
The SPCVM operates in four different regions during a single cycle. These four regions correspond to the
four stages (isovolumic contraction, ejection, isovolumic relaxation, and filling) of the cardiac cycle. In
each region, based on the states of the switch and diode listed in Table 3.3, there is a circuit defining the
SPCVM. Figure C.1 shows the circuits in the four regions of operation of the SPCVM.
If the diode switching times were fixed, the SPCVM would be a periodically time-varying system and a
rich set of analysis tools could be applied to the circuit (see [135] and [136] for examples of such tools).
Using Qh, Va, and Vv as state variables, we see that each of the circuits is linear.
In regions I (isovolumic contraction) and III (isovolumic relaxation), the charge in the time-varying capac-
itor is constant (Q˙h = 0) as there is no blood flow into or out of the heart. In these regions, we have a
linear system given by:
d
dt
QhVa
Vv
 =
0 0 00 −1RaCa 1RaCa
0 1RaCv
−1
RaCv
QhVa
Vv
 . (C.1)
In region II (ejection) there is blood flow out of the heart and thus Qh is not constant. A state space
description of the system in region II is:
d
dt
QhVa
Vv
 =

−Eh(t)
R2
1
R2
0
Eh(t)
R2Ca
−(R2+Ra)
R2RaCa
1
RaCa
0 1RaCv
−1
RaCv

QhVa
Vv
 . (C.2)
Finally, by analyzing the third circuit in Fig. C.1, we obtain a state space model for region IV (filling) as:
d
dt
QhVa
Vv
 =

−Eh(t)
R1
0 1R1
0 −1RaCa
1
RaCa
Eh(t)
R1Cv
1
RaCv
−(R1+Ra)
R1RaCv

QhVa
Vv
 . (C.3)
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Figure C.1: SPCVM circuits for the different regions of operation: the top circuit is for regions I and III,
the middle circuit is for region II, and the bottom circuit is for region IV.
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Ancillaries for the Index-0 Cycle-Averaged Model
D.1 Expressions used in the Index-0 Model
Here, we give the expressions used for C(S10, SD0(t), p) and d(S10, SD0(t), S11, SD1,X1,X2, p). These ex-
pressions were derived using the approximations in (4.35)-(4.40), and can be evaluated using the parameters
in Table 3.1.
The entries of the 3× 3 matrix
C(S10, SD0(t), p) =
c11 c12 c13c21 c22 c23
c31 c32 c33

are as follows:
c11 = −S10Eh0
R1
− SD0Eh0
R2
− 2SD
R
1 Eh
R
1
R2
−2SD
I
1Eh
I
1
R2
− 2S1
R
1 Eh
R
1
R1
− 2S1
I
1Eh
I
1
R1
;
(D.1)
c12 =
SD0
R2
; (D.2)
c13 =
S10
R1
; (D.3)
c21 =
SD0Eh0
CaR2
+ 2
SD
R
1 Eh
R
1
CaR2
+ 2
SD
I
1Eh
I
1
CaR2
;
(D.4)
c22 = −R2 +RaSD0
CaR2Ra
; (D.5)
c23 =
1
CaRa
; (D.6)
c31 =
S10Eh0
CvR1
+ 2
S1
R
1 Eh
R
1
CvR1
+ 2
S1
I
1Eh
I
1
CvR1
; (D.7)
c32 =
1
CvRa
; (D.8)
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c33 = −RaS10 +R1
CvR1Ra
. (D.9)
The entries of the 3× 1 vector
d(S10, SD0(t), S11, SD1,X1,X2, p) =
d1d2
d3

are given below. The expressions simplify somewhat under the reasonable assumption that VvR1 and Vv
I
1
are negligibly small:
d1 = −2(QhR1 EhR1 +QhI1EhI1)
(
S10
R1
+
SD0
R2
)
− 2(QhR2 EhR2 +QhI2EhI2)
(
S10
R1
+
SD0
R2
)
−2
(
SD
R
1 Eh0Qh
R
1 + SD
I
1Eh0Qh
I
1
R2
)
− 2
(
S1
R
1 Eh0Qh
R
1 + S1
I
1Eh0Qh
I
1
R1
)
−2
(
SD
R
1 Va
R
1 + SD
I
1Va
I
1
R2
)
+ 2
(
S1
R
1 Vv
R
1 + S1
I
1Vv
I
1
R1
)
−2
(
S1
R
1
R1
+
SD
R
1
R2
)(
Qh
R
2 Eh
R
1 +Qh
I
2Eh
I
1
)
− 2
(
S1
R
1
R1
+
SD
R
1
R2
)(
Qh
R
1 Eh
R
2 +Qh
I
1Eh
I
2
)
−2
(
S1
I
1
R1
+
SD
I
1
R2
)(
Qh
R
2 Eh
I
1 −QhI2EhR1
)
− 2
(
S1
I
1
R1
+
SD
I
1
R2
)(
Qh
R
1 Eh
I
2 −QhI1EhR2
)
. (D.10)
d2 = 2SD0
(
Qh
R
1 Eh
R
1 +Qh
I
1Eh
I
1
CaR2
)
+ 2SD0
(
Qh
R
2 Eh
R
2 +Qh
I
2Eh
I
2
CaR2
)
+2
(
SD
R
1 Eh0Qh
R
1 + SD
I
1Eh0Qh
I
1
CaR2
)
− 2
(
SD
R
1 Va
R
1 + SD
I
1Va
I
1
CaR2
)
+2
SD
R
1
CaR2
(
Qh
R
2 Eh
R
1 +Qh
I
2Eh
I
1
)
+ 2
SD
R
1
CaR2
(
Qh
R
1 Eh
R
2 +Qh
I
1Eh
I
2
)
+2
SD
I
1
CaR2
(
Qh
R
2 Eh
I
1 −QhI2EhR1
)
+ 2
SD
I
1
CaR2
(
Qh
R
1 Eh
I
2 −QhI1EhR2
)
. (D.11)
d3 = 2S10
(
Qh
R
1 Eh
R
1 +Qh
I
1Eh
I
1
CvR1
)
+ 2S10
(
Qh
R
2 Eh
R
2 +Qh
I
2Eh
I
2
CvR1
)
+2
(
S1
R
1 Eh0Qh
R
1 + S1
I
1Eh0Qh
I
1
CvR1
)
− 2
(
S1
R
1 Vv
R
1 + S1
I
1Vv
I
1
CvR1
)
+2
S1
R
1
CvR1
(
Qh
R
2 Eh
R
1 +Qh
I
2Eh
I
1
)
+ 2
S1
R
1
CvR1
(
Qh
R
1 Eh
R
2 +Qh
I
1Eh
I
2
)
+2
S1
I
1
CvR1
(
Qh
R
2 Eh
I
1 −QhI2EhR1
)
+ 2
S1
I
1
CvR1
(
Qh
R
1 Eh
I
2 −QhI1EhR2
)
. (D.12)
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D.2 Charge Conservation in the Simple Pulsatile Cardiovascular Model
In this section we present results on charge conservation in the index-0 cycle-averaged model. First, we
show that there is charge conservation in the SPCVM. Second, we prove that the (constant) total charge
in the SPCVM and the index-0 component of the total charge in the index-0 cycle-averaged SPCVM are
equal.
By applying the index-0 cycle-average operator, 〈•〉0, to the SPCVM equations, we obtain:
dQh0
dt
= −〈s1(Vh − Vv)〉0
R1
− 〈sD(Vh − Va)〉0
R2
(D.13)
Ca
dVa0
dt
=
〈sD(Vh − Va)〉0
R2
− Va0 − Vv0
Ra
(D.14)
Cv
dVv0
dt
=
〈s1(Vh − Vv)〉0
R1
+
Va0 − Vv0
Ra
. (D.15)
By summing the left-hand sides of (D.13), (D.14) and (D.15), we obtain:
dQtot0
dt
=
dQh0
dt
+ Ca
dVa0
dt
+ Cv
dVv0
dt
= 0 (D.16)
where Qtot0 is the index-0 component of the total charge in the index-0 cycle-averaged model. This result
shows that for any given approximation for SD0, and any Eh, Ca, Cv, R1, R2, and Ra, the total charge in
the index-0 cycle-averaged model is conserved.
Let Qtot be the total charge in the SPCVM. By definition, we have:
Qtot = Qh + CaVa + CvVv . (D.17)
Applying the linear operator 〈•〉0 to (D.17) yields:
Qtot0 = Qtot = Qh0 + CaVa0 + CvVv0 . (D.18)
since Qtot is constant.
The right-hand side of (D.18) is, by definition, the total charge in the index-0 cycle-averaged model. Thus:
Qtot = Qtot0 . (D.19)
D.3 Higher-Order Approximations for the Cycle-Averages
We present expressions for the index-0 cycle-averaged model in which the index-0, index-1, and index-2
cycle-averages are not assumed to be negligible. We only derive these expressions for the index-0 and
index-1 cycle-averages of the product of two signals x(t) and y(t). The extension of the results to three
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signals proceeds in complete analogy.
A useful expression for index-k averages that allows simplification of expressions for higher-index cycle-
averages is that for any signals x(t) and y(t), the following relation holds:
X−kYk +XkY−k = 2(XRk Y
R
k +X
I
kY
I
k ) . (D.20)
If we assume that the index-2 cycle-averages are not negligible, by applying (4.33), we have that:
〈xy〉0 = X0Y0 + 2(XR1 Y R1 +XI1Y I1 ) + 2(XR2 Y R2 +XI2Y I2 ) . (D.21)
〈xy〉R1 = X0Y R1 +XR1 Y0 +XR2 Y R1 +XI2Y I1 +XR1 Y R2 +XI1Y I2 . (D.22)
〈xy〉I1 = X0Y I1 +XI1Y0 +XR2 Y I1 −XI2Y R1 +XR1 Y I2 −XI1Y R2 . (D.23)
which would require changing C(S10, SD0(t), p) and d(S10, SD0(t), S11, SD1,X1,X2, p). In simulations, we
observed that the improvement in results does not justify using such higher-order terms in the index-0
cycle-averaged model, except for Qh and Eh.
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MATLAB implementation for the SPCVM
% SPCVM.m
global T alpha beta Es Ed Ts R1 R2 Ca Cv
t0=0; tf=60; Es=2.5; Ed=0.1; T=1; Ts=T/3; alpha=0.5*T; beta=Ts;
Ca=2; Cv=100; R1=0.03; R2=0.01; tstep=0.02;
x0=[127.383 91.2281 15.0337];
options = odeset(’MaxStep’,tstep);
[t,x]=ode45(@getSPCVM,t0:tstep:tf, x0, options);
Qh=x(:,1); Va=x(:,2); Vv=x(:,3);
time=t’;
for m=1:length(time)
ttemp=mod(time(m),T);%(time(m)-floor(time(m)))/T;
if ttemp<=(T/3)
E(m)=((Es-Ed)*ttemp)/Ts+Ed;
end
if (ttemp>(T/3))&(ttemp<=(T/2))
E(m)=(1/(T/6))*(Ed-Es)*ttemp+3*Es-2*Ed;
end
if ttemp>(T/2)
E(m)=Ed;
end
end
Vh=Qh’.*E;
function dx=getSPCVM(t,x)
ttemp=mod(t,T);
if ttemp<=(T/3)
E=((Es-Ed)*ttemp)/Ts+Ed;
end if (ttemp>(T/3))&(ttemp<=(T/2))
E=(1/(T/6))*(Ed-Es)*ttemp+3*Es-2*Ed;
end if ttemp>(T/2)
E=Ed;
end
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if ttemp<alpha
q1=0;
else
q1=1;
end
if ttemp<beta
q2=1;
else
q2=0;
end
if ((x(1)*E)>=x(2))&(q2==1)
qd=1;
else
qd=0;
end
if t>=15
R3=2;
if t>=30
R3=1;
if t>=45
R3=0.5;
end
end
else
R3=1;
end
dx1=(-(q1/R1) - (qd/R2))*E*x(1) + (qd/R2)*x(2) + (q1/R1)*x(3) ;
dx2=(qd*E/(Ca*R2))*x(1) + (-1/(Ca*R3)-qd/(Ca*R2))*x(2)+...
(1/(Ca*R3))*x(3) ;
dx3=(q1*E/(Cv*R1))*x(1) + (1/(Cv*R3))*x(2) +...
(-q1/(Cv*R1)-1/(Cv*R3))*x(3) ;
dx=[dx1;dx2;dx3];
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MATLAB implementation for the index-0 CAM
% index0CAM.m
global T alpha beta Es Ed Ts R1 R2 Ca Cv
t0=0; tf=60; Es=2.5; Ed=0.1; T=1; Ts=T/3; alpha=0.5*T; beta=Ts;
Ca=2; Cv=100; R1=0.03; R2=0.01; tstep=1;
% initial conditions
x0=[127.383 91.2281 15.0337];
options = odeset(’MaxStep’,tstep);
[t,x]=ode45(@getindex0CAM, t0:tstep:tf, x0, options);
Qh_mfavg0=x(:,1); Va_mfavg0=x(:,2); Vv_mfavg0=x(:,3);
time=t’;
E_0=0.700120374; E_1R=-0.09133141072612; E_1I=-0.47387465212172;
E_2R=-0.2052; E_2I=0.1185;
Qh_1R = 18.68684392876221; Qh_1I = 10.71078134657849; Qh_2R =2.0333;
Qh_2I =-2.5241;
% Calculate the correct form of <Vh> :
Vh_mfavg0=Qh_mfavg0*E_0 + 2*Qh_1R*E_1R + 2*Qh_1I*E_1I + 2*Qh_2R*E_2R
+ 2*Qh_2I*E_2I;
function dx=getindex0CAM(t,x)
if t>=15
R3=1.4;
if t>=30
R3=1;
if t>=45
R3=0.6;
end
end
else
R3=1;
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end
q1_avg=(alpha); q1_1R=-9.999999999841267e-5;
q1_1I=-(1/(2*pi))*(cos(2*pi*q1_avg)-1);
E_0=0.700120374; E_1R=-0.09133141072612; E_1I=-0.47387465212172;
E_2R=-0.2052; E_2I=0.1185;
Qh_1R = 18.68684392876221; Qh_1I = 10.71078134657849; Qh_2R =2.0333;
Qh_2I =-2.5241;
Vh_1R=2.95889924835524; Vh_1I=-27.81509469786276;
Vv_1R=-0.0866; Vv_1I=-0.0333;
Va_1R= -4.95043425370244; Va_1I= -3.62999310428362;
td=(T*Ed/(3*(Es-Ed)))*((x(2)/x(3))-1); qd_avg=beta-td/T;
qd_1I=-(1/(2*pi))*(cos(2*pi*(beta-0.2557))-cos(2*pi*beta));
qd_1R=(1/(2*pi))*(sin(2*pi*beta)-sin(2*pi*(beta-0.2557)));
a11= (-(q1_avg/R1) - (qd_avg/R2))*E_0 - 2*qd_1R*E_1R/R2 -
2*qd_1I*E_1I/R2 - 2*q1_1R*E_1R/R1 - 2*q1_1I*E_1I/R1;
a12=qd_avg/(R2); a13= (q1_avg/R1);
b1= (2*Qh_1R*E_1R + 2*Qh_1I*E_1I + 2*Qh_2R*E_2R +...
2*Qh_2I*E_2I)*(-(q1_avg/R1) - (qd_avg/R2)) - 2*qd_1R*E_0*Qh_1R/R2...
- 2*qd_1I*E_0*Qh_1I/R2 - 2*q1_1R*E_0*Qh_1R/R1...
-2*q1_1I*E_0*Qh_1I/R1 + (2*qd_1R*Va_1R + 2*qd_1I*Va_1I)/R2...
+(2*q1_1R*Vv_1R + 2*q1_1I*Vv_1I)/R1 -2*((q1_1R/R1)+...
(qd_1R/R2))*(Qh_2R*E_1R+Qh_2I*E_1I+Qh_1R*E_2R+Qh_1I*E_2I)...
-2*((q1_1I/R1) + (qd_1I/R2))*(Qh_2R*E_1I - Qh_2I*E_1R +...
Qh_1R*E_2I - Qh_1I*E_2R);
dx1=a11*x(1) + a12*x(2) + a13*x(3) + b1 -195.813036461240;
a21= (qd_avg/(Ca*R2))*E_0 + 2*qd_1R*E_1R/(Ca*R2) +...
2*qd_1I*E_1I/(Ca*R2); a22= (-1/(Ca*R3)-qd_avg/(Ca*R2));
a23=(1/(Ca*R3));
b2= (qd_avg/(Ca*R2))*(2*Qh_1R*E_1R + 2*Qh_1I*E_1I... +
2*Qh_2R*E_2R+ 2*Qh_2I*E_2I) + 2*qd_1R*E_0*Qh_1R/(Ca*R2) +...
2*qd_1I*E_0*Qh_1I/(Ca*R2)- (2*qd_1R*Va_1R...
+2*qd_1I*Va_1I)/(Ca*R2)...
+2*(qd_1R/(Ca*R2))*(Qh_2R*E_1R+Qh_2I*E_1I+Qh_1R*E_2R+Qh_1I*E_2I)...
+ 2*(qd_1I/(Ca*R2))*(Qh_2R*E_1I - Qh_2I*E_1R + Qh_1R*E_2I -...
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Qh_1I*E_2R);
dx2=a21*x(1) + a22*x(2) + a23*x(3) + b2 + 73.741741338509;
a31=(q1_avg/(Cv*R1))*E_0 + (2*q1_1R*E_1R + 2*q1_1I*E_1I)/(Cv*R1) ;
a32=(1/(Cv*R3)); a33=(-q1_avg/(Cv*R1)-1/(Cv*R3));
b3=(q1_avg/(Cv*R1))*(2*Qh_1R*E_1R + 2*Qh_1I*E_1I + 2*Qh_2R*E_2R...
+ 2*Qh_2I*E_2I) + 2*q1_1R*E_0*Qh_1R/(Cv*R1) +...
2*q1_1I*E_0*Qh_1I/(Cv*R1)- (2*q1_1R*Vv_1R...
+2*q1_1I*Vv_1I)/(Cv*R1)+...
2*(q1_1R/(Cv*R1))*(Qh_2R*E_1R+Qh_2I*E_1I+Qh_1R*E_2R+Qh_1I*E_2I)...
+2*(q1_1I/(Cv*R1))*(Qh_2R*E_1I - Qh_2I*E_1R + Qh_1R*E_2I...
-Qh_1I*E_2R);
dx3=a31*x(1) + a32*x(2) + a33*x(3) + b3+ 0.483295537842;
dx=[dx1;dx2;dx3];
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